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Neurogenesis persists in the forebrain subventricular zone (SVZ) where 
neural stem cells (NSCs) reside in a specific niche. Stroke stimulates SVZ NSCs, 
which offer reparative potential, but few new neurons survive long-term.  Thus, 
the capacity for self-repair appears insufficient.  This thesis focuses on NSC 
modulation by endothelial cells within the niche, and stroke or inflammation, with 
the goals of understanding how injury influences neurogenesis and whether 
stimulating injury-induced neurogenesis improves functional recovery. 
Evaluation of the components of injury may improve our understanding of 
how it modulates SVZ neurogenesis.  We examined the influence of in vivo 
exposure to hypoxia or inflammation, or both, on SVZ NSCs using the 
neurosphere (NS) assay.  Mice exposed to acute hypoxia or systemic 
inflammation produced significantly more NS, neurons and oligodendrocytes. 
The combined insults, however, significantly reduced neurogenesis.  This effect 
may be mediated by IL-1β as IL-1β deficient mice generated fewer NS and 
neurons. 
NSCs reside in a vascular niche composed of glia and endothelial cells.  
Angiogenesis and neurogenesis interact in neurogenic regions stimulated by 
stroke. We hypothesized that factors secreted by intact or oxygen-glucose 
deprived (OGD) endothelial cells enhance SVZ neurogenesis.  We found that 
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SVZ NS exposed to endothelial cell co-culture or endothelial cell 
conditioned media (ECCM) increased in numbers and generated neurons and 
glia that appeared more immature. NS exposure to OGD-ECCM, in contrast, 
stimulated neuronal maturation and migration.  These data suggest that intact 
and injured endothelial cells secrete factors that differentially influence SVZ 
NSCs, and offer potential targets to stimulate NSC expansion and integration of 
new neurons after brain injury. 
We also hypothesized that augmenting stroke-induced neurogenesis 
would enhance functional recovery.  We exposed rats to retinoic acid (RA) and 
environmental enrichment (EE), to promote SVZ neurogenesis and post-stroke 
recovery. RA-treatment preserved striatal and hemispheric tissue, and combined 
RA/EE treatment increased SVZ cell proliferation and neurogenesis. These 
interventions did not improve behavioral recovery. Together, these studies 
underscore the complexity of how the stem cell niche and injury influence 
postnatal SVZ neurogenesis.  Future work should target factors from endothelial 
cells, hypoxia and inflammation to promote neurogenesis and enhance the 








Scientists once believed that the adult brain was not capable of 
regeneration; that we were born with a set number of neurons and when these 
neurons died, they were not replaced.  In the late 1960’s, however, Altman and 
Das labeled mitotic cells with tritiated thymidine and discovered that these cells 
produced new neurons in the adult rodent olfactory bulb and dentate gyrus of the 
hippocampus (Altman, 1969, Altman and Das, 1965, Altman and Das, 1966).  
The process of forming new neurons is called neurogenesis and these 
proliferating cells are often referred to as neural stem cells (NSCs).  Advances in 
technology such as the advent of the thymidine analog bromodeoxyuridine 
(BrdU) and retroviral labeling, allowed scientists to more easily identify and study 
these cells.  These advances led to the discovery of proliferative populations of 
cells in the central nervous system of every mammalian species studied to date, 
including humans, as well as many non-mammalian vertebrates (Alvarez-Buylla, 
1992, Bedard and Parent, 2004, Eriksson, et al., 1998, Gould, et al., 1999, 
Kornack and Rakic, 1999, Lois and Alvarez-Buylla, 1993, Pencea, et al., 2001).  
The existence of these neurogenic regions offers potential for the brain to repair 
itself and provides a target for developing therapeutic strategies.
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Important treatment strategies for the future may include enhancing proliferation, 
migration, differentiation and survival of this population of cells.  Thus, the scope 
of this thesis focuses on factors that regulate neurogenesis in the postnatal and 
adult brain, especially after injury, and that may promote brain repair.  
The rodent forebrain contains two proliferative or neurogenic regions that 
persist throughout life, the subventricular zone (SVZ) and the hippocampal 
dentate gyrus (Figure 1.1A-C).  The work encompassed by this dissertation 
focuses on the forebrain SVZ neurogenic region. The SVZ lies along the lateral 
ventricle and gives rise to olfactory bulb interneurons while the dentate gyrus 
produces granule cell layer neurons (Figure 1.1A-C; Reviewed in (Lichtenwalner 
and Parent, 2006). The SVZ contains three types of cells, named type A cells, 
type B cells and type C cells (Doetsch, et al., 1997), all of which are mitotic 
(Figure 1.2).  Type B cells are the putative neural stem cells which comprise 
approximately 23% of the SVZ and are typically identified by expression of glial-
fibrillary acidic protein (GFAP), vimentin or nestin (Figure 1.2).  These self-
renewing cells are relatively quiescent in the normal postnatal/adult brain.  Type 
B cells also give rise to type C cells, known as transit-amplifying cells.  Type C 
cells typically express nestin or the transcription factor Dlx2, are the most actively 
dividing cells of the SVZ and make up about 11% of the SVZ cell population 
(Figure 1.2).  Type C cells give rise to Type A cells, which are neuroblasts 
(Doetsch, et al., 1997, Morshead, et al., 1994) and which account for about 33% 
of the SVZ cells.  Type A cells are migratory and typically express doublecortin 
(DCx), poly-sialylated neural cell adhesion molecule (PSA-NCAM), and class III 
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β-tubulin (TUJ1) [Figure 1.2; (Doetsch, et al., 1997, Doetsch, et al., 2002)].  
These cells also express nestin and Dlx2 but are typically identified with one of 
the immature neuronal markers mentioned above.  Type A cells are generated in 
the SVZ, then migrate tangentially inside astrocytic tubes through the rostral 
migratory stream (RMS) to the olfactory bulb, where they migrate radially and 
differentiate into granule and periglomerular interneurons (Figure 1.1A).      
 
Integration of Adult-Born Neurons 
Evidence exists for integration of new born neurons in the uninjured adult 
brain, but the exact function of these new neurons is still under investigation.  In 
the uninjured brain, new dentate gyrus neurons appear to integrate, as they 
initially receive GABA-mediated synaptic input, send projections to the 
hippocampal CA3 area and display mature electrophysiological properties 
(Carlen, et al., 2002, Hastings and Gould, 1999, Markakis and Gage, 1999, 
Song, et al., 2002, Stanfield and Trice, 1988, van Praag, et al., 2002, Wang, et 
al., 2000).  Given the role of the hippocampus in learning and memory, it is likely 
that these cells contribute to some aspect of learning and memory formation.  
Current studies are investigating this hypothesis and early studies suggest that 
ablation of these new neurons disrupts some forms of memory (Lemaire, et al., 
1999, Leuner, et al., 2004, Shors, et al., 2001).  Newborn olfactory bulb 
interneurons also appear to become functional in the uninjured adult brain.  
These granular and periglomerular neurons survive long-term, extend dendrites 
into other olfactory bulb layers,  receive GABAergic synapses followed by 
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glutamatergic input, and display mature electrophysiological properties (Belluzzi, 
et al., 2003, Carlen, et al., 2002, Carleton, et al., 2003, Petreanu and Alvarez-
Buylla, 2002, Winner, et al., 2002).  Neurons in the olfactory bulb may function in 
olfactory memory and odor discrimination and evidence suggests that new 
olfactory bulb neurons integrate in these circuits {Rochefort, 2002 #217; Gheusi, 
2000 #216; Petreanu, 2002 #215; Carlen, 2002 #213}.   
 
Regulation of the Postnatal/Adult SVZ-Olfactory Bulb Pathway 
 Neurogenesis in the postnatal/adult SVZ-olfactory bulb pathway is 
regulated by numerous factors.  These factors affect various stages of 
neurogenesis, including proliferation, migration, and differentiation.  Some factors 
influence more than one step in this process.  SVZ proliferation increases both in 
vivo and in vitro in response to epidermal growth factor (EGF) in both rats and 
mice (Craig, et al., 1996, Kuhn, et al., 1997, Reynolds, et al., 1992).  SVZ 
proliferation is increased by a number of other growth factors as well, including 
fibroblast growth factor-2 (FGF2), brain derived neurotrophic factor (BDNF), 
heparin-binding epidermal growth factor (HB-EGF), and vascular endothelial 
growth factor (VEGF; (Jin, et al., 2002, Jin, et al., 2003, Kuhn, et al., 1997, 
Pencea, et al., 2001, Rossi, et al., 2006, Zigova, et al., 1998).  Cytokines also 
regulate SVZ proliferation.  Transforming growth factor- α (TGF-α) and ciliary 
neurotrophic factor (CNTF) promote SVZ proliferation (Craig, et al., 1996, Emsley 
and Hagg, 2003, Tropepe, et al., 1997). Other factors such as hormones and 
morphogenic factors may also influence SVZ proliferation.  Noggin and prolactin 
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increase SVZ proliferation while bone morphogenetic proteins (BMPs) decrease 
it (Lim, et al., 2000, Shingo, et al., 2003).   
Progenitor cell migration to the olfactory bulb occurs via a gradient of 
signals providing both attractive and repulsive cues.  Receptors in the ephrin 
family, EphB1-3 and EphA4, are expressed in the SVZ and endogenous 
administration of EphB2 or ephrin-B2 disrupts SVZ NSC migration to the 
olfactory bulb (Conover, et al., 2000, Holmberg, et al., 2005).  The neuregulins 
and selected integrins also provide guidance cues for chain migration of 
progenitors to the olfactory bulb (Anton, et al., 1997, Jacques, et al., 1998), 
whereas Slit-1 and Slit-2 provide repulsive cues to maintain these cells within the 
RMS during migration (Hu, 2001, Mason, et al., 2001, Nguyen-Ba-Charvet, et al., 
2004, Nguyen Ba-Charvet, et al., 2001, Wu, et al., 1999).  Another regulator of 
migration in the SVZ-olfactory bulb pathway is PTEN, which negatively regulates 
migration (Li, et al., 2002), while administration of erythropoietin enhances 
migration (Wang, et al., 2008, Wang, et al., 2004).  Finally, factors such as reelin 
and tenascin-R regulate migration of SVZ neuroblasts once they reach the 
olfactory bulb (Hack, et al., 2002, Saghatelyan, et al., 2004).   
 The factors that regulate proliferation in the SVZ-olfactory bulb pathway 
are often involved in differentiation as well.  For example, FGF promotes 
neurogenesis and increases neuron production in the olfactory bulb while EGF 
directs SVZ-derived cells towards an astrocytic fate (Jin, et al., 2003, Jin, et al., 
2003, Kuhn, et al., 1997).  Other growth factors such as BDNF and HB-EGF also 
increase neurogenesis in the olfactory bulb while VEGF promotes SVZ-derived 
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neuron survival (Ahmed, et al., 1995, Jin, et al., 2002, Jin, et al., 2004, Jin, et al., 
2003, Jin, et al., 2002, Kirschenbaum and Goldman, 1995, Zigova, et al., 1998).  
Finally, noggin and prolactin also increase neuronal differentiation while BMPs 
decrease it (Lim, et al., 2000, Shingo, et al., 2003).  
 
Retinoic Acid 
Neonatal and adult neurogenesis are regulated by developmental signals 
that persist in the brain.  One of these factors is retinoic acid (RA), a vitamin A 
derivative that regulates many processes in central nervous system 
development.  It plays an essential role in anteroposterior patterning of the 
hindbrain and spinal cord (Liu, et al., 2001, Maden, 2002, Melton, et al., 2004), 
dorsoventral patterning of spinal cord neurons (Diez del Corral, et al., 2003, 
Novitch, et al., 2003, Wilson and Maden, 2005) and striatal neuron differentiation 
(Toresson, et al., 1999, Valdenaire, et al., 1998).  RA expression and signaling 
continues in the postnatal and adult brain.  Retinoid binding proteins are 
expressed in the olfactory bulb and SVZ (Zetterstrom, et al., 1999, Zetterstrom, 
et al., 1994), RA receptors persist in the olfactory bulb (Krezel, et al., 1999), and 
the RA synthesizing enzyme RALDH3 is present in the olfactory bulb, rostral 
migratory stream (RMS), and SVZ (Wagner, et al., 2002).  Recently our 
laboratory demonstrated that retinoid signaling enhances proliferation in the 
neonatal mouse SVZ and RMS, directs SVZ-derived NSC migration to the 
olfactory bulb, and increases the numbers of SVZ-derived neurons (Wang, et al., 
2005).  These effects are blocked by inhibiting RA-signaling in postnatal SVZ 
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neurospheres and SVZ-OB slices.   Further, recent studies provide evidence for 
RA influences on the adult brain.  RA-signaling continues in the adult SVZ and 
olfactory bulb, where it influences subtypes of olfactory bulb neurons and SVZ 
neural precursors (Hagglund, et al., 2006, Haskell and LaMantia, 2005). Oral 
retinoid administration increases adult rat SVZ proliferation (Giardino, et al., 
2000), and depletion of RA in adult mice decreases dentate granule cell 
differentiation (Jacobs, et al., 2006).   
 
Environmental Enrichment 
 Adult neurogenesis is also influence by environmental or behavioral 
interventions.  Environmental enrichment (EE) is a commonly used behavioral 
intervention for rodents and primates after brain injury that provides complex 
sensorimotor experiences to promote recovery.  Many studies demonstrate 
improved motor and cognitive function after EE treatment (Dahlqvist, et al., 1999, 
Gobbo and O'Mara, 2004, Komitova, et al., 2002, Ohlsson and Johansson, 
1995).  The timing of EE or related interventions after injury is one factor that 
determines whether it provides beneficial or deleterious effects on recovery or 
secondary neural degeneration (Bland, et al., 2001, Kleim, et al., 2003, Schallert, 
et al., 2000, Tillerson, et al., 2001).  Improvements in function after EE may relate 
to effects on neurogenesis as studies show that it increases dentate gyrus 
neurogenesis by enhancing survival of newly differentiated neurons 
(Kempermann, et al., 1998, Kempermann, et al., 1997, Komitova, et al., 2002, 
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Nilsson, et al., 1999, Wurm, et al., 2007); however, few studies have examined 
the effects of EE on striatal neurogenesis.   
 
Vascular Niche: Uninjured Brain 
Given that neural stem cells with in vivo neurogenic potential are housed 
in two distinct locations in the brain, rather than throughout the brain, the 
microenvironment of these cells likely plays a critical role in their maintenance.  
Influences may be exerted on NSCs through other cell types present in the niche, 
via direct cell-cell contact or secreted factors.  It has long been noted that the lay-
out of blood vessels and neurons follows similar branching patterns (Carmeliet 
and Tessier-Lavigne, 2005, Vesalius, 1543) and reciprocal interactions are seen 
during development. Factors produced by blood vessels provide axonal guidance 
for neurons while nerves produce signals such as vascular-endothelial growth 
factor (VEGF) that guide blood vessels (Honma, et al., 2002, Kuruvilla, et al., 
2004, Mukouyama, et al., 2002).  Neurons and blood vessels also respond to the 
same guidance cues, such as the neuropilins and ephrins (Adams, et al., 1999, 
Soker, et al., 1998, Wang, et al., 1998).  Evidence suggests that factors made by 
blood vessels may influence other nearby cell types via cell contact or at a 
distance (Lichtenwalner and Parent, 2006, Ohab and Carmichael, 2007, 
Riquelme, et al., 2008, Zhang, et al., 2005).  Research on the neurovascular unit, 
the interaction between vessels, astrocytes and neurons, suggests that these cell 
types interact to maintain a homeostatic microenvironment and regulate normal 
central nervous system functioning (Abbott, et al., 2006, Takahashi and 
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Macdonald, 2004).  The neural stem cells of the SVZ are maintained in a stem 
cell niche containing glial and vascular elements, including astrocytes and 
endothelial cells.  Thus, it is likely that astrocytes, endothelial cells, or both 
interact with NSCs in their microenvironment to regulate the stem cell state.     
 
Astrocyte Influence on SVZ Neural Stem Cells   
 The location of astrocytes within the neurogenic niche makes this cell type 
a prime candidate for influencing SVZ NSCs.  Research to date suggests that 
astrocytes may influence multiple stages of neurogenesis in the normal brain.  
Radial glia or radial-glia-like astrocytes in the SVZ and dentate gyrus appear to 
be the neural stem cells that give rise to neuroblasts (Doetsch, et al., 1999, 
Garcia, et al., 2004, Merkle, et al., 2004, Seri, et al., 2001). Astrocytes also 
promote proliferation and neuronal differentiation when cultured with SVZ or 
hippocampal progenitor cells (Lim and Alvarez-Buylla, 1999, Song, et al., 2002).  
Chains of doublecortin-positive neuroblasts migrate from the SVZ thru the RMS 
surrounded by astrocytic tubes (Peretto, et al., 1997, Thomas, et al., 1996).  
Gliosis occurs after injury and the presence of astrocytes within the injury border 
suggests that they may also regulate injury-induced neurogenesis.  Newly 
formed cells localize to sites of injury that contain an increased population of 
astrocytes (Zhang, et al., 2004) that produce trophic factors, such as vascular 
endothelial growth factor (VEGF), which are known to promote SVZ cell 
proliferation and neuron survival (Jin, et al., 2003, Nedergaard, et al., 2003, 
Schanzer, et al., 2004, Sun, et al., 2003).  Gene expression profiling of 
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astrocytes from neurogenic regions cultured with adult NSCs combined with 
candidate testing identified interleukin-6 (IL-6) and IL-1β as mediators of 
neuronal differentiation promoted by astrocytes (Barkho, et al., 2006).  Thus, 
astrocytes play a role in regulating SVZ NSCs; however, they likely interact with 
other cells present in the neurogenic niche to influence NSCs in the normal and 
injured brain.   
 
Endothelial Cell Influence on SVZ Neural Stem Cells: Normal Brain 
Endothelial cells are another key player in the SVZ stem cell niche.  Evidence 
is emerging to suggest that the vasculature may influence adult NSCs.  Recently, 
Palmer et al discovered that endothelial cells are located in the proliferative 
clusters within the neurogenic dentate gyrus, that these cells also proliferate, and 
that nestin-positive NSCs were always located in close proximity to blood vessels 
and proliferating endothelial cells (Palmer, et al., 2000).  Due to the close 
physical proximity of these cells, they suggested that the vasculature may play a 
role in regulating and maintaining dentate gyrus NSCs and coined the phrase 
“vascular niche” to describe this phenomenon.  The presence of blood vessels in 
and around the SVZ and forebrain neural stem cells as well as their role in 
guiding new, radially-migrating olfactory bulb cells to their final location within the 
bulb, suggests that the vasculature may regulate SVZ NSCs as well (Bovetti, et 
al., 2007, Capela and Temple, 2002). 
Strong evidence of an endothelial cell-NSC interaction comes from work 
by Sally Temple’s group (Shen, et al., 2004). They showed that non-contact co-
11 
 
culture of embryonic mouse NSCs with endothelial cells increased NSC 
expansion and markedly stimulated neuron production upon differentiation 
compared to control (embryonic cortical neuron) co-cultures.  Another group 
examining the effects of embryonic NSCs on endothelial cells using the same 
non-contact co-culture system discovered reciprocal interactions between these 
two cell types.  They found that NSCs enhanced the blood brain barrier 
properties of endothelial cells, while endothelial cells suppressed differentiation 
of embryonic NSCs (Weidenfeller, et al., 2007).  Similarly, hippocampal NSCs 
co-cultured with endothelial cells resulted in an increase in the neural stem cell 
population during co-culture and increased neuron production upon 
differentiation after removal of endothelial cells (Guo, et al., 2008).  Other studies 
observed cross-talk between endothelial cells and neural stem cells when these 
cells were in direct contact, noting that endothelial cells migrate into embryonic 
cortical-derived neurospheres when placed directly on top of the spheres (Milner, 
2007) and a percentage of NSCs apparently transdifferentiated to endothelial 
cells after co-culture (Wurmser, et al., 2004).  Earlier studies of the adult songbird 
neurogenic region revealed mechanisms whereby endothelial cells promote 
neurogenesis as they implicated endothelial cell secretion of brain-derived 
neurotrophic factor in this effect (Louissaint, et al., 2002). Thus, endothelial cells 
in the embryonic and adult vertebrate brain appear to secrete factors that 





 The presence of neural stem cells in the forebrain offers the potential for 
brain regeneration after injury.  The neurogenic regions of the postnatal/adult 
rodent brain are influenced by a number of factors, including various brain 
injuries.  Many brain insults influence neural stem cells and may have a positive 
or negative impact on these cells, as well as varying degrees of influence 
depending on the extent of the injury.  One of the most widely-studied of these is 
ischemia-induced neurogenesis, in which the effects of transient focal or global 
ischemia on SVZ and dentate gyrus neurogenesis are evaluated.  After transient 
middle cerebral artery occlusion (tMCAO) in rodents, the population of BrdU-
positive proliferating cells increases in the SVZ and dentate gyrus, peaking 
around 7-10 days after ischemia [Figure 1.3; (Arvidsson, et al., 2002, Jin, et al., 
2001, Kee, et al., 2001, Parent, et al., 2002, Takagi, et al., 1999, Tureyen, et al., 
2004, Zhang, et al., 2001)].  This increase is primarily due to increased 
production of type A and type C cells after stroke (Chen, et al., 2004).  The SVZ 
expands with DCx-positive neuroblasts which migrate out of the SVZ in chains 
alongside astrocytes, similar to their normal migration in the RMS [Figure 1.3C-D; 
(Lois, et al., 1996, Peretto, et al., 1997)] and into the injured striatum during the 
weeks following tMCAO [Figure 1.3C-D; (Arvidsson, et al., 2002, Parent, et al., 
2002)].  These cells become striatal projection neurons and express DARPP-32 
and calbindin, typical markers for striatal medium spiny neurons (Arvidsson, et 
al., 2002, Parent, et al., 2002).  Few new neurons persist for 5 weeks after stroke 
and this percentage is low compared with the substantial increase in proliferating 
and migrating neuroblasts (Arvidsson, et al., 2002, Parent, et al., 2002), 
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suggesting that these cells do not survive long-term after stroke (Figure 1.3E-G).  
Further, there is little evidence to suggest that new neurons that do survive 
become functional and integrate into the existing circuitry.  Neurogenesis also 
increases in the dentate gyrus after tMCAO, even though this area is not directly 
affected by the stroke, resulting in new dentate granule cell layer neurons (Jin, et 
al., 2001, Liu, et al., 1998).  Similarly, cell proliferation and neurogenesis 
increase in the gerbil dentate gyrus and hippocampal pyramidal cell layer after 
global ischemia (Liu, et al., 1998, Nakatomi, et al., 2002).    
 SVZ cell proliferation also increases after stroke induced using other 
models that result in cortical but not striatal damage, as well as other forms of 
injury.  Cortical lesions produced by thermocoagulation or distal MCAO, which 
does not damage the SVZ, substantially increase SVZ cell proliferation by 7 days 
after injury (Gotts and Chesselet, 2005, Gotts and Chesselet, 2005, Ohab, et al., 
2006).  SVZ and dentate gyrus cell proliferation increase after aspiration lesion, 
traumatic brain injury and seizure as well (Chirumamilla, et al., 2002, Parent, et 
al., 1998, Parent, et al., 1997, Rice, et al., 2003, Sundholm-Peters, et al., 2005, 
Szele and Chesselet, 1996). 
 The response of the SVZ after injury is not limited to production of new 
neurons.  SVZ NSCs can differentiate into neurons, astroyctes and 
oligodendrocytes.  Thus, the increase in SVZ progenitor cells in response to 
injury is not limited to neural progenitors, as glial progenitors increase as well.  
Radial glial cells function as glial progenitors and provide a scaffold for 
neurogenesis during development but may also act as neural stem cells in the 
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adult SVZ by dividing and producing astrocytes and neurons (Doetsch, et al., 
1999, Gregg and Weiss, 2003, Merkle, et al., 2004, Weissman, et al., 2003).  
After embolic MCAO, there is an increase in the presence of radial glial cells in 
the SVZ, coinciding with SVZ expansion, and these cells appear to support 
neuron migration after injury (Zhang, et al., 2007).  The ischemic-induced 
astrogliosis that occurs within the ischemic striatum may also provide cues for 
migration of SVZ neuroblasts into the ischemic core (Ohab and Carmichael, 
2007, Zhang, et al., 2005).  Glial progenitors in the SVZ may also give rise to 
increased oligodendrocyte production after injury, but this appears to be more 
specific to demyelinating injuries rather than those in which neurons are primarily 
affected.  For example, after a demyelinating lesion in the corpus callosum, SVZ 
NSCs produce four times as many oligodendrocytes as controls (Menn, et al., 
2006).   Thus, SVZ NSCs may prove to be useful for enhancing cell replacement 
after injury in which glial cells are the primary target of damage.  
 The neonatal SVZ is susceptible to ischemic influence as well.  Hypoxia-
ischemia, a model of neonatal stroke that results in cortical, striatal, and 
hippocampal damage, increases SVZ cell proliferation and induces neuroblast 
migration into the injured striatum of rats and mice, similar to tMCAO in the adult 
rat (Felling, et al., 2006, Ong, et al., 2005, Plane, et al., 2004, Romanko, et al., 
2004, Yang and Levison, 2006).  Very few newly generated neurons survive for 
up to 3 weeks after hypoxia-ischemia, in contrast to tMCAO-induced 
neurogenesis in the adult, where newly generated neurons are present in the 
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injured striatum several weeks after injury (Arvidsson, et al., 2002, Parent, et al., 
2002, Plane, et al., 2004).   
Increased SVZ cell proliferation after hypoxic-ischemic injury is not due 
solely to an increase in neural progenitors but also to an increase in glial 
progenitors as well.  SVZ cells in the neonatal rodent brain give rise to cortical 
and striatal astrocytes as well as oligodendrocytes in the corpus callosum 
(Levison and Goldman, 1993).  After hypoxia-ischemia, many newly formed 
oligodendrocytes are present within the infarct core 4 weeks after injury (Zaidi, et 
al., 2004), suggesting that injury stimulates oligodendrogliogenesis.  More severe 
hypoxic-ischemic insult leads to increased apopotosis of SVZ oligodendrocyte 
progenitors with subsequent white matter dysmyelination (Levison, et al., 2001, 
Romanko, et al., 2004).   
Hypoxia is one component of brain damage due to stroke, and thus may 
also influence neurogenesis.  Interestingly, a short duration of hypoxia alone is 
sufficient to increase SVZ cell proliferation in the neonatal mouse forebrain but 
not in the rat (Ong, et al., 2005, Plane, et al., 2004).  Chronic perinatal hypoxia 
also increases SVZ cell proliferation and cortical neurogenesis (Fagel, et al., 
2006).  Several studies examined the effects of in vitro hypoxia on embryonic 
stem cells and found that culturing embryonic or mesencephalic stem cells in 
lowered oxygen enhanced proliferation, survival, and dopaminergic differentiation 
(Morrison, et al., 2000, Storch, et al., 2001, Studer, et al., 2000).     
 
Endothelial Cell Influence on SVZ Neural Stem Cells: Injured Brain 
16 
 
Stroke increases angiogenesis in the ischemic area (endothelial cell 
proliferation for formation of new blood vessels) and SVZ neurogenesis, but 
whether endothelial cells play a role in stroke-induced neurogenesis is unknown.  
The increased presence of blood vessels, proliferating endothelial cells and 
neuroblasts in the SVZ 5 days after stroke, as well as the correlation between 
increased blood vessel number and neuroblast number after stroke, suggests 
that endothelial cells may modulate stroke-induced neurogenesis (Gotts and 
Chesselet, 2005, Gotts and Chesselet, 2005).  Endothelial cells also appear to 
promote neuroblast migration to the peri-infarct cortex after cortical injury 
produced by distal MCAO (Ohab, et al., 2006).  The vasculature may also play a 
role in neuron survival after stroke, as one study found that neurons close to 
blood vessels were more apt to survive after focal ischemia, whereas those 
furthest from vessels were most affected by stroke (Mabuchi, et al., 2005). 
Further evidence for the regulation of stem cells by the vasculature comes 
from research on brain tumor cells.  Malignant brain tumor cells, some of which 
act stem cell-like in showing multipotency and the ability to self-renew (Al-Hajj, et 
al., 2003, Lapidot, et al., 1994, Singh, et al., 2004), are typically located next to 
capillaries in brain tumors (Calabrese, et al., 2007).  Co-culture of these cancer 
stem cells with endothelial cells maintains the cancer stem cells in a self-
renewing and undifferentiated state (Calabrese, et al., 2007).  Together, these 
studies indicate that endothelial cells exert influences on neural stem cells after 
injury or in other pathologic states.  Thus, increasing the endothelial cell 
population, i.e. promoting angiogenesis, or administering endothelial-derived 
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factors may be a useful tool for promoting neurogenesis and brain repair after 
stroke or other types of brain injury.  
 
Inflammation 
Inflammation is “the response of tissue to injury or irritation that is 
characterized by pain, swelling, redness and heat”  (Dantzer, et al., 2008).  It is 
the immune system’s primary response to injury or infection and is characterized 
by changes in local blood vessels and infiltration of leukocytes (Larsen and 
Henson, 1983).  The inflammatory cascade is initiated soon after insult.   
Leukocyte migration and microglial activation occurs within a few hours as these 
cells migrate to the affected area; upregulated cytokines such as interleuikin-1 
(IL-1), IL-6, and tumor necrosis factor-alpha (TNFα) trigger the progression of the 
inflammatory cascade (Davies, et al., 1998, Rothwell and Hopkins, 1995, 
Schroeter, et al., 1994, Zheng and Yenari, 2004).  These cytokines induce 
expression of adhesion molecules such as intercellular adhesion molecule-1, 
selectins and integrins on the surface of endothelial cells, increasing their 
permeability and allowing infiltration of cells and molecules as the blood-brain 
barrier breaks down (del Zoppo, et al., 2000, Dimitrijevic, et al., 2006, Gong, et 
al., 1998, Lindsberg, et al., 1996, Ritter, et al., 2000, Stamatovic, et al., 2005, 
Yamasaki, et al., 1995, Zhang, et al., 1998).  Inflammation accompanies most 
types of injury and may exert beneficial or harmful effects directly on the brain as 
well.   
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Given that brain injury both stimulates neurogenesis and induces 
inflammation, inflammatory mediators are prime candidates for influencing NSCs 
and neurogenesis. However, the effects of inflammation on neurogenesis are not 
clear, as evidence exists for both increased and decreased neurogenesis due to 
inflammation, as well as maintenance of neural progenitors in an undifferentiated 
state during CNS inflammation (Pluchino, et al., 2005).  Neural stem cells from 
humans and rodents express the inflammatory cytokines IL-1β, IL-6, TNF-α and 
transforming growth factor-β1 (TGF-β1) or receptors for TNF-α, IL-1β and 
interferon-gamma (IFNγ) (Ben-Hur, et al., 2003, Cacci, et al., 2005, Klassen, et 
al., 2003, Wang, et al., 2007).  Pro-inflammatory cytokines such as TNFα and 
IFNγ differentially influence various aspects of neurogenesis depending on the 
age of the animals, locations examined and assays used for evaluation.  Ben-Hur 
et al cultured neural progenitors from newborn rat as striatal spheres and found 
that these cells express receptors for TNFα and IFNγ but not IL-1 (Ben-Hur, et 
al., 2003).  They applied either TNFα or IFNγ to spheres for 48 hours and then 
evaluated proliferation, migration, cell phenotype and cell death.  They observed 
dose-dependent decreases in proliferation after treatment with TNFα and IFNγ 
alone or together, as well as a dose-dependent increase in cell death after IFNγ 
alone or with TNFα but not with TNFα alone (Ben-Hur, et al., 2003).  Further, 
they showed increased migration after exposure to either of these cytokines 
alone or in combination but no difference on cell phenotype (Ben-Hur, et al., 
2003).   
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Studies were also performed to evaluate the effects of cytokines on the 
adult rat neurogenic regions.  One study found that infusion of TNFα into the 
lateral ventricle of the adult rat increased SVZ cell proliferation for the first 24 
hours after infusion.  Proliferation returned to baseline by 48 hours after TNFα 
infusion and no corresponding alterations in cell death were seen (Wu, et al., 
2000).  Other in vivo studies evaluating the effects of TNFα on striatal and 
hippocampal neurogenesis found this cytokine to have detrimental effects on 
neurogenesis.  After stroke induced by MCAO, infusion of TNFα into the lateral 
ventricle of adult rats resulted in a decrease in the number of neuroblasts in the 
striatum and dentate gyrus two weeks after stroke (Heldmann, et al., 2005).  
Monje et al cultured hippocampal precursors and differentiated them in the 
presence of TNFα, IFNγ, IL-6 or IL-1β and found a 50% decrease in 
neurogenesis with TNFα or IL-6 but no significant changes after exposure to IL-
1β or IFNγ (Monje, et al., 2003).  The variability in results from these studies 
makes it difficult to predict the net in vivo effects of these pro-inflammatory 
cytokines on neurogenesis during inflammatory insults.    
Lipopolysaccharide (LPS) is a cell-wall component of gram-negative 
bacteria that is used experimentally to induce systemic inflammation.  LPS binds 
to toll-like receptor-4 (TLR-4) and initiates a signaling cascade that activates 
transcription factors and results in the production of pro-inflammatory cytokines 
including TNF-α and IL-1β.  LPS administration prior to ischemia (as 
preconditioning) results in a neuroprotective effect (Bordet, et al., 2000, 
Heemann, et al., 2000, Kariko, et al., 2004, Tasaki, et al., 1997) and establishes 
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tolerance to a subsequent LPS challenge (Cavaillon, et al., 2003, Fan and Cook, 
2004, Fan, et al., 2004).  LPS administration after hypoxia-ischemia produces the 
opposite effect; after neonatal hypoxia-ischemia, LPS infusion increases 
hemispheric damage and stunts post-ischemic SVZ cell proliferation (Barks, et 
al., 2008).   LPS administration also reduces hippocampal neurogenesis in the 
adult rodent, and when combined with partial status epilepticus, it reduces the 
injury-induced neurogenic response in the dentate gyrus (Ekdahl, et al., 2003).  
These studies suggest that post-insult inflammation may be detrimental to injury-
induced neurogenesis.   
 
Integration and Recovery After Injury 
As described above, there is an abundance of evidence demonstrating 
that injury increases neurogenesis in the forebrain SVZ and dentate gyrus of the 
hippocampus.  Unfortunately, however, there is little evidence to support 
integration and function of newly generated neurons after stroke or their 
involvement in functional recovery.  One study demonstrated that selective cell 
death in cortical layer IV prompted neurogenesis specific to this area; the newly 
formed neurons exhibited pyramidal morphology and a small percentage of these 
cells formed long-distance corticothalamic connections (Magavi, et al., 2000).  
After MCAO, some newly generated striatal neurons express markers of mature 
medium-spiny neurons and form somatodendritic connections with nearby 
neurons (Arvidsson, et al., 2002, Jin, et al., 2003, Parent, et al., 2002, 
Yamashita, et al., 2006, Zhang, et al., 2004).  While these studies provided 
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evidence to support the claims that newly formed neurons become mature and 
begin to display characteristics of integration, no study has yet to provide clear 
evidence for integration and long-distance connection of newly generated striatal 
neurons after stroke.  Previous studies in our laboratory attempted to identify 
long-distance connections from newly generated striatal neurons after stroke 
using retrograde tracer labeling of FluoroGold and BrdU (Lichtenwalner and 
Parent, 2006).  FluoroGold injections into one target of striatal projection 
neurons, the substantia nigra pars reticulata, revealed the presence of striatal 
medium spiny neurons adjacent to BrdU-labeled striatal cells, however, no 
double-labeling was found (Lichtenwalner and Parent, 2006).  Thus, none of the 
stroke-generated neurons in this study formed long-distance connections with the 
targeted region.   
Although there is little evidence to suggest that stroke-generated neurons 
integrate and provide functional contributions, there is a large body of evidence 
suggesting an indirect link of stroke-induced neurogenesis with functional 
recovery.  For example, stroke animals treated with growth factors such as 
epidermal growth factor (EGF), brain-derived neurotrophic factor (BDNF), or 
vascular endothelial growth factor (VEGF) showed increased stroke-induced 
neurogenesis as well as improvements in functional recovery (Andsberg, et al., 
2002, Jin, et al., 2004, Sun, et al., 2003, Zhang, et al., 2000, Zhu, et al., 2003).  
Other factors, such as cytokines and neurotransmitters, also appear to influence 
both neurogenesis and functional recovery after stroke. Administration of 
erythropoietin after MCAO results in increased SVZ neurogenesis and 
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improvements in functional recovery (Wang, et al., 2004).  Mice deficient in 
endothelial nitric oxide synthase (eNOS) display reduced neurogenesis and 
poorer function after stroke (Chen, et al., 2005). 
Together, these findings suggest that the brain’s ability to repair itself may 
be incomplete without the aid of exogenous factors to support cell survival and 
integration and thus promote the formation of long-distance connections.  
Furthermore, it is unclear whether the addition of new neurons into existing 
networks is beneficial and whether or not neurogenesis actually contributes to 
functional recovery.  Determining the functional role of new neurons in both the 
normal and injured brain will provide important clues as to the capability of these 
cells and may also provide insight as to how to increase their capacities after 
injury.  Future studies to determine if neurogenesis is necessary for functional 
improvement should evaluate whether augmenting neurogenesis increases 
recovery or blocking neurogenesis corresponds with decreased functional 
recovery.  Studies using irradiation or directed ablation of endogenous 
precursors or stroke-generated neurons may provide insight as to their functions 
in the normal and stroke-injured brain.  
  
Focal Ischemic Injury Models 
Stroke is one of the most common causes of death in the United States as 
approximately 780,000 people suffer a stroke and about 150,000 people die from 
stroke every year (American Heart Association; 
www.americanheart.org/statistics).  Someone in the U.S. has a stroke about 
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every 40 seconds and most survive their first stroke, making it one of the most 
debilitating diseases in the U.S. (AHA online).  It is estimated that stroke will cost 
the U.S. about $65.5 billion this year, due to long-term care and rehabilitation 
needed from this disease (AHA online).  There are three basic kinds of stroke, 
including ischemic, intracerebral hemorrhage, and subarachnoid hemorrhage.  
Ischemic stroke is the most common, accounting for 87% of all strokes, while 
only 10% are intracerebral hemorrhages, and 3% are subarachnoid hemorrhages 
(AHA online).  A number of animal models exist to study the effects of focal or 
global ischemic injury on the postnatal and adult brain. Models of focal ischemia, 
the main focus of these studies, include temporary and permanent middle 
cerebral artery occlusion (MCAO), distal MCAO, embolic MCAO and 
photothrombosis.  Each model has advantages and disadvantages in replicating 
human stroke and will be discussed further. 
 
Middle Cerebral Artery Occlusion 
 The MCAO model was introduced in the late 1980s and modified in the 
1990s to reduce hemorrhage (Belayev, et al., 1996, Longa, et al., 1989, Schmid-
Elsaesser, et al., 1998).  This model consists of disrupting blood flow from the 
branches of the external carotid artery (ECA) and the extracranial branches of 
the internal carotid artery (ICA) to reduce collateral blood flow, then inserting a 
nylon suture into the ECA and advancing it through the ICA to block blood flow 
into the MCA (Longa, et al., 1989).  The intraluminal suture is removed after a 
given duration of time, usually 60-120 minutes for adult rats, to produce 
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reperfusion.  This is called transient MCAO (tMCAO); permanent MCAO, without 
suture removal, is also a commonly used rodent stroke model.  MCAO produces 
primary ischemic cell death in the ipsilateral striatum and cortex and may extend 
to the thalamus, hypothalamus and substantia nigra (Garcia, 1995, Kanemitsu, et 
al., 2002, Williams, et al., 2004).  Cell death begins in the striatum, is primarily 
necrotic, and occurs rapidly (Carmichael, 2005, Garcia, 1995, Li, et al., 1995). 
Cortical infarction is delayed and consists of more apoptotic cell death 
(Carmichael, 2005, Garcia, 1995, Li, et al., 1995, Linnik, et al., 1995).  This 
results in an ischemic core in the striatum and ischemic penumbra in the cortex 
and peri-infarct striatum.  The early necrotic cell death in the core followed by 
progressive cell death in the penumbra that is associated with hypoxia genes, 
pro-inflammatory cytokines and mediators of oxidative injury (Carmichael, 2005, 
Durukan and Tatlisumak, 2007) make this model well-suited for studying 
potential therapies for human ischemia.  The disadvantage of this model is that it 
results in a fairly large amount of damage in a number of brain areas, whereas 
the majority of human strokes tend to be smaller and more focal, rather than 
involving a number of motor and sensory systems. 
 Another MCAO model that results in more restricted hemisphere damage 
than the permanent or tMCAO models described above is distal MCAO.  There 
are two versions of this model.  The original distal MCAO involved transection of 
the lenticulostriate branches of the MCA at the basal surface of the brain.  This 
requires craniotomy and results in damage to the ipsilateral striatum, subcortical 
white matter, and cortex.  A newer version of this technique, called the 3-vessel 
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occlusion model, involves MCAO on the surface of the brain combined with 
bilateral common carotid artery occlusions.  This model results in damage to the 
cortex, subcortical white matter, and a small portion of the dorsolateral striatum.  
Both of these models involve reperfusion, allowing for return of collateral blood 
flow.  These models produce an infarct core in the cortex, with infarction 
extending laterally and medially over a period of several days to other cortical 
areas as well as the dorsolateral striatum, and are characterized by increased 
apoptosis, microglia infiltration and increased cytokine production.  The main 
advantage of distal MCAO vs. MCAO is that it produces smaller infarcts; 
however, the need for craniotomy weighs against this model.  
 
Embolic or Photothrombotic Stroke 
 At least two other types of focal stroke models are described in the 
literature.  There are three variations of embolic stroke currently in use to study 
cerebral ischemia (Carmichael, 2005, Durukan and Tatlisumak, 2007).  These 
models involve injection of microspheres, macrospheres or thrombotic clots into 
the ICA, which become lodged in the MCA.  Microsphere injection results in 
multiple small, focal infarcts throughout the brain, while macrosphere injection 
produces damage similar to the MCAO model, but without hypothalamic damage.  
Injection of thrombotic clots closely resembles human clot-induced stroke but 
results in smaller and more variable (in size and location) infarcts than the MCAO 
model. Another slightly newer stroke model is the photothrombotic stroke, 
which combines the use of a photosensitive dye and laser activation to produce 
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cortical infarcts. Typically rose Bengal is injected intravenously and the region of 
interest is laser-irradiated minutes later.  This results in focal endothelial damage, 
platelet activation, and simultaneous microvascular occlusion and secondary 
ischemia in the photoactivated area (Carmichael, 2005, Durukan and Tatlisumak, 
2007).  Rapid apoptotic cell death occurs in the targeted area and is 
characterized by microglia activation and increased cytokine production.  This 
model is appealing due to its selectiveness of infarct; a specific cortical region, 
for example the barrel field, can be targeted so that the infarct only occurs in the 
desired area.  This allows for study of an already known circuit and more 
targeted functional therapy.  There is little ischemic penumbra in this model, 
however, as rapid oxidative damage occurs rather than slower expansion of 
infarction that occurs with reperfusion.  Another disadvantage of this model is the 
simultaneous occurrence of intra- and extracellular edema, which differs from the 
intracellular edema alone of human stroke.     
 
Oxygen-Glucose Deprivation 
 Oxygen-glucose deprivation (OGD) is an in vitro stroke model that 
involves removal of glucose from cell culture media combined with cell exposure 
to anoxia.  The duration of anoxia can be altered to produce variations in the 
extent of injury.  Short durations of anoxia are equivalent to preconditioning, in 
which the cells are primed but not damaged, whereas longer durations of anoxia 
induce apoptosis (Andjelkovic, et al., 2003, Keep, et al., 2005, Stanimirovic, et 
al., 1997, Xu, et al., 2000, Zhang, et al., 1999).  “Reperfusion” can be 
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accomplished by returning the OGD-exposed cells to their normal growth 
conditions for a given period of time.  OGD durations that induce injury result in 
an up-regulation of pro-inflammatory cytokines, adhesion molecules, anti-
oxidative enzymes, and pro-angiogenic mediators (Andjelkovic, et al., 2003, 
Fischer, et al., 2002, Haqqani, et al., 2007, Haseloff, et al., 2006, Hu, et al., 2006, 
Murphy and Horrocks, 1993, Stanimirovic and Satoh, 2000, Stanimirovic, et al., 
1997, Zhang, et al., 1999).    
 
Research Objectives 
 The main goal of this dissertation research was to investigate factors that 
regulate postnatal/adult neurogenesis in the intact and injured brain, and that 
may enhance adult-born neuron survival and promote recovery after stroke. 
Factors specific to the local NSC environment such as growth factors and other 
developmental molecules, other cells in the niche, or various components of 
injury exert influences on the SVZ NSC population.  In addition, external factors 
such as exercise, environmental enrichment or oral administration of molecules 
regulating CNS development also influence neurogenesis.  This research made 
use of both in vitro and in vivo techniques to identify how the environment-both 
within the stem cell niche, as well as the external environment- affected SVZ 
neural stem cells in the normal and injured brain.  The use of in vivo and in vitro 
injury models was employed to study the effects of specific components of injury, 
including hypoxia and inflammation, and to determine general effects of stroke or 
treatment after stroke on SVZ neural stem cells. We discovered that factors 
28 
 
secreted by normal endothelial cells maintain SVZ NSCs in their stem cell-like 
state by promoting proliferation and slowing differentiation, while stroke-injured 
endothelial cells produce factors that enhance migration and differentiation of 
SVZ NSCs (Chapter 3).  Further, we found that hypoxia, inflammation, or 
treatment with retinoic acid combined with environmental enrichment stimulates 
SVZ neurogenesis, whereas the combined insult of hypoxia and inflammation 
depresses SVZ neurogenesis (Chapters 2 and 4).  These data provide 
interesting insight into the regulation of postnatal and adult SVZ neural stem cells 
and may provide direction for the development of regenerative therapies for 




Figure 1.1: Neurogenesis in the adult rodent brain. 
Neurogenesis occurs in two regions of the postnatal/adult brain, the 
subventricular zone (SVZ) and dentate gyrus of the hippocampus (parasagittal 
schematic in A).  The SVZ is located along the lateral ventricle (A, arrows in the 
coronal section shown in B) and neural stem cells from this area migrate through 
the rostral migratory stream (RMS in A) to the olfactory bulb (OB in A) where they 
differentiate into interneurons.  The neural stem cells of the dentate gyrus (A, 
arrows in C) migrate a short distance to become neurons in the granule cell layer 





Figure 1.2: Cell types of the SVZ. 
The SVZ contains Type A, Type B and Type C cells, identified by Doetsch, et al, 
1997.  Type B cells are the neural stem cells which are self-renewing and 
express GFAP, Vimentin and Nestin.  Type B cells give rise to Type C cells.  
Type C cells are transit-amplifying cells that express Nestin and Dlx2; these cells 
give rise to Type A cells.  Type A cells express doublecortin (DCx), PSA-NCAM, 
class III β-tubulin, Dlx2 and Hu.  These cells are migrating neuroblasts that leave 
the SVZ and migrate through the RMS to the olfactory bulb.  
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Figure 1.3: Stroke-induced neurogenesis in the adult rodent SVZ and 
striatum. 
The ipsilateral SVZ expands after tMCAO (arrows in A) compared with the 
contralateral SVZ (B).  The expanded SVZ contains an increased population of 
DCx+ cells (green in C) compared with the non-stroke side (D) and these cells 
migrate in to the injured striatum (C) in the weeks after tMCAO.  Myelin 
oligodendrocyte glycoprotein immunoreactivity is shown in red. Newly formed 
neurons are present in the injured striatum 61 days after tMCAO (E, F).  The 
schematic in G shows a comparison between normal and stroke-induced 
neurogenesis.  Under normal conditions, the SVZ is relatively small and 
quiescent and neuroblasts migrate to the olfactory bulb via the RMS.  After 
stroke, the SVZ expands as proliferation increases and cues from the injured 
tissue attract neuroblasts and proliferating cells towards the infarct and peri-
infarct regions, where new neurons are formed, perhaps replacing those lost 
from injury. Adapted from Parent, et al, Ann Neurol 2002. Scale bars: 150 µm in 





Figure 1.4: SVZ neural stem cells reside in a vascular niche in the normal 
and stroke-injured brain. 
In the normal brain, RECA+ (green) blood vessels surround parts of the DCx+ 
(red) SVZ (A).  By 3 days after tMCAO, there is an increase in RECA+ blood 
vessels surrounding the SVZ as well as coursing through the SVZ (B).  By 7d, 
the SVZ is enlarged with DCx+ neuroblasts (C), and blood vessels appear to 
guide these cells out of the SVZ into the injured striatum (box in C, enlarged in 
D).  At 14 days after tMCAO, the SVZ and striatum contain numerous DCx+ 
neuroblasts which appear in areas enriched with RECA+ blood vessels (E).  
DCx+ neuroblasts and RECA+ vessels remain in close contact in the injured 
striatum 28d after tMCAO (F) Scale bars: 100 µm in A (A, E); 50 µm in B (B, C); 
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POSTNATAL MOUSE SUBVENTRICULAR ZONE NEUROGENESIS IS 
INCREASED BY INFLAMMATION OR HYPOXIA BUT IS SUPPRESSED BY 




Neonates and infants are often exposed to a number of insults during 
development and birth, including infection, lack of oxygen, and stroke which can 
lead to a range of cognitive deficits.  The persistence of neurogenesis in the 
postnatal brain provides a pool of cells with the potential to contribute to brain 
repair after injury.  In the postnatal rodent brain, hypoxia-ischemia increases SVZ 
neural progenitor cell (NPC) proliferation and neurogenesis, but few new neurons 
survive long-term.  Evaluation of the components of injury, including hypoxia and 
inflammation, may better our understanding of SVZ neurogenesis in order to 
promote neurogenesis after brain injury.  In vitro hypoxia maintains stem cells in 
a proliferative state or directs neuron specification (Morrison, et al., 2000, Storch, 
et al., 2001, Studer, et al., 2000), but studies on inflammation and neurogenesis 
have shown conflicting results.  Thus, we examined the influence of in vivo 
exposure to hypoxia or inflammation, or the combined insult, on SVZ NPCs using 
the neurosphere (NS) assay.  Mice exposed to acute hypoxia or systemic 
inflammation produced significantly more primary and secondary NS.  
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Upon differentiation, hypoxia or inflammation alone significantly increased 
the generation of neurons and oligodendrocytes from SVZ NS but combined 
exposure led to a significant decline in neurogenesis. This effect may be 
mediated by IL-1β as NS production from IL-1β deficient mice decreased and IL-
1β knockout mice produced fewer neurons.  These results suggest that targeting 
the pathway involved in hypoxia or inflammation may be beneficial for enhancing 
postnatal SVZ neurogenesis and brain repair. 
 
Introduction 
 Prematurely born babies have a high risk of developing neuronal and glial 
injury that often leads to developmental disabilities.  Preterm infants are exposed 
more frequently to insults such as labor stresses, maternal health issues such as 
placental damage or intrauterine infection, and umbilical cord asphyxiation 
(Vannucci and Vannucci, 2005, Vawda, et al., 2007). Term infants also may be 
exposed to insults during birth such as birth asphyxia, multi-organ failure, 
respiratory distress or congenital cardiac anomalies (Back, et al., 2001, Inder, et 
al., 2003, Inder and Volpe, 2000, Inder, et al., 2003, Kinney and Back, 1998, 
Volpe, 2001) which lead to hypoxia or hypoxia-ischemia in the brain.   
The extent of injury and subsequent recovery is influenced by the age of 
onset as well as the severity and repetitiveness of insult (i.e., chronic vs. acute).  
Survival rates for these critically ill neonates are on the rise which has lead to a 
substantial persistant number of children with severe motor and cognitive 
disabilities (Bassan, et al., 2006, Cooke, 2006, Hack, et al., 2002, Paul, et al., 
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2006, Saigal, et al., 2006, Wilson-Costello, et al., 2005).  The most common 
deficits are accompanied by loss of oligodendrocytes in the periventricular white 
matter in the preterm infant and loss of neurons in the cortical gray matter, which 
may further affect development in subcortical regions, since appropriate 
connections may not be formed (Back, et al., 2001, Counsell, et al., 2003, Inder, 
et al., 1999, Inder, et al., 2005, Kinney and Back, 1998, Peterson, 2003, Volpe, 
2001).  Further, neuronal and oligodendroglial progenitors may also be affected, 
and may contribute to prolonged developmental deficits (Back, et al., 2001, 
Curristin, et al., 2002, McQuillen, et al., 2003, Rothstein and Levison, 2005, 
Sheldon, et al., 1996, Sizonenko, et al., 2003). The persistence of a substantial 
number of neonates with severe cognitive and motor deficits suggests a need to 
determine the underlying mechanisms that cause brain injury as well as potential 
therapeutic options for replacing the lost neurons and oligodendrocytes.   
One potential source of intervention may be to promote the endogenous 
neural stem cell population to proliferate, migrate to areas of injury and replace 
dying neurons and oligodendrocytes.  The postnatal forebrain subventricular 
zone (SVZ) and dentate gyrus contain populations of neural stem cells that 
persist into adulthood.  Neural stem/progenitor cells of the SVZ reside along the 
lateral ventricle, migrate through the rostral migratory stream and give rise to 
olfactory bulb interneurons, while those in the dentate gyrus of the hippocampus 
migrate a short distance and differentiate into dentate granule layer neurons 
(Altman, 1969, Cameron and Gould, 1994, Corotto, et al., 1993, Kaplan and 
Hinds, 1977, Kuhn, et al., 1996, Lois and Alvarez-Buylla, 1994).  After 
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experimental stroke induced by neonatal hypoxia-ischemia or middle cerebral 
artery occlusion in adults, neural progenitor cells (NPCs) in the SVZ rapidly 
proliferate.  These proliferating cells and immature neuroblasts migrate out of the 
SVZ into the injured striatum where they become new neurons and glia 
(Arvidsson, et al., 2002, Felling, et al., 2006, Jin, et al., 2001, Ong, et al., 2005, 
Parent, 2003, Plane, et al., 2004, Romanko, et al., 2004, Yang and Levison, 
2006).  More selective brain injury, such as cortical infarct induced by 
thermocoagulation lesion or distal middle cerebral artery occlusion, also 
promotes proliferation in the SVZ and migration of these neuroblasts towards the 
injured area (Gotts and Chesselet, 2005, Gotts and Chesselet, 2005, Gotts and 
Chesselet, 2005, Ohab, et al., 2006). Only a small percentage of neurons 
generated after stroke persist in the injured striatum for at least 5 weeks in the 
adult, and even fewer survive long-term after neonatal stroke, suggesting that the 
potential for endogenous repair is limited without further intervention (Arvidsson, 
et al., 2002, Ong, et al., 2005, Parent, et al., 2002, Plane, et al., 2004).      
Studies on ischemic preconditioning identified hypoxia as a key player in 
dampening the damage incurred by subsequent cerebral ischemia.  Short 
durations of hypoxia exposure are neuroprotective in the adult rodent brain and 
provide protection against stroke- and kainic acid-induced injury (Bunn and 
Poyton, 1996, Dimitrijevic, et al., 2006, Dimitrijevic, et al., 2007, Lin, et al., 2002).  
Hypoxia also alters postnatal forebrain neurogenesis.  Hypoxia alone is sufficient 
to increase SVZ NPC expansion after chronic or acute hypoxia (Fagel, et al., 
2006, Plane, et al., 2004) as well as dentate gyrus and SVZ NPC expansion after 
58 
 
intermittent hypoxia (Zhu, et al., 2005).  After exposure to acute hypoxia on P10, 
which did not produce any overt brain damage, bromodeoxyuridine (BrdU) 
incorporation doubled in SVZ NPCs of mice 14 days after exposure to 45 
minutes of 10% O2 (Plane, et al., 2004).  A similar effect was not seen, however, 
when P7 rats were exposed to 90 minutes of reduced O2 (Ong, et al., 2005).  
After chronic hypoxia exposure on postnatal days 3-11, which elicited a transient 
loss in cortical neurons, SVZ NPC proliferation increased one week after 
cessation of hypoxia, doublecortin-positive neuroblasts were seen migrating 
through the corpus callosum to the nearby cortex, and significantly more BrdU+ 
proliferating cells were located in the cortex one month after hypoxia, many of 
which expressed neuronal markers (Fagel, et al., 2006).  These data suggest 
that mild hypoxic insults or those which produce only transient neuronal damage 
promote SVZ neurogenesis.  
Most studies examining the influence of hypoxia on stem cells do so by 
exposing in vitro cells to hypoxia as simplified model systems.  Such studies 
have evaluated the influence of hypoxia on stem cell proliferation, differentiation 
and survival.  One recent report showed that culture of neural or mesenchymal 
stem cells in lowered oxygen tension (3-5% O2) maintains their proliferative 
potential or induces their differentiation towards a dopaminergic phenotype 
(Chen, et al., 2007, Milosevic, et al., 2007, Morrison, et al., 2000, Storch, et al., 
2001, Studer, et al., 2000, Zhu, et al., 2005, Zhu, et al., 2005).  Embryonic stem 
cells are maintained in an undifferentiated state at lowered oxygen (Ramirez-
Bergeron, et al., 2004, Ramirez-Bergeron and Simon, 2001, Yun, et al., 2005, 
59 
 
Yun, et al., 2002) and rat precursors remain undifferentiated in relative hypoxia 
via Notch signaling (Gustafsson, et al., 2005).  These studies provide evidence 
that hypoxia (or rather more physiological tissue oxygen concentrations) 
functions both to promote proliferation and stem cell maintenance as well as 
direct differentiation into specific neuronal sub-types.  None of these studies 
focused on neonatal forebrain neural stem cells, however, as most focused on 
embryonic stem cells or those derived from regions other than the forebrain.     
Activation of the inflammatory cascade is the immune system’s first 
response to brain injury.  This response is mediated in part by up-regulation of 
the cytokines TNF-α and IL-1β.  Recent evidence indicates that these cytokines 
or their receptors are present in neurogenic regions of the brain (French, et al., 
1999, Klassen, et al., 2003, Koo and Duman, 2008, Sairanen, et al., 1997, Wang, 
et al., 2007).  Neurogenesis that increases after injury may be influenced by the 
post-injury inflammatory response.  Evidence exists for the influence of pro-
inflammatory cytokines on neurogenesis, but results have varied depending on 
age, stem cell location and assays used to evaluate neurogenesis.  IL-1β is up-
regulated after cerebral ischemia (Buttini, et al., 1994, Liu, et al., 1993, Liu, et al., 
2005, Minami, et al., 1992, Sairanen, et al., 1997, Yabuuchi, et al., 1994)  and 
was recently shown to enhance neuronal injury in vivo after stroke and in vitro 
after hypoxia exposure (Boutin, et al., 2001, Fogal, et al., 2007, Legos, et al., 
2000, Minami, et al., 1992), suggesting that it may not be a beneficial player in 
stroke-induced neurogenesis. Indeed, administration of IL-1β decreased 
hippocampal neurogenesis in the adult rat brain (Koo and Duman, 2008) and 
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decreased proliferation of embryonic rat brain precursors in vitro (Wang, et al., 
2007).   
Another pro-inflammatory cytokine, TNF-α, is also expressed in 
neurogenic regions but conflicting data have shown both positive and negative 
effects on neurogenesis.  In TNF-receptor-1 knockout mice, basal and seizure-
induced neurogenesis increases; however, seizure-induced neurogenesis is 
reduced in TNF-R2 knockout mice (Iosif, et al., 2006), suggesting differential 
roles for this cytokine in injury-induced and basal neurogenesis, depending on 
which receptor is activated.  After stroke, inhibition of TNF-α results in decreased 
striatal and hippocampal neuron survival (Heldmann, et al., 2005).  In one in vitro 
study, TNF-α administration led to decreased proliferation but increased 
migration in newborn rat striatal sphere cultures (Ben-Hur, et al., 2003). Other 
work in vivo, however, showed that administration of TNF-α increased SVZ cell 
proliferation (Wu, et al., 2000).  In yet another study, in vitro administration of 
TNF-α or IL-6, but not IL-1β, significantly reduced adult hippocampal 
neurogenesis (Monje, et al., 2003).  Thus, the results from these studies suggest 
that inflammatory cytokines regulate neurogenesis, but the findings are 
inconsistent such that responses to specific interventions targeting these 
molecules are very difficult to predict. 
Another technique used to study inflammation is administration of 
lipopolysaccharide (LPS), a bacterial cell wall component that elicits systemic 
inflammation via the innate immune response (Shaw, et al., 2001, Terrazzino, et 
al., 2002, Vallieres and Rivest, 1997).  Like the effects of pro-inflammatory 
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cytokines on neurogenesis, the effects of LPS are incompletely understood.  LPS 
and one of its receptors, toll-like receptor-4 (TLR-4), recently were examined for 
their effects on neurogenesis.  Administration of LPS to adult rats caused a 
significant decrease in basal hippocampal neurogenesis (Ekdahl, et al., 2003, 
Monje, et al., 2003)  and blocked status epilepticus-induced neurogenesis 
(Ekdahl, et al., 2003).  Similarly, LPS administration after neonatal hypoxia-
ischemia reduces the injury-induced neurogenic response in the SVZ (Barks, et 
al., 2008).   The receptors for LPS, TLR-4 and TLR-2, are present on adult NPCs 
in the SVZ and dentate gyrus (Rolls, et al., 2007), suggesting that LPS may 
directly influence NPCs.  Mice lacking TLR-2 have impaired hippocampal 
neurogenesis whereas those deficient in TLR-4 display enhanced proliferation 
and differentiation (Rolls, et al., 2007).       
Because both hypoxia and inflammation frequently co-exist in critically ill 
neonates with brain injury, we investigated how hypoxia or inflammation, alone or 
in combination, influences neonatal SVZ neurogenesis.  We exposed mice to 
hypoxia, LPS or a combined insult, and examined SVZ NPC self-renewal and 
differentiation using SVZ neurosphere cultures.  We found that in vivo hypoxia or 
LPS exposure significantly increases in vitro NPC expansion and self-renewal as 
well as neurogenesis and oligodendrogliogenesis. The combined insult, however, 
led to decreased SVZ NS expansion and neurogenesis.  These effects may be 
mediated in part by IL-1β, as NS cultured from IL-1β knockout mice also showed 





Neurosphere (NS) Culture 
NS cultures were prepared as previously described (Gritti, et al., 1996, 
Wang, et al., 2005) with slight modifications; all procedures were performed in 
accordance with the policies of the University of Michigan Committee on Use and 
Care of Animals.  Postnatal day 13-15 (P13-15; see below and Figure 2.1) CD-1 
mice (Charles River) were anesthetized with CO2, decapitated, brains removed, 
and placed into ice cold Opti-mem. The forebrain containing the striatal SVZ was 
cut into two coronal slices and the SVZ was dissected out, minced and 
dissociated with trypsin.  SVZ cells were plated at 4-6x104 in 60 mm petri dishes 
and cultured in serum-free media (SFM) containing growth factors [Dulbecco’s 
modified Eagle’s medium (DMEM)/F12 (1:1, Gibco), 20 ng/ml epidermal growth 
factor (EGF; Sigma), 10 ng/ml basic fibroblast growth factor (bFGF; Sigma), 2 
µg/ml heparin, and a defined hormone and salt mixture (100 μg/ml transferrin, 25 
μg/ml insulin, 60 μM putrescine, 30 nM sodium selenite and 20 nM 
progesterone)].  Primary NS were cultured for 6 days in vitro (DIV), then picked 
and re-plated for differentiation in poly-ornithine (Sigma) coated 24 well plates 
(Corning-Costar) or mechanically dissociated and passaged to form secondary 
NS.  Primary NS were differentiated for 7 days (d) in DMEM/F12 plus the 
aforementioned hormone mixture and 1% fetal bovine serum (FBS).  During 
differentiation, half of the medium was replaced every 3 d. 
Primary NS were passaged to form secondary NS as an assay for self-
renewal.  Primary NS were collected and centrifuged briefly, the growth medium 
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aspirated, and the cells re-suspended in fresh SFM.  Cells were mechanically 
dissociated and then plated in 60 mm petri dishes containing fresh SFM at 2-
4x104 and allowed to expand for 5-6 d.  In some experiments, secondary NS 
were expanded in 6 well plates to allow for treatment with LPS or vehicle.  In 
these experiments, secondary NS were plated at 2x104 and were expanded for 6 
d.  Secondary NS were picked and re-plated for differentiation using the same 
protocol described above for primary NS. 
 
Identification of Toll-Like Receptor-4 (TLR-4) 
 Brains were harvested from P15 mice and NS were expanded for 6 days.  
RNA was isolated after 6 d NS expansion using the Trizol method.  NS were 
collected and centrifuged at 700 rpm for 2 min.  NS were washed with ice-cold 
PBS, transferred to 1.5 ml centrifuge tubes, centrifuged at 500 rpm for 2 min at 
room temperature, and the supernatant was aspirated.  NS were lysed with Trizol 
at room temperature for 4 min.  Chloroform was added to the cells and mixed by 
vigorous shaking for 3 min.  NS were then centrifuged at 1200 rpm for 16 min at 
4°C.  The aqueous phase was transferred to a fresh tube; isopropanol was 
added and incubated at -20°C for 1 h to precipitate the RNA.  Tubes containing 
RNA were centrifuged at 1200 rpm for 15 min at 4°C and then the RNA pellet 
was rinsed with 75% ethanol.  RNA pellet was allowed to dry at room 
temperature for 15 min and then was dissolved in 40 µl of water.  RT-PCR was 
performed to identify TLR-4 and CD14 (co-factor for TLR-4).  RNA from spleen 





LPS is a bacterial cell wall component that induces white matter damage 
and expression of the cytokines IL-1β and TNF-α when administered to neonatal 
animals (Cai, et al., 2000, Gilles, et al., 1977, Gilles, et al., 1976).  In experiment 
one (Figure 2.1), LPS from E. coli (Sigma, St. Louis, MO) was dissolved (0.02 
mg/ml) in sterile 0.9% (w/v) NaCl. CD-1 mice received intraperitoneal (i.p.) 
injections of 0.2 mg/kg LPS on days P10-P12 and 0.1 mg/kg on P13-P14 using a 
25-guage needle attached to a 250 µl Hamilton syringe in a volume of 10 µl/g 
body weight.  Control mice received an equal volume (10 µl/g body weight) of 
sterile 0.9% NaCl (vehicle).  This administration protocol was chosen based on 
previous studies that reported normal weight gain, body temperature and blood 
glucose levels (Barks, et al., 2008) in normal and hypoxia-ischemia-exposed 
neonatal mice.  Mice were killed on P15 for SVZ neurosphere cultures using the 
methods described above.  Primary NS were expanded for 6 days and then 
counted and their diameters measured.  Primary NS were picked and re-plated 
for differentiation for 7 days or dissociated and re-plated to form secondary NS.  
Secondary NS were expanded for 6 d, counted and their diameters measured, 
and then differentiated for 7 d. Primary and secondary NS were fixed on day 7 of 
differentiation and then immunostained. 
In experiments four and five (Figure 2.1), LPS was applied to 
neurospheres during primary NS differentiation or secondary NS expansion.  
LPS was reconstituted to 1 mg/ml with sterile Hanks Balanced Salt Solution 
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(Gibco) and stored at -20°C until use.  For application to primary NS during 
differentiation, LPS was further diluted to 1 ng/ml, 10 ng/ml, 100 ng/ml or 1 µg/ml 
in NS differentiation media (DMEM/F12 + hormone mix + 1% FBS).  As a control, 
an equal volume of Hanks Balanced Salt Solution was diluted in NS 
differentiation media.  NS were differentiated for 2 d, and then NS differentiation 
media was completely removed from each well and replaced with 1 ml/well of 1 
ng/ml, 10 ng/ml, 100 ng/ml or 1 µg/ml LPS or vehicle.  LPS or vehicle was 
removed 24 h later and a complete media replacement performed with NS 
differentiation media.  Primary NS continued to differentiate until 13 DIV (total of 
7 d of differentiation) and were fixed and immunostained.  In some experiments, 
secondary NS were treated with LPS during expansion.  Secondary NS were 
expanded for 2 d and then treated with LPS in the same doses mentioned above 
for differentiating primary NS.  For these experiments, LPS was diluted in serum-
free NS media, applied to expanding secondary NS for 24 hours, and then 
replaced with normal SFM for the duration of NS expansion.  After 6 d of 
secondary NS expansion, NS were picked and re-plated for differentiation as 
described above.     
 
Hypoxia 
 In experiment two (Figure 2.1), P10 CD-1 mice (Charles River) underwent 
hypoxia treatment for 45 min, which does not elicit brain injury (Jensen, 1995).  
Animals were placed in glass jars, partially submerged in a water bath (36.5°C), 
and exposed to 10% oxygen (O2), balance nitrogen for 45 minutes; controls were 
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removed from the dam and placed into a warm incubator (36.5°C) for the 
duration of hypoxia-exposure.  Brains were harvested on P13, 3 d after hypoxia, 
for primary NS culture, using the methods described above (See “Neurosphere 
Culture”).  For these experiments, primary NS were expanded for 6 d and then 
NS were counted and their diameters measured.  Primary NS were then picked 
and re-plated for differentiation or dissociated and re-plated for secondary NS 
expansion.  Primary NS were differentiated for 7 d and then fixed and 
immunostained.  Secondary NS were expanded for 6 d and then counted and 
their diameters measured.  Some secondary NS were picked and re-plated for 
differentiation.  Secondary NS were differentiated for 7 d and then fixed and 
immunostained.        
 
Combined Hypoxia and LPS 
 In experiment three (Figure 2.1), P10 CD-1 mice were exposed to 45 
minutes of hypoxia (10% O2) as described above for experiment two.  Control 
mice were removed from the dam and placed into a 36.5°C incubator with normal 
(normoxic) airflow for 45 minutes.  All animals were subsequently returned to the 
dam.  Two hours after hypoxia/normoxia exposure, animals received i.p. 
injections of 0.2 mg/kg LPS or sterile 0.9% NaCl as described above (See “LPS 
administration”).  Mice received one injection per day thereafter, of 0.2 mg/kg 
LPS (or vehicle) on P11-P12 and 0.1 mg/kg LPS on P13-P14.  Treatment groups 
were as follows: Hypoxia-exposure plus LPS-injections (Hyp+LPS), Hypoxia-
exposure plus NaCl-injections (Hyp+NaCl), or normoxia-exposure plus NaCl-
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injections (Norm+NaCl).  We did not include an LPS-treated normoxia group 
because this would be a replication of the LPS-treatment group in experiment 1.  
Mice were killed on P15 for primary NS culture, using the aforementioned 
methods.  Primary NS were expanded for 6 d, and then counted, their diameters 
measured, and then NS were picked and re-plated for differentiation or passaged 
for secondary NS expansion.  Primary NS were differentiated for 7 d and then 
fixed and immunostained.  Secondary NS were expanded for 6 d, and their 
numbers counted and diameters measured. 
 In experiment 4 (Figure 2.1), P10 mice underwent 45 min of hypoxia at 
10% O2 exposure using the same methods described above.  Brains were 
harvested on P13 to start primary SVZ NS cultures.  Primary NS were expanded 
for 6 days in SFM, and then picked and re-plated for differentiation.  Primary NS 
were treated with 1 ng/ml, 10 ng/ml or 100 ng/ml LPS on day 2 of differentiation.  
LPS was diluted in NS differentiation media; media was aspirated from NS and 
then replaced with media containing LPS.  After 24 h, LPS-treated media was 
removed from differentiating primary NS and replaced with normal differentiation 
media.  Differentiation continued for 4 more days; cells were fixed and 
immunostained after 7 d of differentiation. 
 
Interleukin-1β (IL-1β) experiments 
 For experiment 6 (Figure 2.1), primary NS were cultured from the SVZ of 
P15 IL-1β-knockout or wild-type mice of the same hybrid background (provided 
by the laboratories of Drs. David Irani and Geoff Murphy, respectively) using the 
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methods described above.  Cells were plated at 6x104 in 60 mm petri dishes and 
were expanded for 6 d.  Primary NS were counted and their diameters measured 
at 6 DIV and then picked and re-plated for differentiation.  Primary NS were 
differentiated for 7 d and then fixed and immunostained.   
  In additional experiments as a continuation of experiment 6 (Figure 2.1), 
recombinant murine IL-1β protein (PeproTech) was added to primary NS derived 
from IL-1β-knockout or WT mice during differentiation.  Previous reports 
suggested that doses of 10-100 ng/ml alter hippocampal neural stem cells in vitro 
(Koo and Duman, 2008) and 0.8 ng/ml and higher increased proliferation of 
embryonic NPCs in vitro (Wang, et al., 2007).  Thus, in these experiments IL-1β 
was diluted to a concentration of 1 ng/ml, 10 ng/ml or 100 ng/ml and added to 
differentiating primary NS, following the same timing used for LPS administration 
during differentiation (See Figure 2.1, Experiment 5).    
 
Immunofluorescence Staining 
All primary NS were fixed with 4% paraformaldehyde after 7d of 
differentiation and immunostained.  Cells were immunostained using markers to 
identify neurons [1:1000 anti-rabbit β-III-tubulin, Babco; 1:800 anti-rabbit 
doublecortin (DCx), (Parent, et al., 2002)], astrocytes [1:500 anti-mouse Glial-
Fibrillary Associated Protein (GFAP), Sigma], radial glia (1:100 anti-mouse ZRF-
1, ZFIN), oligodendrocytes [1:600 anti-rat Myelin Basic Protein (MBP), 
Chemicon; 1:200 anti-mouse RIP, Chemicon], progenitor cells [1:100 anti-mouse 
Nestin, Chemicon; 1:500 anti-rabbit NG2, Chemicon; See appendix].  Cells were 
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washed with PBS, blocked with 10% serum (in PBS + 0.2% triton + BSA), and 
incubated in primary antibodies overnight at 4°C.  After washes, cells were 
incubated in fluorescent secondary antibodies for 1.5 hour at room temperature.  
All secondary antibodies were used at 1:800 and included goat-anti-rabbit Alexa 
594, goat-anti-mouse Alexa 488, and goat-anti-rat Alexa 488 (Molecular Probes).  
Cells were washed with PBS, counterstained with bisbenzamide, and stored in 
PBS.   
 
Microscopy and Image Analysis 
Primary and secondary NS were counted in 2x60mm petri 
dishes/condition for each experiment on a Leica inverted light microscope for at 
least 4 separate experiments. Fifty primary and secondary NS were measured at 
random from the center of each 60 mm petri dish using a 10X objective lens on a 
Leica inverted light microscope for each condition in at least 4 separate 
experiments.  Differentiated cells were imaged using a Leica fluorescent 
microscope and SPOT-RT digital camera.  NS were selected based on similar 
bisbenzamide nuclear labeling density and a minimum of 3 NS/condition were 
photographed for quantification using a 20X objective.  Images were imported 
into Adobe Photoshop CS2 for analysis.  β-III-tubulin+ neurons and MBP+ 
oligodendrocytes were counted using Adobe Photoshop, with examiner  blinded 
to condition (n≥3 NS/condition for at least 3 experiments) and results imported 





Analysis of variance (ANOVA) with post-hoc t-tests were used to compare 
differences between groups for all neuron and oligodendrocyte quantitative 
analyses using Statview.  Quantification of neurosphere size and number was 
compared using ANOVA, or using paired student’s t-tests for 2-group analyses.  
Results are presented as mean ± standard error of the mean (SEM) and 
considered significant when p≤0.05. 
 
Results 
LPS administration in vivo increases SVZ neurogenesis in vitro 
 We used the SVZ NS assay to investigate the role of in vivo inflammation 
on subsequent postnatal SVZ neurogenesis in vitro.  Mice were injected with LPS 
on P10-P14 and primary NS cultures were prepared from these animals on P15 
(Figure 2.1, Experiment 1).  After 6 days of expansion, significantly more primary 
NS were produced from mice injected with LPS than from vehicle-injected mice 
(Figure 2.2A, p=0.03). No difference was seen in the size of primary NS 
produced from these mice (Figure 2.2B).  Primary NS were dissociated and 
passaged to form secondary NS for assessment of self-renewal.  Significantly 
more secondary NS were produced from LPS-injected mice than from vehicle-
injected mice (Figure 2.2C, p=0.05).  Similar to primary NS, no difference was 
found in the size of secondary NS produced from LPS- or NaCl-injected mice 
(Figure 2.2D).   
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 We next examined the phenotype of NS-derived cells differentiated from 
mice that were administered LPS or vehicle (Figure 2.1, Experiment 1).  
Immunofluorescence staining was performed to identify neurons using antibodies 
to β-III-tubulin and DCx.  Numerous neurons were produced from vehicle and 
LPS-injected mice with a significant increase in the number of neurons produced 
from LPS-injected mice compared with controls (Figure 2.3A-C; p=0.04).  SVZ-
derived NS also gave rise to astrocytes and oligodendrocytes after 7 days of 
differentiation.  No obvious differences were seen in GFAP-positive astrocytes 
produced from LPS or vehicle-treated mice (data not shown).  We then used 
MBP antibodies to identify myelin-forming oligodendrocytes and found an 
increase in MBP+ oligodendrocyte production in LPS-administered mice 
compared with controls (Figure 2.3D-F; arrows; p=0.04).   
 
Hypoxia exposure increases SVZ NPC expansion and neurogenesis 
 P10 CD-1 mice underwent acute hypoxia exposure (Figure 2.1, 
Experiment 2) and were killed on P13 to assess hypoxia-mediated effects on 
SVZ NPCs in vitro.  In order to determine if hypoxia increased SVZ NPC 
expansion, SVZ-derived NPCs were cultured in SFM containing growth factors to 
promote NS expansion.  After 6 days of expansion, primary NS were counted 
and their diameters measured.  Mice exposed to a brief duration of hypoxia 3 
days prior to culturing NS produced significantly more primary NS than control 
mice (Figure 2.4A, p<0.01).  Increased primary NS production was not 
accompanied by an alteration in NS size (Figure 2.4B).  Hypoxia-exposed mice 
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also produced significantly more secondary NS than controls (Figure 2.4C, 
p<0.05), but secondary NS size was unchanged (Figure 2.4D).   
 We next differentiated NS from hypoxia-exposed or control mice to 
determine the effects of hypoxia on the production of neurons or glia.  Primary 
NS were expanded for 6 days and then placed in differentiation media for 7 days.  
Immunostaining was performed with antibodies to β-III-tubulin and DCx to identify 
neurons, GFAP to identify astrocytes, and MBP to identify oligodendrocytes.  
When NS of similar density were compared, we found a significant increase in 
the number of neurons present in NS generated from hypoxia-exposed mice 
compared with controls (Figure 2.5A-C, p=0.05).  Oligodendrocytes are typically 
produced in relatively small quantities in postnatal SVZ NS differentiated for 7 
days.  More MBP-positive oligodendrocytes were apparent in NS from hypoxia-
exposed mice than were found in NS from control mice (Figure 2.5D, E).  
Quantification of similar density areas confirmed a significant increase in the 
number of oligodendrocytes produced in NS from hypoxia-exposed mice 
compared with controls (Figure 2.5F, p<0.05).   
 
Combined exposure to hypoxia and LPS decreases neurogenesis 
 In experiments one and two above, we found that a single insult (hypoxia 
or LPS exposure) prior to culturing NS resulted in increased SVZ neurogenesis 
and oligodendrogliogenesis. In clinical practice, however, one of these insults 
often is accompanied by a second insult in the pre-term or term infant.  Thus, we 
examined the in vitro response of SVZ NPC after in vivo exposure to hypoxia and 
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systemic inflammation (LPS).  We first examined the influence of combined in 
vivo hypoxia and LPS exposure on SVZ NPC expansion and self-renewal by 
counting and measuring primary and secondary NS.  Hypoxia alone significantly 
increased primary NS production (Figure 2.4A, 6A, p≤0.01) compared to normal 
controls (Figure 2.6A), whereas hypoxia plus LPS-exposed mice produced 
significantly fewer primary NS than hypoxia-exposed mice (Figure 2.6A, p=0.01) 
and trended toward decreased NS production compared to normoxia-exposed 
vehicle controls (Figure 2.6A, p=0.08).  Hypoxia exposure with or without LPS 
exposure did not alter primary NS size (Figure 2.6B).  A similar effect was seen 
on secondary NS production.  Mice exposed to hypoxia alone produced 
significantly more secondary NS than controls (Figure 2.6C, p=0.02).  Mice 
exposed to hypoxia and LPS produced significantly fewer secondary NS than 
mice exposed to hypoxia alone (Figure 2.6C, p<0.01) or than control mice 
(Figure 2.6C, p=0.01).  No differences in secondary NS size were detected from 
mice exposed to hypoxia with or without LPS compared to controls (Figure 2.6D). 
 We next examined the effects of the combined inflammation and hypoxic 
insult on neurogenesis.  Mice were exposed to the insult prior to the start of NS 
cultures, and then NS were expanded for 6 days and differentiated for 7 days 
(Figure 2.1, Experiment 3).  Cells were fixed and immunostained on day 7 of 
differentiation to identify neurons and glia.  Immunofluorescence labeling with 
antibodies to β-III-tubulin and DCx identified neurons.  Very few neurons were 
present in NS from mice exposed to both hypoxia and LPS (Figure 2.7A) 
compared to controls (Figure 2.7C), whereas NS from mice exposed to hypoxia 
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and vehicle produced an abundance of β-III-tubulin-positive neurons (Figure 
2.7B).  Quantification of β-III-tubulin immunoreactive cells revealed a significant 
decline in neuron production in NS from hypoxia plus LPS exposed mice 
compared with controls (Figure 2.7D, p<0.05) or hypoxia alone (Figure 2.7D, 
p<0.01).  NS from hypoxia and vehicle exposed mice produced substantially 
more neurons than controls (Figure 2.7D, p<0.05). 
 In experiments one and two, we found that systemic LPS administration or 
in vivo hypoxia exposure led to increased in vitro neuron and oligodendrocyte 
production from SVZ NPCs.  As mentioned above, when these insults were 
combined, however, we found a decrease in neurogenesis.  Therefore, we 
wanted to determine if a similar suppression occurred in oligodendrocyte 
production after a combined insult.  Thus, NS were expanded and differentiated 
as described from mice exposed to hypoxia followed by 5 days of LPS injections 
(Figure 2.1, Experiment 3).  Differentiated NS were immunostained with an 
antibody to MBP to identify oligodendrocytes.  NS from mice exposed to LPS and 
hypoxia produced few MBP+ oligodendrocytes and their presence was typically 
observed only in very high density NS (Figure 2.7E).  Exposure to hypoxia and 
vehicle prior to culture resulted in an increase in the presence of MBP-positive 
cells in NS differentiated from these mice (Figure 2.7F) compared to those from 
control mice (Figure 2.7G).  NS of similar density were selected based on their 
bisbenzamide labeling for quantification of MBP-positive oligodendrocytes.  
Quantification supported the significantly increased presence of MBP-positive 
cells in NS from mice exposed to hypoxia and vehicle-treatment compared to NS 
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from normal controls (Figure 2.7H, p=0.04) or hypoxia and LPS-exposed mice 
(p=0.06; Figure 2.7H) with strong trends toward significant differences.  Together 
these data indicate that the combined insult decreases SVZ neurogenesis below 
control levels but does not result in a similar reduction to oligodendrocyte 
production.  
 To further elucidate the effects of an in vivo insult on in vitro neurogenesis 
and oligodendrogliogenesis, we next examined how in vivo hypoxia exposure 
combined with in vitro LPS exposure affected SVZ NPCs.  In these experiments, 
mice were exposed to hypoxia on P10 and primary NS were cultured from these 
animals at P13.  LPS was added to differentiating NS as in previous experiments 
and NS were fixed and immunostained after 7 days of differentiation (Figure 2.1, 
Experiment 4).  Immunofluorescence staining with an antibody to β-III-tubulin 
revealed that administration of LPS to NS from hypoxia-exposed mice resulted in 
production of few neurons after 7 days of differentiation (Figure 2.8A).  In 
accordance with our results from experiment 2, we found that vehicle-
administered NS from hypoxia-exposed mice resulted in increased neuron 
production (Figure 2.8E).  Administration of LPS to NS from normal mice also 
resulted in increased neuron production (Figure 2.8B) compared with vehicle-
treated NS (Figure 2.8F).  Oligodendrocyte production was also examined in 
these experiments.  An abundance of MBP-positive cells were present in both 
LPS and vehicle-treated NS from hypoxia mice (Figure 2.8C, G).  Qualitatively 
more MBP-positive oligodendrocytes were also present in LPS-treated NS from 
normal mice (Figure 2.8D) compared with vehicle controls (Figure 2.8H).  Thus, 
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combined in vivo hypoxia exposure and in vitro LPS exposure does not appear to 
decrease oligodendrocyte production in NS cultures. 
 
Inflammation-induced neurogenesis occurs in a dose-dependent manner 
 As mentioned above, we found similar effects of decreased neurogenesis 
on SVZ NPCs in vitro when mice were exposed to hypoxia in vivo combined with 
in vivo or in vitro LPS exposure. We also found increased neurogenesis when 
mice were exposed to hypoxia alone or LPS alone prior to the start of NPC 
culture.  To examine LPS effects on NPS in more detail, we exposed NPCs to 
different concentrations of LPS in vitro. Prior to doing this, however, we wanted 
to confirm that SVZ-derived NS expressed the LPS receptor TLR-4 to determine 
whether LPS may directly influence the cultured NPCs. RT-PCR of mRNA 
obtained from expanded NS showed expression of TLR-4 and its co-receptor 
CD14 (Figure 2.9A).   
We next investigated the effects of in vitro LPS exposure on SVZ 
neurogenesis.  Primary NS were expanded for 6 days and then passaged to form 
secondary NS or differentiated for 7 days.  NS were exposed to incremental 
doses from 1 ng/ml-1 µg/ml of LPS on day 2 of primary NS differentiation or day 
2 of secondary NS expansion (Figure 2.1, Experiment 5).  We found no effect on 
the differentiation of secondary NS that were exposed to LPS during expansion 
(data not shown).  NS that were exposed to 1 ng/ml LPS during differentiation 
produced substantially more β-III-tubulin-positive neurons than their vehicle 
counterpart (Figure 2.9B vs. G; F, p<0.05) or than any other dose of LPS (Figure 
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2.9B-J).  Neuron production was similar between NS administered 10 ng/ml LPS 
(Figure 2.9C) and vehicle controls (Figure 2.9H). Very few β-III-tubulin-positive 
neurons were present in NS administered 100 ng/ml or 1 µg/ml LPS during 
differentiation compared to controls (Figure 2.9D-E vs. I-J; F, p<0.05) or lower 
doses of LPS (Figure 2.9, p<0.01).   
 Next we examined the influence of in vitro LPS administration on the 
formation of oligodendrocytes from SVZ NPCs.  Because we found that in vivo 
LPS administration led to increased oligodendrocyte production, we examined 
whether this effect also occurred after in vitro LPS administration to differentiating 
NS.  MBP immunofluorescence staining showed more oligodendrocytes present 
in LPS-exposed NS than vehicle-exposed NS at all doses (Figure 2.10).  
Quantification of MBP-immunoreactive cells revealed that the 1 µg/ml LPS 
treatment significantly increased oligodendrocyte number compared to vehicle-
treated controls (Figure 2.10I, p<0.05), however, administration of lower doses of 
LPS trended toward an increase in MBP-positive cell number compared with their 
corresponding controls (Figure 2.10I, p=0.07-0.11).   
 
IL-1β mediates inflammation-induced changes in SVZ neurogenesis 
 We sought to determine the underlying factors responsible for 
inflammation-induced increases in SVZ neurogenesis and 
oligodendrogliogenesis.  LPS is a potent stimulator of the pro-inflammatory 
cytokine IL-1β (Cai, et al., 2000).  Previous studies suggest that IL-1β decreases 
adult rat hippocampal NPC proliferation both in vivo and in vitro, and decreases 
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in vitro proliferation of embryonic rat NPCs (Koo and Duman, 2008, Wang, et al., 
2007).  These studies also show effects on NPC survival, in that apoptosis 
increases after administration of IL-1β, but it has no effect on NPC differentiation 
or migration (Koo and Duman, 2008, Wang, et al., 2007).  We therefore 
investigated whether IL-1β plays a role in the neurogenic response of neonatal 
SVZ NPCs to in vivo or in vitro inflammatory insult as demonstrated by the 
results in experiments 1-5 above.  We first cultured primary NS from IL-1β 
knockout mice and evaluated primary NS size and number, as well as 
differentiation of NS cells into neurons and glia (Figure 2.1, Experiment 6).  We 
found a decrease in primary NS production from IL-1β knockout mice compared 
to wild-type controls (Figure 2.11A, p=0.01).  This decrease suggests that IL-1β 
may be responsible, at least in part, for the inflammation-induced increase in 
SVZ NS expansion.  To confirm that IL- 1β is involved in the inflammation-
induced increase in neurogenesis, future experiments could be performed in 
which LPS is administered to IL-1β knockout mice and then NS production and 
neurogenesis evaluated.  No difference was apparent in the size of NS produced 
from IL-1β knockout mice or controls (Figure 2.11B), also similar to our results 
with LPS administration (Figure 2.2).   
 We next examined the effects of IL-1β on NS differentiation.  NS were 
differentiated for 7 days and then fixed and immunostained to identify neurons 
and glia.  NS from IL-1β knockout mice produced relatively few β-III-tubulin-
positive or DCx-positive neurons compared to those from wild-type controls 
(Figure 2.11 C-F).  Similarly, NS from IL-1β knockout mice contained fewer MBP-
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positive oligodendrocytes than those from wild-type controls (Figure 2.11G, H).  
Expression of the oligodendrocyte progenitor marker, NG2, was also examined.  
Fewer NG2-immunoreactive cells were present in NS from IL-1β knockout mice 
than from wild-type NS (Figure 2.11I, J).  Together, these data implicate that IL-
1β may mediate inflammation-induced increases in neurogenesis and 
oligodendrogliogenesis.   
 Further evidence supporting the role of IL-1β in mediating inflammation-
induced increases in postnatal SVZ neurogenesis and oligodendrogliogenesis 
will be examined in future experiments.  To strengthen the link between IL-1β 
deficiency-induced decreases in SVZ neurogenesis and inflammation-induced 
increases in neurogenesis, recombinant IL-1β will be added to primary NS from 
wild-type or IL-1β knockout mice.  We hypothesize that IL-1β is responsible for 
mediating inflammation-induced neurogenesis in the postnatal SVZ.  If our 
hypothesis is correct, the addition of IL-1β to differentiating wild-type NS cultures 
should result in increased production of neurons and oligodendrocytes.  Further, 
addition of IL-1β protein to differentiating NS from IL-1β knockout mice should 
rescue the effect of decreased neuron and oligodendrocyte production.   
Additionally, these effects could further be confirmed by LPS administration to IL-
1β knockout mice.                    
  
Discussion 
 Cerebral ischemia increases neurogenesis in the forebrain SVZ of the 
postnatal and adult rodent but the underlying mechanisms are not well 
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understood.  We hypothesized that inflammation or hypoxia, factors associated 
with ischemia, alters postnatal SVZ neurogenesis.  We tested this by exposing 
postnatal mice to hypoxia or LPS, and then culturing SVZ NPCs from the mice, 
or administering LPS directly to NS cultured from normal or hypoxia-exposed 
mice.  We found that in vivo exposure to LPS or hypoxia increases primary and 
secondary NS production and stimulates the generation of neurons and 
oligodendrocytes (Table 2.1).  In vitro LPS administration also increased 
neurogenesis and oligodendrogliogenesis (Table 2.1).  When these insults were 
combined, however, NS formation, neurogenesis and oligodendrogliogenesis 
decreased significantly (Table 2.1).  We also demonstrated that inflammation-
induced changes in postnatal SVZ neurogenesis and oligodendrogliogenesis are 
dose-dependent and may be mediated via the pro-inflammatory cytokine IL-1β. 
 Our findings present novel insight into injury-associated alterations in 
postnatal SVZ NPCs that may be beneficial for developing treatment strategies to 
enhance the endogenous repair mechanisms after neonatal brain injury.  
Premature babies are often exposed to infection, hypoxia and other insults that 
result in brain injury or stroke.  Due to improvements in pediatric care, more 
premature babies survive today than in the past but often suffer cognitive and 
motor dysfunction ranging from mild learning disabilities to severe cognitive and 
motor impairment.  Thus, more advanced therapeutic options are needed to 
promote the survival of neurons and glia after these insults and to reduce long-
term cognitive disability.  Our findings indicate that exposure to an isolated insult 
may stimulate the brain’s ability to repair itself, given that individual stressors 
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increased SVZ neurogenesis.  Exposure to multiple insults, however, may be 
detrimental to the neonatal brain, as we found decreased neurogenesis after 
exposure to a combination of insults.  One recent study examined the influence 
of an additional inflammatory challenge after hypoxia-ischemia in the neonatal 
rodent brain by administering LPS following hypoxia-ischemia (Barks, et al., 
2008).  In this study, the injury-induced response of SVZ NPCs was blunted after 
exposure to both insults (Barks, et al., 2008), whereas hypoxia-ischemia alone 
increased SVZ cell proliferation (Barks, et al., 2008, Ong, et al., 2005, Plane, et 
al., 2004).  Our study also supports a detrimental synergistic effect of combined 
brain insults that may decrease the ability of SVZ NPCs to repair the damaged 
brain.  Finding the downstream pathway(s) through which hypoxia and 
inflammation interact therefore may offer a potential therapeutic strategy.  In 
addition, we identified IL-1β as a candidate mediator of inflammation-induced 
SVZ neurogenesis and oligodendrogliogenesis.  Treatment strategies specifically 
targeting this cytokine to increase injury-induced neurogenesis in the postnatal 
brain may be useful. 
 Few studies have examined the influences of hypoxia and inflammation on 
postnatal SVZ NPCs as the majority focus on adult hippocampal NPCs.  Results 
from these studies suggest that inflammation inhibits adult hippocampal 
neurogenesis.  For example, administration of LPS to adult rats resulted in 
decreased hippocampal neurogenesis (Ekdahl, et al., 2003, Monje, et al., 2003), 
although administration of LPS to hippocampal precursors in culture produced no 
effect on neurogenesis (Monje, et al., 2003).  Activation of TLR-4, the receptor for 
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LPS, resulted in decreased NPC proliferation in cultures from adult mice and 
suppression of TLR-4 resulted in increased proliferation and enhanced neuronal 
differentiation (Rolls, et al., 2007). Similarly, LPS administration inhibited 
differentiation of adult mouse NPCs into neurons.  TLR-4 deficient mice also 
show increased proliferation and neuronal differentiation in the adult dentate 
gyrus (Rolls, et al., 2007).  Together, these data suggest that inflammation 
suppresses hippocampal neurogenesis in adult mice.   
In terms of the adult SVZ, the response to inflammation appears more 
complex. Several studies found that TNF-α administration increased SVZ 
proliferation in the adult rat (Wu, et al., 2000) but decreased proliferation of 
newborn rat SVZ NPCs and adult rat hippocampal progenitors in vitro (Ben-Hur, 
et al., 2003, Monje, et al., 2003).  The effects of this pro-inflammatory cytokine 
differ after injury as well.  Blockade of TNF-α after stroke results in decreased 
survival of new neurons in the striatum, whereas TNF-R1 deficient mice 
produced more hippocampal neurons after status epilepticus, but TNF-R2 
deficient mice displayed decreased hippocampal neurogenesis after status 
epilepticus (Heldmann, et al., 2005, Iosif, et al., 2006). 
Effects of other pro- and anti-inflammatory cytokines on neurogenesis 
appear to be complex as well.   Two recent studies suggest that IL-1β decreases 
proliferation in embryonic forebrain NPCs and adult hippocampal NPCs (Koo and 
Duman, 2008, Wang, et al., 2007).  Our data, however, show decreased NPC 
expansion (reduced number of NS) as well as decreased neurogenesis and 
oligodendrogliogenesis in SVZ NPCs derived from IL-1β deficient mice.   Our 
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methods and those from the other groups all differ with regard to the age of 
animals used, source of isolated NPCs and assays used; thus, IL-1β mediated 
effects on neurogenesis may be age and location-specific.  Our findings of 
increased SVZ NPC expansion, neurogenesis and oligodendrogliogenesis are 
opposite from those of previous reports of LPS administration on neural 
progenitors; however, ages, species, source of NPCs and methods used to 
evaluate these effects differed as well (Ekdahl, et al., 2003, Monje, et al., 2003, 
Rolls, et al., 2007).   
 Hypoxia may be a critical contributor to brain injury in premature infants 
and postmortem data show that the SVZ may be damaged after severe hypoxia 
(Calame, 1985; Barkovich, 1990; Barkovich, 1995; Behcer, 2004; Bell, 2005; 
Chao, 2006; Takizawa, 2006).  In the pre-term fetal sheep brain, severe hypoxia 
results in SVZ cell death while severe hypoxia-ischemia in the neonatal mouse 
brain also results in SVZ damage, blunting the neurogenic response (Levison, et 
al., 2001, Plane, et al., 2004).  Neonatal mice exposed to mild hypoxia or 
hypoxia-ischemia have an increased neurogenic response, with increased SVZ 
proliferation and neuroblast production (Levison, et al., 2001, Plane, et al., 2004).  
Similarly, SVZ proliferation is increased in mice exposed to chronic perinatal 
hypoxia (Fagel, et al., 2006), while both SVZ and dentate gyrus proliferation 
increase after intermittent hypoxia exposure (Zhu, et al., 2005, Zhu, et al., 2005).  
Together these studies suggest that hypoxia with or without ischemia can 
enhance the brain’s endogenous repair mechanism or, when severe, render it 
incapable of contributing to brain repair.  
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 The influence of hypoxia on NPCs may be more easily identified in vitro.  
As a consequence, many studies examine NPCs cultured in lowered oxygen to 
determine what role, if any, hypoxia plays in NPC maintenance and 
neurogenesis.  Most studies report that in vitro hypoxia maintains stem cells in a 
more proliferative or undifferentiated state, regardless of age or location from 
which cells were isolated (Chen, et al., 2007, Gustafsson, et al., 2005, Milosevic, 
et al., 2007, Morrison, et al., 2000, Storch, et al., 2001, Studer, et al., 2000, Yun, 
et al., 2005, Zhu, et al., 2005).  In vitro hypoxia also induces differentiation of 
neuronal subtypes, specifically dopaminergic neurons (Milosevic, et al., 2005, 
Morrison, et al., 2000, Storch, et al., 2001, Studer, et al., 2000). Together these 
studies provide support for the role of hypoxia in regulating NPCs, although none 
of these studies specifically examined the influence of hypoxia on postnatal SVZ 
NPCs.  Our findings of hypoxia-induced increases in postnatal SVZ NPC self-
renewal, neurogenesis and oligodendrogliogenesis are novel.  The 
demonstration of increased NS production after hypoxia exposure in this study 
provides further support for the role of hypoxia in promoting NPC proliferation.  
Previous studies reported increased dopaminergic differentiation but not 
increased neurogenesis or oligodendrogliogenesis.  These studies also focused 
on midbrain progenitors or embryonic neural stem cells and did not investigate 
oligodendrocyte production.  Thus, the differences reported in our study both 
provide support to previous studies and differ from these studies as a result of 
age of hypoxia exposure, region of interest, and timing of NPC evaluation.   
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 Our findings suggest that NPCs derived from the SVZ can promote 
neurogenesis and oligodendrogliogenesis in response to inflammation or 
hypoxia, while the response is dampened when both insults are combined.  
Inflammation and hypoxia are involved in cerebral ischemia and may be key 
players in the post-injury response. Targeting one or both of these pathways for 
treatment of perinatal brain injury therefore may enhance brain repair and 
decrease cognitive or motor dysfunction later in life.      
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Figure 2.1: Schematic of experiments. 
In experiment 1, mice were injected with 0.2 mg/kg LPS or NaCl on P10-P12 and 
then 0.1 mg/kg LPS or NaCl on P13-14.  Mice were killed on P15 for primary NS 
cultures.  Primary NS were expanded for 6 d and then passaged to form 
secondary NS, or differentiated, fixed and immunostained to identify neurons, 
astrocytes, oligodendrocytes and NPCs/radial glia. In experiment 2, P10 mice 
were exposed to 45 min of hypoxia at 10% O2 or normal air and then were killed 
on P13 for primary NS cultures.   Primary NS were expanded for 6 d and then 
differentiated for 7d or passaged to form secondary NS. In experiment 3, mice 
were subjected to 45 min of hypoxia at 10% O2 (or normal air) on P10, followed 
by injections of 0.2 mg/kg LPS (or NaCl) on P10-P12 and 0.1 mg/kg LPS (or 
NaCl) on P13-P14.  Brains were harvested on P15 for primary NS culture, 
expanded for 6 d and then differentiated or passaged to form secondary NS.  In 
experiment 4, P10 mice underwent 45 minutes of hypoxia, as in experiment 2, 
and were killed on P13 for primary NS culture.  Primary NS were expanded for 6 
days and then differentiated.  LPS was added to differentiating primary NS 
cultures on day 2 of differentiation and removed after 24 h. Primary NS were 
differentiated for a total of 7 d and then fixed and immunostained to identify 
neurons, astrocytes and oligodendrocytes.    In experiment 5, primary NS were 
cultured from P15 CD-1 mice, expanded for 6 d and then differentiated.  LPS was 
added to primary NS on day 2 of differentiation for 24 h.  Primary NS were 
differentiated for a total of 7 d and then fixed and immunostained.  Some primary 
NS were passaged after 6d of expansion to form secondary NS that were 
exposed to LPS on day 2 of expansion for 24 h.  Secondary NS were expanded 
for 6 days total and then differentiated for 7 d, fixed and immunostained.  In 
experiment 6, primary NS cultured from IL-1β-/- or wild-type mice were expanded 









Figure 2.2: LPS-treated mice produce more NS. 
Mice were injected with 0.2 mg/kg LPS (or NaCl) on P10-P12, 0.1 mg/kg LPS (or 
NaCl) on P13-14 and brains were harvested on P15 for primary NS culture.  Mice 
injected with LPS produced twice as many NS as vehicle-injected controls (A, 
*p=0.03), with no difference in primary NS size (B; p=0.3).  After passage of 
primary NS, LPS-injected mice produced nearly twice as many secondary NS as 




Figure 2.3: LPS-treated mice produce more SVZ-derived neurons and 
oligodendrocytes in vitro. 
Mice received i.p. injections of 0.2 mg/kg LPS on P10-P12 and 0.1 mg/kg LPS on 
P13-P14; controls received NaCl injections.  Primary NS cultured from P15 mice 
were expanded for 6 d and then differentiated for 7 d, fixed and immunostained 
with antibodies to β-III-tubulin (A, B) or MBP (D, E).  LPS-injected mice produced 
NS that generated more β-III-tubulin+ neurons than controls (A-C; *p=0.04), and 
more MBP+ oligodendrocytes than vehicle-injected mice (arrows in D-E, F; 










Figure 2.4: Neurosphere production increases in hypoxia-exposed mice. 
P10 CD-1 mice were exposed to 45 minutes of hypoxia (10% O2) and brains 
harvested on P13 for primary NS cultures.  Mice exposed to hypoxia produced 
significantly more primary NS than controls (A, **p<0.01).  Primary NS diameters 
measured after 6 days of NS expansion showed no difference in the size of 
primary NS produced from hypoxia versus control mice (B).  Primary NS then 
were passaged to form secondary NS.  After 6 days of secondary NS expansion, 
hypoxia-exposed mice produced significantly more secondary NS than controls 








Figure 2.5: Neurogenesis and oligodendrogliogenesis increase in vitro after 
in vivo hypoxia-exposure. 
P10 mice underwent 45 minutes of hypoxia and brains were harvested on P13 
for NS culture.  Primary NS were expanded for 6 days, differentiated for 7 days, 
and immunostained to identify neurons using an antibody to β-III-tubulin.  β-III-
tubulin+ neurons were present in differentiated NS from both groups, but NS from 
hypoxia-exposed mice contained more neurons than normoxic controls (A-C; 
*p=0.05).  NS from mice exposed to hypoxia also produced more MBP+ 









Figure 2.6: SVZ neurosphere production decreases after exposure to 
hypoxia and LPS.   
P10 mice underwent 45 min of hypoxia and were injected with 0.2 mg/kg LPS (or 
NaCl) 2 hours later; mice received i.p. injections of the same dose on P11-12, 
followed by 0.1 mg/kg LPS on P13-14.  Mice were killed on P15 for primary NS 
culture.  Animals exposed to hypoxia and vehicle injections produced significantly 
more primary NS than normoxic mice that received vehicle injections (A, 
**p=0.01).  Mice exposed to hypoxia and LPS produced significantly fewer 
primary NS than those exposed to hypoxia alone (A, ++p=0.01) and trended 
toward decreased NS production compared to normoxia-exposed vehicle 
controls (A, p=0.08).  No difference was seen between groups in the size of 
primary NS produced (B).  Significantly fewer secondary NS were produced from 
hypoxia- and LPS-exposed mice than normoxia plus vehicle (C, **p=0.01) or 
hypoxia plus vehicle (C,++p<0.01).  Hypoxia-exposed mice produced significantly 
more secondary NS than normoxia mice (C,*p=0.02).  We found no difference in 
secondary NS size between groups (D). 
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Figure 2.7: Combined hypoxia and LPS exposure decreases SVZ 
neurogenesis but not oligodendrogliogenesis in vitro.   
Mice were exposed to hypoxia on P10 and received i.p. injections of LPS on 
P10-P14.  Primary SVZ NS cultures were prepared from P15 mice.  Mice 
exposed to hypoxia plus LPS produce few SVZ NS-derived β-III-tubulin+ neurons 
(A), whereas mice exposed to hypoxia plus vehicle treatment produce 
substantially more β-III-tubulin+ neurons than controls (B, C).  Quantification of β-
III-tubulin+ neurons revealed a significant increase in neuron production in 
hypoxia-exposed mice compared with normoxia-exposed controls (D, *p<0.05), 
and significantly fewer β-III-tubulin+ neurons from mice exposed to hypoxia plus 
LPS compared with hypoxia plus vehicle (D, ++p<0.01) or normoxia plus vehicle 
(D, *p<0.05).  Mice exposed to hypoxia plus LPS produced NS that gave rise to a 
small number of MBP+ oligodendrocytes after 7 days of differentiation (E).  
Those exposed to hypoxia plus vehicle treatment produce numerous MBP+ 
oligodendrocytes, almost twice as many as NS from mice exposed to both insults 
or neither insult (E-G).  Quantification of MBP+ oligodendrocytes revealed that 
NS derived from hypoxia-exposed mice generate significantly more MBP+ cells 
compared to controls (H, *p=0.04) and trended toward an increase compared to 






Figure 2.8: In vivo hypoxia exposure combined with in vitro LPS also 
decreases SVZ neurogenesis but not oligodendrogliogenesis.   
Primary NS were expanded from P13 mice that were exposed to hypoxia 
on P10.  LPS or vehicle was added to primary NS on the second day of 
differentiation and removed 24 h later.  NS from hypoxia-exposed mice 
that were treated with LPS during differentiation produced very few 
neurons compared to all other conditions (A, B, E, F).  NS from normoxic 
mice treated with LPS in vitro (B) or NS from hypoxia-exposed mice that 
were exposed to vehicle during differentiation (E) produced considerably 
more neurons than controls (F).  More MBP+ cells were present in NS 
from hypoxia-exposed mice treated with LPS (C) or vehicle (G) during 
differentiation than in NS from controls (H).  LPS-exposed NS from 
normoxic mice also appeared to contain more MBP+ cells (D) than 






Figure 2.9: Cultured NS express TLR-4 and CD14, and increase 
neurogenesis in response to in vitro LPS treatment.    
NS derived from P15 mice were expanded for 6 days, mRNA extracted 
and RT-PCR performed for TLR-4 and CD14. NS show strong expression 
of TLR-4 and CD14 and were present in spleen (S) and Liver (L), which 
were used as a positive control (A).  No reverse transcriptase was present 
in the negative control (- in A).  In experiment 5, SVZ-derived primary NS 
were cultured from P15 mice.  NS were expanded for 6 days and then 
differentiated.  1 ng/ml-1 µg/ml LPS was added to differentiating NS on 
day 2 of differentiation and removed 24 h later.  NS were differentiated for 
a total of 7 d and then were fixed and immunostained to identify neurons.  
NS treated with 1 ng/ml LPS produced numerous β-III-tubulin+ neurons 
(B), more than the vehicle-treated controls (G-J) or any other LPS doses 
(C-E).  Administration of 10 ng/ml LPS also produced numerous β-III-
tubulin+ neurons (C), however, these appeared similar in number to 
controls (H). Administration of 100 ng/ml or 1 µg/ml LPS resulted in 
production of fewer β-III-tubulin+ neurons (D, E) than their corresponding 
controls (I, J).  Quantification of β-III-tubulin+ neurons revealed a 
significant increase in the number of neurons produced from NS 
administered 1 ng/ml LPS  compared to the corresponding control (F, 
*p<0.05).  Administration of the 2 highest doses of LPS resulted in a 
significant decline in neuron production versus controls (F, *p<0.05) or 1 







Figure 2.10: LPS-treatment in vitro increases 
oligodendrogliogenesis.   
In experiment 5, SVZ-derived primary NS were cultured from P15 mice, 
expanded for 6 d and differentiated.  1 ng/ml-1 µg/ml LPS was added to 
differentiating NS on day 2 for 24 h.  NS were differentiated for a total of 7 
d and then fixed and immunostained to identify oligodendrocytes.  NS 
treated with 1 ng/ml, 10 ng/ml or 100 ng/ml LPS (A, C, E) during primary 
NS differentiation produced more MBP+ oligodendrocytes than vehicle 
treated NS (B, D, F).  NS treated with 1 µg/ml LPS produced 
approximately 3-times as many MBP+ cells (G) as vehicle-treated NS (H).  
Quantification of MBP+ cells revealed a trend toward increased 
oligodendrocyte production after administration of 1ng/ml LPS (I, p=0.07) 
but no significant differences between oligodendrocyte numbers with 10 
ng/ml or 100 ng/ml LPS-administration compared with corresponding 
vehicle-treated NS.  Administration of 1µg/ml LPS significantly increased 
the number of MBP+ cells at 7 d of differentiation versus vehicle control 






Figure 2.11: IL-1β deficient mice show reduced NS self-renewal and 
in vitro neurogenesis.   
Primary NS were cultured from the SVZ of P15 IL-1β knock-out or wild-
type mice.  NS were expanded for 6 d, and then counted and their 
diameters measured.  Significantly fewer primary NS were produced from 
IL-1β knock-out mice than from wild-type controls (A, **p=0.01), but no 
difference was seen in the size of primary NS (B).  Primary NS were 
differentiated and then fixed and immunostained after 7d.  Primary NS 
from IL-1β knock-out mice contained fewer β-III-tubulin+ (C) or DCx+ (E) 
neurons than NS from wild-type controls (D, F).  Primary NS from IL-1β 
knock-out mice also gave rise to fewer MBP+ cells than wild-type controls 
(G, H), as well as fewer NG2+ glial progenitors (I, J).  Scale bars: 100 µm 










TABLE 2.1: Summary of effects of inflammation or hypoxia on SVZ NPCs. 
 
TREATMENT SELF-RENEWAL NEUROGENESIS 
OLIGO-
GENESIS 
IN VITRO LOW DOSE LPS ------------------
  
IN VITRO HIGH DOSE LPS ------------------
  
IN VIVO LPS 
   
IN VIVO HYPOXIA 
   





IN VIVO HYPOXIA + LPS 
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INTACT AND INJURED ENDOTHELIAL CELLS DIFFERENTIALLY 





Neural stem cells (NSCs) persist in the mammalian subventricular zone (SVZ) 
within a stem cell niche containing glial and vascular elements, such as 
endothelial cells.  Recent work suggests that endothelial cells stimulate 
embryonic mouse NSC expansion and neuron production (Shen, et al., 2004).  
Stroke increases angiogenesis and SVZ neurogenesis, but the role of endothelial 
cells in the latter process is unknown. We hypothesized that factors secreted by 
intact or oxygen-glucose deprived (OGD; an in vitro stroke model) endothelial 
cells enhance postnatal SVZ neurogenesis.  To test this, P15 mouse SVZ-
derived neurospheres (NS) were co-cultured (non-contact) with primary mouse 
endothelial cells, or exposed to endothelial cell-conditioned media (ECCM).  To 
determine the influence of injured endothelial cells on SVZ NSCs, ECCM from 
intact or OGD-exposed (OGD-ECCM) endothelial cells was applied to primary 
NS during expansion.  ECCM significantly increased primary NS production and 
cell proliferation.   Differentiated NS yielded more immature neurons after 
exposure to endothelial cells or ECCM.  NS expanded in OGD-ECCM gave rise 
to neurons with longer processes compared with controls or intact ECCM.  
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Co-culture or ECCM altered astrocyte morphology to radial glial- or reactive 
astrocyte-like cells with long processes and increased nestin expression.  Myelin 
basic protein+ oligodendrocytes also appeared more immature. OGD-ECCM also 
stimulated neuroblast migration compared to controls.  These data suggest that 
intact endothelial cells secrete a factor(s) that stimulates SVZ NSC expansion 
and maintains NSC immaturity, while OGD-exposed endothelial cells stimulate 
NSC migration and maturation. 
 
Introduction 
Neural stem cells persist into adulthood in the mammalian forebrain SVZ 
and hippocampal dentate gyrus, where they give rise to olfactory bulb 
interneurons and dentate granule neurons, respectively (Altman, 1969, Cameron 
and Gould, 1994, Corotto, et al., 1993, Kaplan and Hinds, 1977, Kuhn, et al., 
1996, Lois and Alvarez-Buylla, 1994).  Many endogenous molecules and 
exogenous influences, such as exercise, injury and growth factors, modulate the 
proliferation, migration and differentiation of these cells.  Little is known, however, 
about the factors that maintain these cells in their quiescent state or that 
stimulate them after injury.  These factors may be produced or secreted by other 
cells in the local environment. SVZ NSCs reside along the lateral wall of the 
lateral ventricle within a stem cell niche containing vascular and glial elements 
which likely interact with NSCs via direct cell-cell contact or through secreted 
factors to maintain their stem cell-like state.   
One of the first studies to investigate the stem cell microenvironment in 
the rodent brain identified endothelial cells as a prominent cell type within the 
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stem cell niche of the dentate gyrus (Palmer, et al., 2000).  In that study the 
authors demonstrated that clusters of proliferating cells in the rodent dentate 
gyrus contained both endothelial cells and NSCs, suggesting that endothelial 
cells play an important role in dentate gyrus neural stem cell proliferation or 
maintenance (Palmer, et al., 2000).  Two other studies revealed the important 
influence of the vascular niche on regulating aspects of neurogenesis.  When 
angiogenesis was induced in the neurogenic region of the songbird brain, known 
as the higher vocal center, neurogenesis significantly increased in this area; 
when angiogenic factors were inhibited, neurogenesis decreased in the higher 
vocal center (Louissaint, et al., 2002).  A more recent study examined the role of 
the vasculature in migration of new cells in the olfactory bulb and found these 
cells migrate radially alongside blood vessels to their final locations within the 
olfactory bulb (Bovetti, et al., 2007).  Together, these studies suggest that 
endothelial cells are an important part of the stem cell niche, but their precise role 
in regulating NSCs may differ depending on species and location.     
Evidence for the influence of endothelial cells on NSCs may be easier to 
obtain by evaluating their interactions in vitro.  Three studies published to date 
have examined the interactions of endothelial cells and embryonic NSCs.  One of 
these studies involved co-culture of endothelial cells with embryonic NSCs in a 
non-contact manner using transwell inserts, and found increased self-renewal of 
NSCs and increased neuron production after co-culture (Shen, et al., 2004).  
Another group used the same non-contact co-culture system with endothelial 
cells and embryonic neural progenitors to investigate the role of progenitors on 
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the blood-brain barrier (Weidenfeller, et al., 2007).  This group focused on the 
influence of neural progenitors on endothelial cells and found enhanced barrier 
properties that required the presence of the neural progenitors (Weidenfeller, et 
al., 2007).  As a side note, they noticed suppressed differentiation of neural 
progenitors after co-culture, suggesting a two-way interaction between neural 
and endothelial elements of the niche (Weidenfeller, et al., 2007).  The 
importance of potential interactions between endothelial cells and NSCs during 
development was noted when a novel 3-D co-culture system was developed, in 
which endothelial cells seeded directly onto NS from embryonic NSCs attached 
to the NSCs and migrated into the NS (Milner, 2007).  This suggests a two-way 
interaction between neural and vascular elements of the niche.  Together, these 
studies suggest that endothelial cells and NSCs interact during embryonic 
development to influence the development of both NSCs and the blood-brain 
barrier. 
Experimental stroke in postnatal and adult rodents increases 
neurogenesis in the forebrain SVZ.  After neonatal hypoxia-ischemia, adult 
middle cerebral artery occlusion or adult thermocoagulation lesion, the SVZ 
expands and contains increased numbers of bromodeoxyuridine+ (BrdU) 
proliferating cells and doublecortin+ (DCx) neuroblasts (Arvidsson, et al., 2002, 
Gotts and Chesselet, 2005, Ong, et al., 2005, Parent, et al., 2002, Plane, et al., 
2004).  The SVZ NSCs migrate towards injured areas and differentiate into 
neurons and glia, potentially to replace those lost to injury (Arvidsson, et al., 
2002, Parent, et al., 2002, Plane, et al., 2004).  In the normal brain, SVZ NSCs 
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are relatively quiescent; those cells that do proliferate give rise to neuroblasts 
that migrate to the olfactory bulb and differentiate into olfactory bulb neurons.  
Thus, stroke-induced neurogenesis likely results from alterations within the 
neurogenic niche of the SVZ that promote proliferation combined with cues from 
the injured area that redirect SVZ-derived neuroblasts to migrate and differentiate 
in the injured regions.   
In addition to stimulating neurogenesis, stroke and other brain lesions 
increase angiogenesis.  Endothelial cell proliferation, blood vessel formation and 
neuroblast production increases in the SVZ after cortical thermocoagulation 
lesion (Gotts and Chesselet, 2005, Gotts and Chesselet, 2005), and after cortical 
stroke produced by distal middle cerebral artery occlusion, SVZ neuroblasts 
migrate to the peri-infarct cortex and locate alongside blood vessels (Ohab, et al., 
2006).  Additional evidence of an interaction between endothelial cells and SVZ-
derived neuroblasts comes from a study in which endostatin, an angiogenesis 
inhibitor, was administered for one week after stroke.  This treatment resulted in 
a significant decrease in newly formed blood vessels and neuroblasts, 
suggesting that their interaction may be responsible for stroke-induced increases 
in neurogenesis. Most recently, Teng et al co-cultured normal endothelial cells or 
those from the ischemic boundary with SVZ NSCs and found that normal rat 
brain endothelial cells increased proliferation while those from the ischemic 
border increased neuronal differentiation (Teng, et al., 2008).  This study 
provides strong evidence for an interaction between endothelial cells and SVZ 
NSCs in the normal and stroke-injured brain (Wang, et al., 2008).   
119 
 
Other pathological conditions also appear to involve NSC-vascular niche 
interactions. One such condition is the growth of malignant brain tumors, some of 
which have cells with stem-like properties of multipotency and self-renewal (Al-
Hajj, et al., 2003, Lapidot, et al., 1994, Singh, et al., 2004).  Cancer stem cells 
identified by double-label expression of nestin and CD133 are often found 
located next to capillaries in brain tumors. These cells maintain a self-renewing 
and undifferentiated state when cultured with endothelial cells (Calabrese, et al., 
2007).  Together, these studies suggest that endothelial cells regulate SVZ NSCs 
after stroke or other brain insults.  
One final line of evidence suggesting an interaction between endothelial 
cells and NSCs comes from studies demonstrating that angiogenic factors alter 
stroke-induced neurogenesis. Endothelial nitric oxide synthase deficient mice 
have decreased SVZ proliferation, decreased neuroblast production and 
decreased angiogenesis after focal cerebral ischemia (Chen, et al., 2005).  
Erythropoietin (EPO), the growth factor that regulates red blood cell production, 
also influences neurogenesis both in development and after stroke.  EPO and 
EPO-receptor deficient mice show severe defects in embryonic neural 
development and decreased SVZ cell proliferation into the postnatal period (Tsai, 
et al., 2006).  EPO administration after stroke increases vessel density at the 
infarct border, stimulates proliferation and neuroblast production in the SVZ, 
improves functional recovery, and increases VEGF levels (Wang, et al., 2004).  
Thus, SVZ NSCs reside in a microenvironment in which they likely respond to 
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factors produced by endothelial cells; after stroke, endothelial factors from the 
infarct region may also serve as modulators of SVZ-derived NSCs.  
To investigate how normal or injured endothelial cell-secreted factors 
modulate postnatal SVZ NSCs, we examined the influence of normal and 
oxygen-glucose deprived (OGD, an in vitro stroke model) endothelial cells on 
postnatal SVZ NSCs cultured as NS.  We hypothesized that endothelial cells 
secrete factors that augment neurogenesis in the intact and injured postnatal 
mammalian SVZ.  SVZ-derived NS were co-cultured with endothelial cells in a 
non-contact system or differentiated in endothelial cell-conditioned media 
(ECCM).  We also expanded NS in conditioned media collected from intact or 
OGD-treated endothelial cells.  We found that expansion in intact ECCM 
increased primary NS production and cell proliferation.  Intact endothelial cells 
delayed SVZ neural stem cell differentiation to yield neurons with shorter 
processes, whereas OGD-treated endothelial cells produced the opposite effect. 
Intact endothelial cells or ECCM also altered the morphology of glia to more 
immature-appearing forms and under some conditions significantly increased 
oligodendrocyte production.   NS expansion in OGD-ECCM also promoted 
neuroblast chain migration.  Together these results suggest that intact 
endothelial cells secrete factors that maintain postnatal SVZ NSCs in an 
immature state, but after stroke-like injury, the endothelial cell influence on NSCs 





Primary Neurosphere (NS) Culture 
NS cultures were prepared as previously described (Gritti, et al., 1996, 
Wang, et al., 2005) with slight modifications; all procedures were performed in 
accordance with the policies of the University of Michigan Committee on Use and 
Care of Animals.  Postnatal day 15 (P15) CD-1 mice (Charles River) were 
anesthetized with CO2, decapitated, brains removed, and placed into ice cold 
Opti-mem. The forebrain containing the striatal SVZ was cut into two coronal 
slices and the SVZ was dissected out, minced and dissociated with trypsin.  SVZ 
cells were plated at 6x103 to 6x104 depending on experiment and size of wells 
(see below) and cultured in serum-free media (SFM) containing growth factors 
[Dulbecco’s modified Eagle’s medium (DMEM)/F12 (1:1, Gibco), 20 ng/ml 
epidermal growth factor (EGF; Sigma), 10 ng/ml basic fibroblast growth factor 
(bFGF; Sigma), 2 µg/ml heparin, and a defined hormone and salt mixture (100 
μg/ml transferrin, 25 μg/ml insulin, 60 μM putrescine, 30 nM sodium selenite and 
20 nM progesterone)].  Primary NS were cultured for 6 days in vitro (DIV), then 
picked and re-plated for differentiation in poly-ornithine (Sigma) coated 24 well 
plates (Corning-Costar) or mechanically dissociated and passaged to form 
secondary NS.  Unless otherwise described, primary NS were differentiated for 7 
d in DMEM/F12 plus the aforementioned hormone mixture and 1% fetal bovine 
serum (FBS).  For all experiments, half of the medium was replaced every 3 d. 
 
Endothelial Cell Culture 
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Primary mouse brain endothelial cells (EC) or a brain endothelial cell line 
(bEnd.3) were used for all experiments and cultured as previously described 
(Andjelkovic, et al., 2003).  Primary endothelial cells were cultured from 4- to 6-
week-old CD-1 mouse brain microvessels in Dulbecco’s Modified Eagle Medium 
(DMEM, Invitrogen) supplemented with 10% inactivated fetal calf serum 
(Invitrogen), 2.5 g/mL heparin (Sigma, St. Louis, MO, U.S.A.), 20 mM HEPES, 2-
mM glutamine, antibiotic/antimycotic (Invitrogen), and endothelial cell growth 
supplement (BD Bioscience, NJ, U.S.A.) using six-well plates coated with 
collagen IV (BD Bioscience, KY, U.S.A.).  The brain endothelial cell line (bEnd.3) 
was purchased from ATCC (American Type Culture Collection, VA, U.S.A.). Cells 
were plated and grown in the recommended cell media (DMEM, 10% FBS, 1 × 
AA, 2 mM glutamine) in the presence of 10% CO2. 
  
Co-culture Experiments 
In experiment one, primary NS were cultured with primary mouse brain 
endothelial cells in a non-contact manner, similar to the system described by 
Shen et al (Shen, et al., 2004).   Endothelial cells were plated in 12 well plates 
and weaned from 10% serum to SFM over 3 d in order to culture them in the 
same media as NS.  SVZ cells were plated on transwell inserts (40µm pore size, 
Corning) at 5x104 cells/insert and expanded alone for 3 d (Figure 3.1).  NS-
containing transwell inserts were then placed into wells containing endothelial 
cells in SFM.  Controls included NS grown in SFM on membranous inserts with 
NIH3T3 cells (fibroblast cell line) or no cells in the well below. NS expansion 
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continued for 3 more days.  At 6 DIV, similarly sized NS were picked and re-
plated on poly-ornithine coated 24 well plates in differentiation media.   
 
Conditioned Media Differentiation Experiments 
Conditioned media (CM) was collected from primary mouse brain 
endothelial or NIH3T3 cells grown in DMEM with 10% normal calf serum (NCS).  
CM was collected approximately 24 h after application to cells, filtered, and 
stored at -20°C until use.  For experiment two, NS were plated at 6x104 
cells/60mm dish and expanded in SFM for 6 d, then were picked and re-plated 
on poly-ornithine coated 24 well plates for differentiation in 100% or 50% (diluted 
1:1 with DMEM) CM from endothelial or 3T3 cells, or in unconditioned (control) 
media containing matching 10% or 5% NCS (Figure 3.1).  NS were differentiated 
in CM for 7 d, with half of the medium replaced every 3 d. 
 
Oxygen-Glucose Deprivation (OGD) 
All OGD experiments were performed using the mouse bEnd.3 cell line. 
OGD was performed as previously described (Andjelkovic, et al., 2003). 
Confluent bEnd.3 cells were transferred into a temperature-controlled (37° ± 1°C) 
anaerobic chamber (Coy Laboratory, MI) containing a gas mixture composed of 
5% CO2, 10% H2, 85% N2. The culture medium was replaced with deoxygenated 
glucose-free, serum-free DMEM and cells were maintained in the anaerobic 
chamber for 1 or 5 hours.  OGD-exposed cells were removed from the anaerobic 
chamber, the medium replaced with fresh serum-free DMEM and returned to 
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normoxic conditions (5% CO2/95% air) for up to 24 hours (re-oxygenation; Figure 
3.6).  Control cell cultures were not exposed to OGD.  Serum-free conditioned 
media was collected from injured endothelial cells at 6, 12 or 24 hours post-OGD 
(OGD-ECCM), or from intact endothelial (ECCM) or NIH3T3 cells (3T3CCM). 
Unconditioned media was used as an additional control.  All media was filtered 
and stored at -20°C until use. 
 
Normal vs. OGD-Endothelial Cell CM Experiments 
For experiment three, SVZ cells were plated at 1.0x104 cells/well in 12 well 
plates and expanded alone in SFM containing doubly concentrated growth 
factors for approximately 24 hours (Initial experiments were performed without 
doubling the concentration of growth factors, which resulted in dilution of growth 
factors after the addition of CM.  Fewer NS were produced in these experiments 
and differentiated cells appeared unhealthy).  An equal volume of conditioned (or 
unconditioned) media was then added to each well and NS expansion continued 
until 6 DIV.  Primary NS were picked and re-plated for 4 or 7 d of differentiation in 
1% FBS or were passaged and re-plated in SFM (no conditioned media) to form 
secondary NS (Figure 3.1).     
To assess migration, primary NS were grown alone for 5d, then picked 
and re-plated in matrigel (Figure 3.1, Experiment 4) following similar methods to 
those published previously (Katakowski, et al., 2005, Nguyen-Ba-Charvet, et al., 
2004, Wichterle, et al., 1997).  NS were incubated at 37°C for 30 minutes to allow 
the matrigel to solidify. CM or control media was added to each well and NS were 
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placed in 37°C/5% CO2 incubator.  Phase-contrast images of NS were captured 
at 24 hours and 3 days post-plating.  NS were fixed and immunostained at 3d 
post-plating for astrocytes and immature neurons.   
 
Immunofluorescence Staining 
All primary NS were fixed with 4% paraformaldehyde at 4 or 7 d of 
differentiation and immunostained.  Cells were immunostained using markers to 
identify neurons [(See Appendix); 1:400 anti-mouse MAP2abc, Sigma; 1:1000 
anti-rabbit β-III-tubulin, Babco; 1:800 anti-rabbit doublecortin (DCx), Parent et 
al(Parent, et al., 2002)], astrocytes [1:500 anti-mouse Glial-Fibrillary Associated 
Protein (GFAP), Sigma], radial glia (1:100 anti-mouse ZRF-1, ZFIN; 1:50 anti-
mouse RC2, Hybridoma Bank), oligodendrocytes [1:600 anti-rat Myelin Basic 
Protein (MBP), Chemicon], neural progenitors (1:100 anti-mouse Nestin, 
Chemicon; 1:500 anti-rabbit NG2, Chemicon), proliferating cells (1:1000 anti-
rabbit Ki67, Vector Labs), and apoptotic cells (1:1000 anti-rabbit cleaved 
Caspase-3, BD).  Cells were washed with PBS, blocked with 10% serum (in 
PBS+0.2% triton+BSA), and incubated in primary antibodies overnight at 4°C.  
After washes, cells were incubated in fluorescent secondary antibodies for 1.5 h 
at room temperature.  All secondary antibodies were used at 1:800 and included 
goat-anti-rabbit Alexa 594, goat-anti-mouse Alexa 488, and goat-anti-rat Alexa 
488 (Molecular Probes).  Cells were washed with PBS, counterstained with 





CM was collected from intact NIH3T3 or endothelial cells after 6 or 12 h of 
cell exposure, or from OGD-treated endothelial cells 6 or 12 hours after 
termination of OGD.  Media was separated into fractions using 5kD molecular 
weight cut-off filters, thus separating the media into fractions containing proteins 
with a molecular weight of less than or greater than 5kD.  These fractions were 
re-constituted in DMEM and applied to primary NS using the same methods as in 
Experiment 3 (Figure 3.1).  To assess which fraction contained the proteins 
potentially responsible for the results found in experiment 3, we counted the 
number of primary NS at 6DIV, and then differentiated NS for 4d and 
immunostained for MAP2abc, Ki67, β-III-tubulin, and p27.  One sample/condition 
was sent to the Michigan Proteome Consortium for further analysis.  The 
samples were run on a 1D gel stained with Sypro Ruby to identify the molecular 
weights of the proteins present in CM. Then trypsin digestion was performed 
using the MassPrep robot.  The peptides were extracted from the gel plugs with 
30µl of 2% acetonitrile 0.1% TFA. Five microliters of Maldi matrix was added to 
each extract and the extracts were dried using a Speed Vac. The peptides were 
dissolved in 5µl of 60% ACN 0.1% TFA and an aliquot of each sample was 
spotted onto a Maldi target.  MS/MS analysis was performed and the data 
acquired was put into an automated database search with GPS software using 
the MASCOT search engine (AppliedBiosystems). 
 
Microscopy and Image Analysis 
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Primary and secondary NS were counted and diameter measured in 2 
wells/condition/experiment on a Leica inverted light microscope for at least 4 
separate experiments. Differentiated cells were imaged using a Leica fluorescent 
microscope and SPOT-RT digital camera.  NS were selected based on similar 
bisbenzamide labeling density and a minimum of 3 NS/condition were 
photographed for quantification using a 20X objective.  Images were imported 
into Adobe Photoshop v. 7.0 or ImageJ for analysis.  β-tubulin+ neuronal 
processes were measured in ImageJ with examiner  blinded to condition (n≥3 
NS/condition for at least 3 experiments) and results imported into Microscoft 
Excel for graphic analysis. Oligodendrocytes were quantified in 3 or more 
separate experiments by counting MBP+ cells in ≥3 20x fields/condition in a 
blinded fashion.  Cell proliferation and cell death were quantified in a similar 
manner for Ki67+ and Caspase3+ cells, respectively.  Migration experiments 
were quantified in ImageJ by measuring the distance from the center of the NS to 




Analysis of variance (ANOVA) with post-hoc t-tests were used to compare 
differences between groups for all quantitative analyses using Statview.  Results 
are presented as mean ± standard error of the mean (SEM) and considered 





Endothelial cell factors influence neuronal differentiation 
The interaction of components in the stem cell microenvironment, such as 
endothelial cells in close contact with NSCs, likely serves to regulate the 
persistence of neurogenesis after birth.  To examine the influence of endothelial 
cells on postnatal SVZ NSCs, we first cultured primary NS with endothelial cells 
(or NIH3T3 cells or alone in cell-free media) in a non-contact co-culture system.  
We evaluated the effects of non-contact co-culture on primary NS formation and 
primary NS differentiation (Figure 3.1, Experiment 1).  We found no difference in 
primary NS number (Figure 3.2A, p=0.3) or size (Figure 3.2B, p=0.3) after co-
culture with endothelial cells compared to co-culture with NIH3T3 cells or NS 
alone.   
Recent studies of embryonic NSCs suggested that endothelial cells 
stimulate neurogenesis (Shen, et al., 2004).  We, therefore, examined whether 
endothelial cells increase neuron production from postnatal SVZ-derived NSCs.  
We evaluated neurogenesis in NS after co-culture with endothelial cells (Figure 
3.1, Experiment 1) or in NS differentiated in ECCM (Figure 3.1, Experiment 2).  In 
experiment one, we found no increase in neuron production, however, there was 
a difference in the morphology of β-tubulin+ or DCx+ neurons produced from NS 
co-cultured with endothelial cells compared to those from controls.  β-III-tubulin-
positive neurons derived from endothelial co-cultured NS displayed significantly 
shorter processes than controls (Figure 3.3A, B, p<0.01).  Similar results were 
seen for DCx-labeled immature neurons (data not shown). The length of β-
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tubulin+ processes was measured and on average, β-tubulin+ processes from 
co-cultured NS were less than half the length of those found in control NS (Figure 
3.3C).  Similarly, in experiment two, NS differentiated in ECCM gave rise to 
clusters of β-tubulin+ neurons with very short processes (Figure 3.3D), compared 
with those from controls which typically contained longer processes that contact 
other cells (Figure 3.3E).  Process length measurements revealed that NS 
differentiated in ECCM (50 or 100%) contained significantly shorter neuronal 
processes than controls at approximately one-third of their length (Figure 3.3F, 
p<0.01). 
 
Endothelial cell-secreted factors alter glial morphology 
 Next we sought to determine if endothelial cells influence the formation of 
glial cells from SVZ-derived NS.  We first examined nestin immunoreactivity to 
assess effects on the formation of stem cells/radial glia.  In experiment one, we 
found that NS grown alone and differentiated in 1% FBS contained few nestin-
positive cells after 7d of differentiation (Figure 3.4C). NS co-cultured with 
endothelial cells contained many nestin-positive cells that displayed radial 
processes and expressed higher levels of nestin (Figure 3.4A) than in control 
cultures (Figure 3.4B-C).  We found similar results using the ZRF-1 antibody that 
labels radial glia in zebrafish (Raymond, et al., 2006, Strausberg, et al., 2002, 
Thisse, 2004), with minimal labeling in control cultures and enhanced expression 
in radial processes of endothelial co-cultured NS (data not shown).  We next 
performed immunofluorescence staining with a GFAP antibody to identify 
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astrocytes. This staining revealed GFAP-positive cells with altered morphology in 
NS co-cultured with endothelial cells compared to controls (Figure 3.4D-F).  
GFAP-positive cells derived from endothelial co-cultured NS contained numerous 
processes extending off of each cell, resembling reactive astrocytes (Figure 
3.4D) compared with those from both controls, which were typically large, flat 
GFAP+ astrocytes (Figure 3.4E-F).   
We also performed nestin and GFAP immunostaining in experiment two to 
label stem cells/radial glia and astrocytes, respectively, in NS differentiated in 
conditioned medium.  Similar to the pre-differentiation co-culture experiments, we 
found strong nestin-reactivity in radial processes of 100% and 50% ECCM-
differentiated NS (Figure 3.4G, M). Fewer cells from 3T3CCM-differentiated NS 
strongly expressed nestin, and these cells resembled astrocytes without radial 
morphology (Figure 3.4H, N).  Very little nestin expression was detected in serum 
controls and the rare labeled cells resembled normal astrocytes when present 
(Figure 3.4I, O).  GFAP-positive cells from ECCM-differentiated NS resembled 
the nestin-positive cells in these NS, with positive staining present in radial 
processes (Figure 3.4J, P).  GFAP-positive cells from both 3T3CCM and serum 
controls displayed more typical astrocyte morphology (Figure 3.4K-L, Q-R).   
SVZ NSCs cultured as NS give rise to neurons, astrocytes and 
oligodendrocytes.  Postnatal SVZ neural progenitors also give rise to 
oligodendrocytes in vivo (Ganat, et al., 2006, Goldman, 1995, Levison and 
Goldman, 1993).  We therefore examined the influence of endothelial cell-
secreted factors on oligodendrocytes generated by SVZ-derived NS.  In 
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experiment one, we found that MBP-positive oligodendrocytes from endothelial 
co-cultured NS appeared smaller in size and displayed little branching compared 
with those from controls, which appeared larger with more elaborate branching 
patterns (Figure 3.5 A-C).  We wanted to determine if there was also a difference 
in the number of oligodendrocytes produced from endothelial co-cultured NS.  
Quantification of MBP-positive cells showed  no difference in the number of 
oligodendrocytes produced from endothelial co-cultured NS compared with NS 
grown alone (Figure 3.5D).  NS co-cultured with 3T3 cells generated significantly 
fewer MBP+ cells than NS grown alone (Figure 3.5D, p<0.01).  The morphology 
of MBP-positive oligodendrocytes was also examined in experiment two, in NS 
differentiated in conditioned medium.  NS differentiated in 50 or 100% ECCM 
produced small MBP-positive oligodendrocytes with little branching (Figure 3.5E, 
G), similar to those from NS co-cultured with endothelial cells.  MBP-positive 
oligodendrocytes from control CM differentiation were generally larger than those 
from ECCM-differentiated NS and contained highly branched MBP-positive cells 
(Figure 3.5F, H).  The number of MBP-positive oligodendrocytes was significantly 
increased in 50% ECCM-differentiated NS compared with all other conditions 
(Figure 3.5I, p<0.01).   These results suggest that factors secreted by endothelial 
cells alter oligodendrocyte production, but these findings should be confirmed 
with use of additional oligodendrocyte markers. 
 One recent study suggested that NSCs could trans-differentiate into 
endothelial cells after exposure to endothelial cells in co-culture (Wurmser, et al., 
2004).  We therefore performed immunostaining to assay for endothelial cells 
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using an anti-Glut-1 antibody. No immunoreactivity was seen in NS expanded 
with primary endothelial cells or in those differentiated in ECCM (data not 
shown).  Endothelial cells from co-culture were included as a control and all of 
these cells expressed Glut-1 (data not shown).  Previous studies examining the 
influence of endothelial cells on embryonic NSCs found increased self-renewal 
after co-culture of these two cell types (Shen, et al., 2004).  The effects of 
endothelial cells on NS expansion or self-renewal could not be tested in the 
current experiments because the endothelial cells were cultured in serum.  We 
describe additional experiments below evaluating the effects of endothelial cells 
on NSC self-renewal using serum-free CM. 
    
Endothelial factors increase neurosphere production and proliferation 
 Stroke-induced neurogenesis is evident within a week of insult as the SVZ 
expands with proliferating cells (Arvidsson, et al., 2002, Jin, et al., 2001, Parent, 
et al., 2002, Tureyen, et al., 2005, Zhang, et al., 2001).  The vascularity of the 
brain is also altered after stroke.  Angiogenesis, the formation of new blood 
vessels, increases after experimental stroke in the peri-infarct regions as a result 
of endothelial cell proliferation (Chen, et al., 2003, Chen, et al., 2004, Chen, et 
al., 2003, Ohab, et al., 2006, Wang, et al., 2008, Wang, et al., 2004).  Endothelial 
cell proliferation increases soon after injury and peaks 5 d after stroke (Gotts and 
Chesselet, 2005).  The correlation of stroke-induced angiogenesis and 
neurogenesis led us to question whether stroke-injured endothelial cells may 
regulate SVZ NSCs.  We used oxygen-glucose deprivation, a widely used in vitro 
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stroke model that results in a preconditioning effect after short durations and cell 
damage and eventual cell death after longer durations, to induce ischemic 
preconditioning or injury to endothelial cells. Conditioned media was collected for 
application to SVZ NS during expansion [Figure 3.6; (Andjelkovic, et al., 2003, 
Hu, et al., 2006, Kapinya, et al., 2002, Keep, et al., 2005, Perez-Pinzon, et al., 
1995)].  In experiment three, media conditioned for 6 or 12 h by intact NIH3T3 
(control) or endothelial cells, or OGD-exposed endothelial cells (labeled 6 h 
ECCM, 12 h ECCM, etc) was tested for its effects on NS cultures.  For these 
experiments, the bEnd.3 cell line was used rather than primary endothelial cells 
because of the availability of the cell line.  Data shown in the following sections is 
from 5 h OGD, unless otherwise noted.  Results from 1 h OGD were similar but 
slightly less marked than those from 5 h OGD when the same assays were 
evaluated.   
Primary NS were expanded for 24 h in serum-free media and then for 5 d 
in intact ECCM or 3T3CCM (or unconditioned media as an additional control), or 
OGD-ECCM (Figure 3.1, Experiment 3).  On day 6 of NS expansion, primary NS 
were counted and their diameters measured to determine effects on NS 
formation.  We found a significant increase in the number of NS produced when 
expanded in intact 12 h ECCM compared with control conditions (Figure 3.7A).  
We found similar results after 1h OGD (Figure 3.7C, p=0.01 for 12h ECCM vs. 
12h 3T3CCM or UNCOND).  Some NS were re-plated for differentiation while 
others were passaged to examine self-renewal as secondary NS.  No significant 
difference was found in the number of secondary NS produced between 
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conditions, but a trend toward an increase in secondary NS production was seen 
when primary NS were expanded in 12 h ECCM (p=0.08; Figure 3.7D).  This 
trend was also evident after 1h OGD followed by 12 h media collection (Figure 
3.7F; p=0.06-0.07 for 12h ECCM vs. 12 h 3T3CCM or UNCOND and for 12 h 
OGD-ECCM vs. 12 h 3T3CCM or UNCOND).  No significant difference from 
controls emerged in the size of primary or secondary NS after expansion in intact 
ECCM or OGD-ECCM (Figure 3.7B, E).  Next we evaluated the effects of intact- 
or OGD-ECCM on cell proliferation.  We examined Ki67 immunostaining after 4 d 
of differentiation and found a significant increase in the number of Ki67-positive 
cells after NS expansion in ECCM (Figure 3.7H, K, M) compared with controls 
(Figure 3.7G, J, M, p<0.01) and a significant decrease in Ki67 cell number in 
ECCM vs. OGD-ECCM (Figure 3.7I, L, M, p<0.05).  We also assayed for 
apoptosis after 4 d of differentiation using activated Caspase-3 immunostaining.  
We found no difference in activated caspase-3 immunoreactivity between ECCM, 
OGD-ECCM or controls (data not shown).  Together, these data indicate that 
factors secreted from normal endothelial cells increase SVZ NS formation and 
proliferation without altering apoptosis. 
 
Endothelial-secreted factors alter NSC maturation 
 In our first few studies described above, NS expansion with primary 
endothelial cells before differentiation, or NS differentiated in ECCM, led to 
altered neuron and glial morphology.  In those experiments, β-tubulin-positive 
neurons from endothelial co-culture or ECCM differentiation contained shorter 
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processes and typically appeared as clusters of cells, whereas controls had 
significantly longer processes that contacted other cells and cell bodies were 
more dispersed (Figure 3.3).  We asked whether similar effects would be seen 
with NS expanded in serum-free ECCM, and if these effects would be similar if 
the endothelial cells were exposed to OGD before collecting ECCM.  NS were 
expanded for 5d in serum-free conditioned media from intact or OGD-treated 
endothelial cells, or control 3T3 cells, and then differentiated in normal medium 
for 4 or 7 d (Figure 3.1, Experiment 3; Figure 3.6).  After 4 d of differentiation, NS 
expanded in ECCM contained MAP2abc-positive cells with short or no processes 
(Figure 3.8C) while MAP2abc-positive cells in controls had a mix of short and 
medium processes (Figure 3.8A, B).  NS expanded in OGD-ECCM gave rise to 
MAP2abc-positive neurons with much longer processes than controls (Figure 
3.8D).  Results were similar with 6 h and 12 h media; data shown are from 12 h 
media for all conditions.   
Next we evaluated whether these differences persisted, or instead if 
process outgrowth in NS treated with intact ECCM “caught up” with controls or 
OGD-ECCM process outgrowth slowed to match controls.  To evaluate this, we 
immunostained for neuron-specific β-III-tubulin after 7 d of differentiation.  We 
found that β-tubulin-positive neurons from intact ECCM-expanded NS maintained 
shorter process length than controls, and β-tubulin-immunoreactive neurons from 
OGD-ECCM-expanded NS continued to have longer processes than controls 
(Figure 3.8F-I).  Results were similar with 6 h and 12 h media; data shown are 
from 12 h media for all conditions.  The number of processes per cell and length 
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of each β-tubulin-positive process was counted and measured in fields with 
similar cell densities.  Quantification of β-tubulin-positive process length 
confirmed that neurons from intact 6h ECCM contained significantly shorter 
processes than controls, as did 12 h ECCM (Figure 3.8E, p<0.05).  This analysis 
also confirmed that β-tubulin-positive processes from 6 h OGD-ECCM and 12 h 
OGD-ECCM were significantly longer than those from controls (Figure 3.8E, 
p<0.01).  We found no difference between conditions in the number of 
processes/cell or in the number of neurons/field (Figure 3.8J, data not shown). 
 
Endothelial factors alter glial morphology 
 Due to the altered morphology of Nestin-, GFAP- and MBP-positive cells 
seen after co-culture with endothelial cells or differentiation in serum-containing 
ECCM (Figures 4 & 5), we examined whether similar changes occurred after NS 
expansion in serum-free intact- or OGD-ECCM.  After primary NS were 
expanded in CM as shown in Figure 3.1, Experiment 3, NS were differentiated for 
4 d and then immunostained for nestin.  We found that the nestin-positive cells 
from ECCM-expanded NS resembled those from experiments one and two in 
that they displayed long radial processes (Figure 3.9C, arrowheads), whereas 
little nestin was expressed in the unconditioned control (Figure 3.9A);  although 
nestin morphology varied in 3T3CCM controls, it was not present in radial 
processes (Figure 3.9B).  NS expanded in OGD-ECCM gave rise to a mixed 
population of nestin positive cells, some with numerous short processes (Figure 
3.9D, arrows) and others with lighter expression and very long processes (Figure 
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3.9D, arrowheads).  After 7 d of differentiation, these differences in morphology 
persisted.  ECCM-expanded NS contained numerous GFAP-positive radial glial-
like processes (Figure 3.9G).  These GFAP-positive cells from ECCM-expanded 
NS resembled both the nestin-positive cells seen in these conditions after 4d of 
differentiation and the GFAP-positive cells generated after differentiation in 
ECCM or following NS/endothelial cell co-culture in experiments one and two.  
The GFAP-positive cells found in controls were typically flat astrocytes with 
few/no processes (Figure 3.9E-F) while those from OGD-ECCM displayed 
numerous short processes (Figure 3.9H, arrow) or were long radial fibers (Figure 
3.9H, arrowhead), similar to nestin staining at 4 d (Figure 3.9D).  We found 
similar results for nestin and GFAP expression with 6 h and 12 h media; data 
shown in Fig. 9 are from 12 h media for all conditions.   
 The influence of intact- or OGD-ECCM on SVZ NS-derived 
oligodendrocyte formation was evaluated by MBP immunostaining.  Few 
oligodendrocytes were produced and there was no obvious difference in the 
number of MBP-positive cells produced by intact- or OGD-ECCM expanded NS 
or in their morphology (data not shown).  NS in some experiments were also 
stained with various antibodies to identify endothelial cells (Glut-1 or CD31).  We 
found no evidence of transformation of SVZ-derived NSCs into endothelial cells 
(data not shown).     
 
Factors from OGD-ECCM increase chain migration 
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 Given our findings of increased process outgrowth or more rapid 
differentiation of NSCs induced by OGD-treated endothelial cells, we next 
examined whether factors from intact or OGD-treated endothelial cells would 
increase neuronal migration from SVZ-derived NS.  In these experiments, NS 
were expanded alone for 5d, and then were plated in 3-dimensional matrigel 
culture to promote chain migration.  Conditioned medium collected after either 6 
or 12 hours was added to the cultures after plating in matrigel, and NS were 
cultured for an additional three days (Figure 3.1, Experiment 4).   NS incubated 
with intact ECCM showed some chain migration at 24 h, but appeared similar to 
controls at this time (Figure 3.10A, B, E, F).  NS in OGD-ECCM exhibited 
significantly more migration at 24 h post-plating in matrigel than controls (Figure 
3.10 C, G).  At 3 d post-plating in matrigel, NS in OGD-ECCM contained 
significantly longer chains than those in controls, while NS in intact ECCM 
remained similar to controls or trended toward less migration (Figure 3.10H).  
Quantification of chain length at 3 d probably underestimated the migratory 
effect, as differences were more apparent at 24 h (Figure 3.10A-C, E-G, p<0.05) 
but control and ECCM cultures started to “catch-up” to OGD-ECCM cultures. 
Immunofluorescence double-labeling confirmed that the long chains extending 
from NS cultured in OGD-ECCM were MAP2abc-positive immature neurons 
(green) with very few GFAP-positive astrocytes (red) present (Figure 3.10D).   
 
Preparation of CM for Proteomic Analysis 
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 We found clear differences in the way intact endothelial cells influence 
SVZ NSCs compared with OGD-treated endothelial cells.  In order to determine 
the factors secreted by intact or OGD-treated endothelial cells that may be 
involved in these effects, we first separated the media into two fractions.  
Conditioned media from intact 3T3s, intact ECs and OGD-treated ECs was 
separated into fractions less than or greater than 5kD with molecular weight cut-
off filters.  These fractions were applied to primary NS after 24hr of expansion, 
and then evaluated for effects on primary NS production at 6DIV and on 
differentiation after 6DIV expansion plus 4d differentiation.  We found that the 
>5kD fraction of intact ECCM produced the most primary NS (Figure 3.11A) 
compared with the <5kD fraction of intact ECCM or fractions from any other 
condition.  After 4d differentiation, more Ki67-immunoreactive cells were present 
in the >5kD ECCM condition than in any other fraction or condition (data not 
shown).  We also observed shorter MAP2abc-immunoreactive neuronal 
processes in NS expanded in >5kD ECCM (Figure 3.11F), compared to controls 
(Figure 3.11B, E) or the <5kD fraction of ECCM (Figure 3.11C) similar to results 
seen with the whole ECCM.  MAP2abc-positive neurons had much longer 
processes after NS expansion in the >5kD fraction of OGD-ECCM (Figure 3.11G) 
compared with the smaller fraction (Figure 3.11D) or other conditions (Figure 
3.11B-C, E-F).  Together these results suggest that the CM fraction containing 
proteins of molecular weight greater than 5kD is responsible for the increase in 
primary NS production and proliferation seen with intact ECCM, as well as the 





The results from these experiments suggest that both intact and OGD-treated 
endothelial cells influence the proliferation, migration, and differentiation of 
postnatal striatal SVZ-derived NSCs in vitro (Table 3.1).  We found that NS 
expansion in intact ECCM promotes NS production and cell proliferation.  
Regardless of whether primary NS were co-cultured with endothelial cells, 
expanded in ECCM or differentiated in ECCM, β-tubulin- and DCx-positive 
neurons derived from these NS were more clustered and had significantly shorter 
processes than controls. Nestin- and GFAP-positive glial cells derived from these 
NS also displayed altered morphology, similar to radial glia or reactive 
astrocytes.  We also found increased oligodendrocyte production during 
exposure to ECCM under certain conditions, and more immature-appearing 
oligodendrocytes were generated after neurosphere co-culture with endothelial 
cells or differentiation in ECCM. Finally, NS expanded in OGD-ECCM displayed 
faster chain migration and neuron process outgrowth, opposite of the effects of 
intact ECs or ECCM on SVZ neural progenitors.  
NSCs may prove to be a useful therapeutic tool for many diseases and 
conditions; however, a better understanding of what regulates these cells is 
needed to optimize their use as an effective treatment.  The local environment or 
stem cell niche likely contributes to the maintenance of these cells in the normal 
brain, as well as their alterations after injury.  Blood vessels are in close contact 
with SVZ NSCs in vivo, thus allowing for the influence of endothelial cell-secreted 
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factors within the stem cell niche, which may play an important role in regulating 
NSCs.  The goal of this study was to determine how normal and stroke-injured 
endothelial cells regulate postnatal SVZ neurogenesis.  We found that intact 
endothelial cells secrete factors that increase primary neurosphere production 
and cell proliferation, and exposure to these factors before or during 
differentiation leads to more immature-appearing neurons and glia.  Our findings 
suggest that endothelial cells within the stem cell niche serve as important 
modulators of postnatal SVZ neural progenitors by maintaining these cells in a 
more undifferentiated or stem-cell like state.  The findings of increased NS 
production and cell proliferation support the notion that endothelial cell-secreted 
factors function to maintain postnatal SVZ NSCs in a stem cell-like state.  The 
presence of more immature-appearing neurons and glia after exposure to 
endothelial cell-secreted factors provides further support for the function of 
endothelial cells within the SVZ niche in maintaining these NSCs in a more 
undifferentiated state.     
 Only a few recent studies have examined the interaction of intact 
endothelial cells and NSCs using a similar system in vitro.  Two of these studies 
focused on embryonic NSCs isolated from the developing cortex and another 
used postnatal rat hippocampal NSCs, whereas we examined the effects of 
endothelial cells on postnatal mouse NSCs isolated from the striatal SVZ (Guo, 
et al., 2008, Shen, et al., 2004, Weidenfeller, et al., 2007).  Previous reports 
describing the interaction of embryonic or hippocampal NSCs and endothelial 
cells used co-culture with transwell inserts to avoid direct cell contact (Guo, et al., 
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2008, Shen, et al., 2004, Weidenfeller, et al., 2007).  We followed similar 
methods to those published previously, although we were specifically interested 
in the effects of endothelial cell factors on postnatal SVZ NSCs.  Besides the 
differences in age and location of NSCs, the timing of the previous studies 
differed from our own.  The embryonic NSCs were cultured as NS for 4d, 
dissociated and then co-cultured with endothelial cells for only 1 day 
(Weidenfeller, et al., 2007) or cultured as NS alone for 7d, then co-cultured with 
endothelial cells for 3d or as NSCs at clonal density (not as spheres) with 
endothelial cells for 7d (Shen, et al., 2004).  The study that used rat hippocampal 
cells dissociated the spheres and co-cultured these dissociated NSCs with 
endothelial cells for 7 days (Guo, et al., 2008).  They evaluated NSCs after 7d of 
co-culture or 7d of co-culture plus 4d of differentiation (Guo, et al., 2008).  All of 
the aforementioned studies placed the NSCs in the bottom of the well with the 
endothelial cells in the insert above, the opposite of our assay. 
Despite the variations in methodology, some of our results were similar to 
those published previously, while many of our findings on the interaction of 
normal endothelial cells and NSCs were novel.  Shen found that during NSC and 
endothelial cell co-culture, NSCs produced larger clones with more nestin+ and 
Lex+ progenitors than the control co-culture of cortical cells and NSCs (Shen, et 
al., 2004). This group also primarily used an endothelial cell line not of brain 
origin. Guo (2007) and Weidenfeller (2007) found increased nestin expression 
immediately after co-culture of NSCs and endothelial cells but neither group 
commented on clone size (Guo, et al., 2008, Weidenfeller, et al., 2007).  Cancer 
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stem cells, which give rise to malignant tumors, express nestin and directly 
contact tumor capillaries in glioblastomas (Calabrese, et al., 2007).  When these 
cells were cultured as tumor spheres with endothelial cells, the resulting spheres 
were 5 times larger than controls, suggesting that endothelial cells also maintain 
cancer stem cells in their stem cell-like state.   
The previous studies, with the exception of Calabrese, et al, (2007), used 
dissociated cells in their co-culture systems, allowing them to use 
immunocytochemistry to evaluate self-renewal (Calabrese, et al., 2007, Guo, et 
al., 2008, Shen, et al., 2004, Weidenfeller, et al., 2007).  We did not perform 
antibody labeling at the end of co-culture to evaluate the number of NSCs 
expressing nestin or Lex due to the nature of the neurosphere assay.  These 
proliferative clusters of cells contain hundreds to thousands of cells and it is not 
possible to see every cell within the sphere.  To evaluate self-renewal, we 
counted the number of primary and secondary NS produced in each condition 
and measured the diameter of the NS.  Although we found no significant increase 
in the number of primary NS produced after co-culture with endothelial cells, we 
found a significant increase in primary NS production after growth in ECCM, 
further supporting the hypothesis that factors from normal endothelial cells 
maintain NSC expansion.  The increased nestin expression seen by the other 
groups as well as increased clone size corroborates our findings, which suggest 
that factors from endothelial cells maintain postnatal SVZ neural progenitors in a 
stem cell-like state.   
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We found altered morphology of GFAP+ and Nestin+ cells, as well as the 
presence of radial glial markers RC2 and ZRF1 after NS co-culture with 
endothelial cells, expansion in ECCM or differentiation in ECCM.    The altered 
morphology of GFAP+ and nestin+ cells, combined with increased expression of 
nestin, RC2 and ZRF1 suggests that endothelial cell-secreted factors also 
maintain postnatal SVZ-derived NSCs in a more undifferentiated or progenitor-
like state, consistent with a radial glia-like phenotype.  Similarly, Weidenfeller 
found alterations in astrocyte and progenitor cell morphology after co-culture with 
endothelial cells, and suggested that these cells also displayed more precursor-
like morphology (Weidenfeller, et al., 2007).  We evaluated cell proliferation by 
counting Ki67+ cells to determine if there was an increase in the number of 
actively proliferating stem cells.  We found an increase in the number of Ki67+ 
cells after 4d of differentiation from NS expanded in normal ECCM compared 
with controls, suggesting that proliferation is increased.  This increase was not 
due to changes in cell death, as we found no difference in caspase-3 
immunoreactivity between groups.  Our results concur with those from Teng et al 
(2008), in which proliferation was increased after co-culture of adult SVZ NSCs 
with endothelial cells (Teng, et al., 2008).  Although Shen did not comment on 
the morphology of glial cells from endothelial cell/NSC co-culture, they found an 
increase in BrdU+ cells after co-culture, also suggesting increased proliferation of 
NSCs (Shen, et al., 2004).  
We found no difference in the number of neurons from those co-cultured 
with endothelial cells compared to control cells; however, we found a significant 
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difference in the length of β-tubulin+ processes.  Neuronal processes were 
significantly shorter than controls regardless of whether we co-cultured NSCs 
and endothelial cells during neurosphere expansion, expanded NS in ECCM, or 
differentiated them in ECCM.  The first two conditions suggest a priming effect 
because NS were not exposed to endothelial cell-secreted factors during 
differentiation, but exposure prior to differentiation still influenced their 
subsequent development. Weidenfeller allowed NSCs to differentiate after 
removing them from co-culture with endothelial cells and also found β-tubulin+ 
neurons with reduced number and length of processes compared with 
progenitors cultured alone (Weidenfeller, et al., 2007).  When hippocampal NSCs 
were allowed to differentiate alone for 4d after 7d of co-culture with endothelial 
cells, neurofilament expression increased, suggesting an increase in the number 
of neurons produced from co-cultured NSCs (Guo, et al., 2008). Shen found 
increased neuron production after 4 d of differentiation when embryonic NSCs 
were cultured as NS with endothelial cells, but did not report any differences in 
neuronal morphology (Shen, et al., 2004).  In a study recently published by Teng 
et al, (2008) co-culture of normal adult SVZ stem cells with endothelial cells from 
the ischemic border led to increased neuron production whereas co-culture of 
normal endothelial cells and adult SVZ NSCs increased proliferation but not 
neuronal production (Teng, et al., 2008).  In contrast, to the above studies, we 
found no increase in neuron production but altered neuronal morphology. This 
difference may reflect the different locations from which the NSCs were isolated 
146 
 
(e.g., VZ vs. hippocampus vs. SVZ) or differences in the ages of animals from 
which the cells were derived.           
  We noted that MBP+ oligodendrocytes generated after NS/endothelial 
cell co-culture or during ECCM differentiation were smaller and displayed less 
branching, suggesting that these oligodendrocytes may be more immature than 
those from control cultures. The altered oligodendrocyte morphology and 
increased production after differentiation in diluted ECCM are novel findings, as 
Shen found no difference in oligodendrocyte production or morphology and 
Weidenfeller did not detect oligodendrocytes in their cultures (Shen, et al., 2004, 
Weidenfeller, et al., 2007).  The specific conditions required for this effect in our 
experiments, 50% diluted ECCM, may relate in part to the amount of serum (5%) 
in the media. 
No studies to date have evaluated the influence of injured endothelial cells 
on postnatal SVZ NSCs.  Endothelial cell proliferation increases in the SVZ after 
stroke and peaks around 5 days after stroke, whereas SVZ expansion is 
increased by 3 d after stroke and SVZ cell proliferation peaks at 7d after stroke 
(Gotts and Chesselet, 2005, Gotts and Chesselet, 2005, Zhang, et al., 2001).  
Numerous studies have shown correlation between stroke-induced angiogenesis 
and stroke-induced neurogenesis, however the direct effects of injured 
endothelial cells on NSCs have not been evaluated (Chen, et al., 2004, Gotts 
and Chesselet, 2005, Ohab, et al., 2006, Sun, et al., 2003, Taguchi, et al., 2004, 
Thored, et al., 2007).  Therefore, we examined the influence of stroke-injured 
endothelial cells, using OGD as an in vitro stroke model, on SVZ NSC 
147 
 
proliferation, self-renewal, migration, and differentiation.  We found no significant 
difference in self-renewal (secondary NS size or number) after neurosphere 
expansion in OGD-ECCM.  In contrast, OGD-ECCM significantly promoted chain 
migration and increased neuronal process outgrowth compared with normal 
ECCM or controls.  Thus, factors secreted by stroke-injured endothelial cells 
induce SVZ NSCs to migrate faster and stimulate their differentiation.   
Using a stroke model that results in a cortical lesion, a recent study 
reported clusters of neuroblasts adjacent to newly formed endothelial cells in the 
peri-infarct region, as well as the presence of migrating neuroblasts alongside 
blood vessels towards and into the peri-infarct cortex (Ohab, et al., 2006).  To 
provide further support for the interaction of endothelial cells and neuroblasts, the 
authors blocked post-stroke angiogenesis using endostatin, which resulted in a 
marked decrease in the number of new endothelial cells and neuroblasts in the 
peri-infarct cortex. However, these effects may result from either direct cell-cell 
relationships or secreted factors (Ohab, et al., 2006).  After administration of the 
angiogenic factor angiopoietin-1, significantly more doublecortin+ neuroblasts 
were found in the peri-infarct cortex (compared with vehicle), again located in 
close proximity to endothelial cells (Ohab, et al., 2006).  These data suggest that 
endothelial cells near the infarct region may provide cues that attract neuroblasts 
to migrate to this area.  This idea fits well with our in vitro results, where OGD-
injured ECCM promoted faster neuroblast chain migration and differentiation.   
Our finding that factors from OGD-endothelial cells enhance neuron 
process outgrowth is novel and provides interesting insight into the function of 
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normal vs. injured endothelial cells in the neurogenic niche.  Under normal 
circumstances, endothelial cells appear to provide factors that maintain the niche 
in a more proliferative and undifferentiated state. After injury, however, these 
factors may be down-regulated, and novel endothelial cell-secreted molecules 
induce NSCs to migrate out of the SVZ and differentiate more quickly.  Our 
hypothesis is that endothelial cells in the SVZ, which is not damaged in the 
aforementioned stroke models, are activated to increase proliferation and self-
renewal of the NSCs, while endothelial cells in the infarct and peri-infarct regions 
down-regulate these factors and instead provide cues to attract NSCs to migrate 
to this region and differentiate quickly to replace the dying cells.  Thus, different 
combinations of endothelial cell-secreted factors likely contribute to maintain 
NSCs in their normal state and promote their migration and differentiation after 
injury.  If this model is correct, identifying these factors may provide significant 
therapeutic benefits for a number of diseases and conditions in which neurons 
are lost.  One set of factors could be administered to increase NSC proliferation 
while another could potentially be used to direct these cells towards an injured 
brain region and promote their differentiation. 
The specific endothelial cell-secreted factors that influence neurogenesis 
have not yet been identified.  Others have tested retinoic acid, forskolin, fetal 
bovine serum, or LIF+VEGF, and found that none of these factors stimulate in 
vitro neurogenesis in embryonic NSCs (Shen, et al., 2004).  Several studies 
suggest that VEGF, a pro-angiogenic factor expressed by endothelial cells 
(Palmer, et al., 2000), may be a prime candidate as it promotes normal and 
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stroke-induced neurogenesis (Meng, et al., 2006, Schanzer, et al., 2004, Sun, et 
al., 2006, Sun, et al., 2003), and stimulates adult NSC proliferation and neuronal 
differentiation in vitro via upregulation in endothelial cells isolated from the 
ischemic border (Teng, et al., 2008), and enhances NSC survival (Wada, et al., 
2006).  Other pro-angiogenic factors such as stem cell factor (Jin, et al., 2002, 
Sun, et al., 2006), matrix metalloproteinase-2 & 9 (Wang, et al., 2006) and 
pigment-epithelial-derived factor (Pumiglia and Temple, 2006, Ramirez-Castillejo, 
et al., 2006) also regulate NSCs in a variety of ways and are potential 
candidates.   
Our findings suggest that endothelial cells are an important component of the 
neurogenic niche and function to maintain postnatal SVZ neural progenitors in 
their stem cell-like state in the intact brain, whereas stroke-injured endothelial 
cells prompt SVZ neural progenitors to migrate and differentiate, potentially 
serving as an endogenous repair mechanism for neuronal replacement after 
injury.  These data provide important implications for treatment of stroke and 
other diseases where neuron replacement could be stimulated by administration 
of endothelial cell-secreted factors.  Thus, an important future direction is to 
identify these factors and determine their precise role(s) in modulating neural 
progenitor cells so that these factors may be manipulated after stroke or other 
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Figure 3.1: Schematic showing neurosphere (NS) culture methods for each 
experiment.   
For all experiments, the subventricular zone (SVZ) was dissected from P15 mice, 
trypsinized, and plated as single cells in serum-free media containing EGF and 
bFGF.  For experiment one, primary NS were expanded alone for 3d in transwell 
inserts, and then the inserts were transferred to wells containing primary 
endothelial cells in the serum-free media described above.  NS were co-cultured 
with endothelial cells in this non-contact system for 3d, and then were removed 
and differentiated alone for 7d in media containing 1% serum. NS were then fixed 
and immunostained to identify neurons, astrocytes, oligodendrocytes, stem 
cells/radial glia and endothelial cells. For experiment two, NS were expanded 
alone for 6d and then were differentiated in conditioned media (CM) containing 5 
or 10% serum for 7d.  NS were fixed and stained as in experiment one.  In 
experiment three, primary NS were expanded alone for 24 h, and then CM from 
normal or oxygen-glucose deprived (OGD) endothelial cells was added.  After 
another 5 days cultured in (serum free) OGD- or normal CM, primary NS were 
counted and measured, and then 1) passaged as secondary NS; 2) differentiated 
for 4d (and examined for immature neurons, stem cells/radial glia, cell cycle 
markers and cell death); or 3) differentiated for 7d and immunostained as in 
experiments one and two.  For experiment four, primary NS were expanded 
alone for 5d, and then were picked and re-plated in matrigel plus serum-free 
conditioned media for 3d to assess chain migration.  Primary NS were then fixed 















Figure 3.2: Endothelial cell co-culture with primary NS does not alter SVZ 
NS production.   
Primary NS were expanded alone for 3d and then co-cultured with endothelial 
cells, 3T3 cells or alone for 3d.  Primary NS numbers were counted and 
diameters measured at 6DIV.  There was a slight but insignificant increase in 
primary NS production after co-culture with endothelial cells compared with 
controls (A).  The increase in NS production was mainly due to an increase in the 
number of small NS produced, as NS co-cultured with endothelial cells or control 


















Figure 3.3: Endothelial cell-secreted factors keep neurons in a more 
immature state.   
A-C: Primary NS were expanded in non-contact co-culture with primary 
endothelial cells, NIH3T3 cells or alone, and then were differentiated alone for 
7d.  β-tubulin+ neurons from NS expanded with endothelial cells displayed short 
processes and cells tend to be clustered (A), whereas those expanded with 3T3 
cells or alone extended longer processes that tended to contact other neurons 
(B).  Quantification of neuron process length revealed that neurons derived from 
NS co-cultured with endothelial cells had significantly shorter processes (C, 
*p<0.01) than either control group.  D-F: Similarly, primary NS differentiated in 
(10% serum-containing) ECCM from primary mouse endothelial cells contained 
clusters of β-tubulin+ neurons with shorter processes (D) than controls, which 
display long processes that contacted other cells and were less clustered (E).  
Measurement of process length revealed that β-tubulin+ neurons from 100% or 
1:1 diluted (50%) ECCM were typically one-third of the length of controls (F; 
*p<0.01) Scale bar: 50 µm. 
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Figure 3.4: Endothelial cell-secreted factors alter neural 
progenitor/glial morphology. 
A-F: Primary NS expanded with primary endothelial cells and then 
differentiated for 7d showed nestin+ cells with long radial processes (A),  
while those expanded with 3T3 cells gave rise to fewer nestin+ cells that 
had a more typical astrocyte morphology (B), NS expanded alone had 
minimal or undetectable nestin expression (C).  NS differentiated after 
expansion with endothelial cells showed GFAP+ cells that displayed a 
more reactive astrocyte-like morphology (D) compared to the more typical 
flat GFAP+ astrocytes from control co-cultures (E, F).  G-L: After 
differentiation in ECCM (experiment 2), nestin is expressed in long 
processes (G) whereas its expression level is low and present in cells of 
typical astrocyte morphology in 3T3CCM-differentiated NS (H) or minimal 
in serum controls (I).  GFAP+ cells from ECCM-differentiated NS have 
numerous long processes, more typical of radial glia (J) and resemble 
those that express nestin (G).  GFAP+ cells from 3T3CCM-differentiated 
NS display a variety of morphologies (K), but do not typically contain radial 
glial-like cells, while those from serum controls have a normal astrocyte 
morphology (L).  M-R: NS differentiated in diluted ECCM (50%) contain 
nestin+ cells similar to those seen after differentiation in 100% ECCM, with 
strong nestin-immunoreactivity in long radial processes (M).  Nestin+ cells 
from diluted controls resemble those from 100% CM (Figure 4N-O, Q-R) 
with more typical astrocyte morphology. GFAP+ cells from diluted ECCM 
contain numerous long processes (P) similar to those seen in 100% 
ECCM while diluted 3T3CCM (Q) and serum controls (R) have more 
typical astrocyte morphology and expression.  Scale bars: 100 µm in A (for 






Figure 3.5: Endothelial cell-secreted factors influence 
oligodendrocyte formation.  
MBP+ oligodendrocytes derived from NS co-cultured with primary 
endothelial cells are typically small and display little branching (A). 
Significantly fewer MBP+ oligodendrocytes are formed from NS co-
cultured with 3T3 cells (B, D, *p<0.01) compared with the no cell control 
(C).  Those MBP+ cells from 3T3/NS co-culture that are present tend to 
have a larger immunoreactive center than those from other conditions and 
larger but more simple (one “ring”) branching patterns (B).  Quantification 
of MBP+ cells from fields of similar density revealed no difference in 
oligodendrocyte number between endothelial co-cultured NS and those 
cultured alone (D).  NS also were differentiated in undiluted (100%) or 
half-diluted (50%) ECCM (E, G) or 3T3 cell CM (F, H), and 
oligodendrocyte numbers identified by MBP immunostaining were 
quantified. ECCM-differentiated NS contained mostly small MBP+ 
oligodendrocytes with little branching (E), similar to those seen in NS from 
co-culture with endothelial cells (A).  MBP+ cells incubated with 3T3CCM 
displayed a variety of morphologies (F, H) and were typically similar in 
number to those from NS treated with 100% ECCM (I).  NS differentiated 
in 50% ECCM produced more MBP+ oligodendrocytes (G, I, *p<0.01) and 














Figure 3.6: Methods for Oxygen-Glucose Deprivation (OGD) of endothelial 
cells.   
The bEnd.3 cell line was used for all OGD experiments.  Growth media was 
removed from bEnd.3 cells, cells were washed briefly and then put into serum-
free, glucose-free media.  Cells were put into an anoxic chamber and oxygen 
was removed from the media.  Cells underwent 1 or 5hr OGD, then were 
removed from the chamber and placed into fresh SFM.  Cells were maintained at 
37°C in 10% CO2 during the reperfusion time.  SFM was collected from intact or 
OGD-exposed endothelial cells (or intact 3T3 cells) after 6, 12, or 24 hours for 




Figure 3.7: Endothelial cell-secreted factors increase NS production 
and SVZ NSC proliferation.  
A-F: SVZ-derived NS were expanded in CM from intact (ECCM) or OGD-
exposed endothelial cells (OGD-ECCM) or control media (3T3CCM or 
unconditioned).  The number and size of NS was measured after 6d of 
expansion and data graphed as percent of unconditioned control (A-B, D-
E; CM/unconditioned X 100%).  Expansion in intact 12h ECCM led to 
significantly more primary NS produced than in other conditions (A; 
*p≤0.01). There was no difference in primary NS size after expansion in 
CM (B).  Similar results were obtained for primary NS number in 1hr OGD 
experiments compared with 5h OGD experiments, and only the intact 12h 
ECCM condition showed more primary NS (C, p<0.05). After NS 
expansion in CM, cells were dissociated, re-plated in SFM and then 
expanded to form secondary NS.  Secondary NS number was increased, 
though not significantly (p=0.08) in 12hr ECCM compared with controls (D) 
and there was no difference in secondary NS size (E).  Secondary NS 
production was similar between 1hr and 5hr OGD experiments (F).  G-M: 
Primary NS were expanded in CM for 6d, differentiated in 1% serum for 
4d, and then were immunostained for Ki67.  NS expanded in 3T3CCM (G, 
J) or OGD-ECCM (I, L) contained very few Ki67+ cells.  NS expanded in 
intact ECCM contained significantly more Ki67+ cells compared to all 
other conditions (G-M).  Quantification of similar density NS revealed that 
those exposed to intact ECCM contained 2.5-3 times as many Ki67+ cells 
as in the OGD-ECCM groups, and approximately twice as many as in 







Figure 3.8: Endothelial cell-secreted factors alter NSC maturation.   
A-D: After 4d of differentiation, NS expanded in intact ECCM contain 
MAP2abc+ neurons with very short/no processes (C, arrows) compared to 
those from controls which contain neurons with a mixture of process 
lengths (A, B).  MAP2abc+ neurons derived from NS expanded in OGD-
ECCM display long processes, characteristic of more mature neurons (D, 
arrows).  F-I:  Similar effects were seen with β-tubulin staining.  After 7d of 
differentiation, NS expanded in intact ECCM contained β-tubulin+ neurons 
with very short processes (H, arrows) compared with those from controls 
which contained neurons with a mixture of short and long processes (F-
G).  β-tubulin+ neurons derived from NS expanded in OGD-ECCM 
displayed long processes, characteristic of more mature neurons (I, 
arrowheads).  E, J: Quantification of β-tubulin+ process length as a 
percent of the unconditioned media control (CM/unconditioned X 100%; 
dashed line) revealed a significant decrease in neuronal process length 
after NS expansion in intact ECCM and a significant increase in length 
after expansion in OGD-ECCM compared to controls (E, *p≤0.01, +p≤0.05 
vs. controls).  No difference was seen in the number of processes/cell (J).  









Figure 3.9: Endothelial cell-secreted factors alter glial morphology.  
A-D: Nestin expression after 4d of differentiation was low in unconditioned 
media (UNCOND) controls and present in astrocyte-like cells (A) while 
controls cultured with 3T3CCM displayed varied morphologies (B). NS 
expanded in intact ECCM and then differentiated for 4d contained strong 
nestin expression in radial glial-like cells with long processes (C, 
arrowheads).  NS that were expanded in OGD-ECCM produced some 
cells that maintained strong nestin-immunoreactivity with several short 
processes, characteristic of type II astrocytes (D, arrows), while other cells 
with lower nestin expression resembled radial glia (D, arrowheads).  After 
7d of differentiation, NS expanded in control media contain mostly large, 
flat GFAP+ astrocytes (arrows in E, F), while GFAP+ cells from ECCM-
expanded NS (G, arrowheads) maintain the radial glial-like morphology 
displayed in nestin+ cells after 4d of differentiation (C, arrowheads). 
GFAP+ cells from OGD-ECCM expanded NS display the morphology of 
type II astrocytes (H, arrows) and radial glial-like cells (H, arrowheads).  








Figure 3.10: Endothelial cell-secreted factors alter neuroblast chain 
migration.   
Primary NS were expanded for 5d and re-plated in matrigel for chain 
migration assays.  CM was added to NS upon re-plating in matrigel and 
NS were photographed at 24 h and fixed at 3d after plating in matrigel.  
NS incubated with intact ECCM collected over 6 or 12hr in serum-free 
medium (B, F) appeared similar to controls at 24h (A, E).  NS plated in 
OGD-ECCM collected 6 or 12h post-OGD displayed increased migration 
at 24h (C, G), with numerous chains extending out from the NS.  After 3d 
in matrigel, NS immunostained for MAP2abc+ (green) and GFAP (red) 
typically contained numerous immature neurons and few astrocytic 
processes (D).  The length of the longest chain was measured from the 
center of each neurosphere and graphed as a percent of the 
unconditioned control group (CM/unconditioned X 100%).  OGD-ECCM-
treated NS contained significantly longer chains compared with all other 
conditions (H, *p≤0.05 for 6h OGD-ECCM, p≤0.01 for 12h OGD-ECCM).  







Figure 3.11: Effects of different CM fractions on primary NS.   
CM was collected from intact 3T3 cells, intact endothelial cells or OGD-
exposed endothelial cells and separated into fractions less than or greater 
than 5kD.  These fractions were applied to primary NS 24h post-plating 
(same as in experiment 3) and NS allowed to expand for 5 more days.  
Primary NS were counted and then differentiated following the same 
methods as in experiment 3.  The most NS were produced from the >5kD 
fraction of 12h ECCM (A), similar to the results seen in experiment 3.  
Both fractions of 3T3CCM contained MAP2abc+ cells with a mix of short, 
medium and long processes (B, E).  MAP2abc+ neurons in the <5kD 
fraction of intact ECCM also displayed a mix of process lengths (C) while 
those from the >5kD fraction of ECCM have very short or no processes 
(F), similar to those from experiment 3.  Both fractions of OGD-ECCM 
contained Map2abc+ neurons with moderate and long processes (D, G).  







Table 3.1: Summary of the effects of endothelial cells on SVZ neural stem 
cells. *Oligodendrocytes (oligos) increased dramatically in number only in 50% 
diluted ECCM.  Other glial effects (+) involved alteration of Nestin- and GFAP-
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RETINOIC ACID AND ENVIRONMENTAL ENRICHMENT ALTER 




Neurogenesis increases in the adult rodent forebrain subventricular zone (SVZ) 
after experimental stroke. Newborn neurons migrate to the injured striatum, but 
few survive long-term and little evidence exists to suggest that they integrate or 
contribute to functional recovery.  One potential strategy to improve stroke 
recovery is to stimulate neurogenesis and integration of adult-born neurons by 
using treatments that enhance neurogenesis.  We examined the influence of 
retinoic acid (RA), which stimulates neonatal SVZ and adult hippocampal 
neurogenesis, and environmental enrichment (EE), which enhances survival of 
adult-born hippocampal neurons.  We hypothesized that the combination of RA 
and EE would promote survival of adult-generated SVZ-derived neurons and 
improve functional recovery after stroke.  Adult rats underwent middle cerebral 
artery occlusion, received BrdU on days 5-11 after stroke and were treated with 
RA/EE, RA alone, EE/vehicle or vehicle alone and were killed 61 days after 
stroke.  Rats underwent repeated MRI and behavioral testing.  We found that 
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RA/EE treatment preserved striatal and hemisphere tissue and increased SVZ 
neurogenesis as demonstrated by Ki67 and doublecortin (DCx) immunolabeling. 
All treatments influenced the location of BrdU- and DCx-positive cells in the post-
stroke striatum.  RA/EE increased the number of BrdU/NeuN-positive cells in the 
injured striatum but did not lead to improvements in behavioral function.  These 
results demonstrate that combined pharmacotherapy and behavioral 
manipulation enhances post-stroke striatal neurogenesis and decreases infarct 
volume without promoting detectable functional recovery.  Further study of the 
integration of adult-born neurons in the ischemic striatum is necessary to 
determine their restorative potential. 
 
Introduction 
The capacity of the adult mammalian brain to generate new neurons has 
been well established over recent years.  Neural stem cells from the adult 
forebrain subventricular zone (SVZ) give rise to olfactory bulb (OB) interneurons 
while those in the hippocampal dentate gyrus generate new neurons in the 
granule cell layer (Altman, 1969, Cameron and Gould, 1994, Corotto, et al., 
1993, Kaplan and Hinds, 1977, Kuhn, et al., 1996, Lois and Alvarez-Buylla, 
1994).  Brain insults such as seizure, stroke, and traumatic brain injury activate 
these neural stem cells, causing them to proliferate more rapidly, migrate away 
from these areas into injured regions, and form new neurons and glia (Arvidsson, 
et al., 2002, Goings, et al., 2004, Parent, et al., 2002, Parent, et al., 2002, Zhang, 
et al., 2001).  Stroke increases the production of doublecortin (DCx)- and 
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polysialylated neural cell adhesion molecule (PSA-NCAM)-positive neuroblasts in 
the SVZ and striatum; however, few cells survive long-term to become functional 
striatal neurons (Arvidsson, et al., 2002, Ohab, et al., 2006, Parent, et al., 2002).  
This latter finding suggests that interventions are necessary to enhance the long-
term survival of new neurons after stroke.  Moreover, structural and behavioral 
examination is critical to determine whether the newborn neurons integrate 
appropriately and contribute to functional recovery after focal ischemic insults. 
Many factors are involved in regulating neurogenesis during development. 
The plasticity exhibited by the brain after injury suggests that these factors also 
may be good candidates for enhancing post-stroke neurogenesis, and one 
developmental molecule of particular interest in this regard is retinoic acid (RA).  
During development, RA plays an essential role in anteroposterior patterning of 
the hindbrain and spinal cord (Liu, et al., 2001, Maden, 2002, Melton, et al., 
2004), dorsoventral patterning of spinal cord neurons (Diez del Corral, et al., 
2003, Novitch, et al., 2003, Wilson and Maden, 2005) and striatal neuron 
differentiation (Toresson, et al., 1999, Valdenaire, et al., 1998).  RA expression 
and signaling continues in the postnatal and adult brain.  Retinoid binding 
proteins are expressed in the SVZ-olfactory bulb pathway (Zetterstrom, et al., 
1999, Zetterstrom, et al., 1994), RA receptors persist in the olfactory bulb 
(Krezel, et al., 1999), and the RA synthesizing enzyme RALDH3 is present in the 
olfactory bulb, rostral migratory stream (RMS), and SVZ (Wagner, et al., 2002).   
We and others have found that retinoid signaling is a key regulator of postnatal 
and adult SVZ-olfactory bulb neurogenesis, and that exogenous retinoid 
180 
 
administration stimulates this process (Calza, et al., 2003, Haskell and LaMantia, 
2005, Wang, et al., 2005).  RA signaling also appears necessary for adult 
hippocampal neurogenesis as depletion of RA in adult mice decreases dentate 
granule cell differentiation (Jacobs, et al., 2006).  These studies led us to 
investigate whether RA enhances post-stroke striatal neurogenesis.   
Environmental enrichment is a commonly used behavioral intervention for 
rodents and primates after brain injury.  Many studies demonstrate the positive 
effects of environmental enrichment (EE) on functional recovery after injury, 
although the timing of EE or related interventions after injury is one factor that 
determines whether it provides beneficial or deleterious effects on recovery or 
secondary neural degeneration (Bland, et al., 2001, Kleim, et al., 2003, Schallert, 
et al., 2000, Tillerson, et al., 2001).  Other work also shows positive effects on 
dentate gyrus neurogenesis (Kempermann, et al., 1998, Kempermann, et al., 
1997, Komitova, et al., 2002, Nilsson, et al., 1999, Wurm, et al., 2007), in that EE 
enhances neuron survival; however, few studies have examined the effects of EE 
on striatal neurogenesis.   
Given that RA stimulates forebrain SVZ neurogenesis and EE enhances 
the survival of some adult-born neurons and improves functional recovery, we 
hypothesized that combining oral RA-treatment with EE would enhance the 
generation and long-term survival of SVZ-derived striatal neurons as well as 
increase functional recovery after stroke.  We treated adult rats with RA/EE, RA 
alone, EE/vehicle or vehicle alone after experiencing a focal ischemic insult, and 
examined the effects of treatment on SVZ and striatal neurogenesis, stroke 
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volume and sensorimotor function.  We found that RA/EE treatment preserved 
striatal and hemisphere tissue, increased SVZ neurogenesis, influenced the 
location of newborn cells in the post-stroke striatum, and increased the number 
of new striatal neurons but did not improve behavioral recovery detectably. 
 
Methods  
Transient Middle Cerebral Artery Occlusion 
Adult (210-250 gram) male Sprague-Dawley rats (Charles River) were 
used for all experiments and all procedures were approved by the University of 
Michigan Committee on Use and Care of Animals.  Animals were group housed 
on a 12-hour reverse light-dark cycle and provided with food and water ad 
libitum.  Rats were anesthetized with a ketamine/xylazine mixture (100mg/kg, 
intraperitoneal). Body temperature was maintained using a 37°C re-circulating 
water pad.  Transient middle cerebral artery occlusion (tMCAO) was produced for 
90 minutes using the external carotid artery insertion method as described 
previously (Longa, et al., 1989).  Briefly, the left common carotid artery was 
exposed through a midline incision, and the internal and external carotid arteries 
separated.  A 3.0 nylon monofilament with tip rounded by heat was placed in the 
external carotid artery and advanced through the internal carotid artery until 
resistance was felt. The monofilament was left in place for 90 minutes and then 
removed under anesthesia.  Animals were observed until they recovered from 
anesthesia.  This protocol produced infarcts involving the striatum and cortex 





The thymidine analog, bromodeoxyuridine (BrdU, Roche, Indianapolis, IN) 
was used to label cells in S-phase (Miller and Nowakowski, 1988).  Rats received 
twice daily intraperitoneal (i.p.) injections of BrdU (50mg/kg in sterile PBS, 6 
hours apart) on days 5-11 after tMCAO.  This timing was chosen based on 
previous studies showing that SVZ proliferation peaks approximately one week 
after stroke (Parent, et al., 2002, Zhang, et al., 2001) and to limit labeling of the 
earlier post-injury glial response.   
 
MRI 
All animals received T2-weighted MRIs on days 7 and 59 post-tMCAO.  
T2-weighted MRIs were performed using a 7.0 tesla, 18.3 cm horizontal bore 
magnet as previously described (Chenevert, et al., 1997, Kim, et al., 1995, 
Moffat, et al., 2006).  Serial coronal slices were acquired at 1.5 mm intervals 
through the rostro-caudal extent of the brain, resulting in 13 slices/animal.  
Animals were randomly assigned to treatment groups using day 7 MRI.  To keep 
infarct size consistent between groups, we excluded animals with greater than 
88% or less than 65% residual hemispheric volume at the level of the striatum on 





On day 7 post tMCAO, animals were randomly assigned to one of four 
treatment groups: combined RA-enriched diet and environmental enrichment 
(RA/EE), RA-enriched diet and standard environment (RA/SE), normal diet and 
environmental enrichment (NML/EE) or control with normal diet and SE 
(NML/SE).  Animals in the RA groups received the RA-enriched diet on days 7-
41 post tMCAO to prolong proliferation and enhance survival of newly generated 
neuroblasts.  Animals in the EE groups were placed into monkey cages 
containing an assortment of tunnels, ropes and wire mesh for climbing, chew 
toys, hidden snacks, and a number of other rodent toys during their dark cycle on 
days 8-27 post tMCAO to promote functional recovery and enhance survival of 
newly generated neurons.  Animals were rotated through 4 different monkey 
cages, each with a unique set-up.  Unlike previous studies, EE rats were not 
housed continuously in EE cages, but instead were introduced to the EE cages 
on a gradual basis (1 hr/day for 2 days, 2 hr/day for 2 days, 3 hr/day for 
remainder) and housed there for a maximum of 3 hours/day.  This protocol was 
chosen to more closely mimic the intermittent nature of human rehabilitative 
therapy.   
 
Behavioral Testing 
Animals underwent a set of sensorimotor tests on day 6 post-tMCAO to 
determine initial deficits, and the battery was repeated on days 28 and 60 post-
tMCAO to measure recovery over time.  All behavioral testing was performed 
during the dark cycle.  Hind-limb deficits were measured on the tapered, ledged 
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beam test as previously described (Zhao, et al., 2005).  The number of ipsilateral 
and contralateral hindlimb “foot faults” was counted on 4 video-recorded 
trials/animal/time point. Forelimb asymmetry was assessed using the cylinder 
test as well as vibrissae-evoked placing (Schallert, et al., 2000, Schallert, et al., 
2002).  For the cylinder test, animals were placed into a plexiglass cylinder and 
all trials were video-recorded via an angled mirror for blinded analysis. The 
number of ipsilateral, contralateral, and bilateral forepaw wall contacts for weight 
support or shifting was counted and the percent use of the affected limb 
calculated using the formula: [(ipsilateral/total)-(contralateral/total)] x 100% 
(Woodlee, et al., 2005).  Animals underwent 10 trials/side/time point of vibrissae-
evoked placing and the number of placings was recorded.     
 
Histopathology 
On day 61 post-tMCAO, animals were deeply anesthetized with sodium 
pentobarbital and perfusion-fixed with saline followed by 4% paraformaldehyde 
(PFA).  Brains were removed and post-fixed in 4% PFA overnight, cryoprotected 
in 30% sucrose, then frozen in powdered dry ice.  Coronal serial sections were 
cut at 40 µm on a cryostat, collected into tris, then transferred into cryoprotectant 
and stored at -20°C.  To confirm lesion severity from MRI analyses, 4 striatal 
level sections/animal were mounted onto slides, Nissl-stained using cresyl violet, 






Diaminobenzidine immunohistochemistry was performed with antibodies 
to doublecortin (DCx) and BrdU using previously published protocols [See 
Appendix; (Parent, et al., 2002, Plane, et al., 2004)].  For BrdU staining, sections 
were rinsed in Tris, denatured in 2N HCl at 37ºC for 30 min, neutralized in 0.1M 
boric acid for 10 min, rinsed, blocked with 10% normal horse serum (Invitrogen, 
Carlsbad, CA), and incubated overnight at 4ºC with anti-BrdU antibody (1:1000 
dilution; mouse monoclonal, Roche Applied Science, Indianapolis, IN).  Sections 
were rinsed, incubated in secondary antibody (1:200 biotinylated horse anti-
mouse IgG, Vector Labs) for 1 hour, rinsed, signal amplified with Vector ABC kit, 
developed with stable diaminobenzidine (Invitrogen), mounted onto slides, 
dehydrated and cleared in ethanol and xylenes, and coverslipped using 
Permount (Sigma).  DCx immunostaining followed a similar protocol except that 
sections were put into 1% H2O2 for 30 min instead of 2N HCl and boric acid.  
Sections were blocked with normal horse or goat serum and incubated either in 
goat anti-DCx (1:2000, overnight, Santa Cruz) or rabbit anti-DCx antibody 
(1:1000 for 2 nights, (Parent, et al., 2002); biotinylated horse anti-goat or goat 
anti-rabbit IgG secondary antibodies were used.  For Ki67 immunofluorescence 
(See Appendix), sections were washed with Tris-Buffered Saline (TBS), blocked 
in goat serum, then incubated in rabbit anti-Ki67 (1:1000, Vector Labs) overnight 
at 4°C.  Sections were washed in TBS, incubated in goat-anti-rabbit Alexa 488 
(1:800, Invitrogen) at room temp for 1.5 hours.  Sections were washed, mounted 
onto slides and allowed to dry, then coverslipped with an anti-fade medium (Pro-
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Long, Invitrogen).   Double-label immunofluorescence staining was performed as 
previously described to identify the phenotype of newly formed cells (Parent, et 
al., 2002, Plane, et al., 2004).  Sections were stained with antibodies to (See 
Appendix) BrdU (1:250 rat, Accurate Chemical) and NeuN (1:1000, mouse 
monoclonal, Chemicon), Map2ab (1:400, mouse monoclonal, Sigma), GFAP 
(1:500, mouse monoclonal, Sigma), Rip (1:200, mouse monoclonal, Chemicon), 
ED-1 (1:200, mouse-anti-rat, Serotec) or Glut-1 (1:400, rabbit polyclonal, 
Chemicon).   
 
Quantitative Analyses 
Intact hemispheric and striatal areas were measured on MRIs at striatal 
levels (3 images/animal/timepoint) and stroke volume calculated (Area X Slice 
Thickness X #Slices). Area measurements were also obtained from Nissl stained 
striatal sections (n=4/animal) to confirm MRI findings. Unbiased stereology was 
performed on every 12th section (n=5 sections) to count striatal BrdU+ cells.  
Striatal areas were outlined at low magnification and BrdU-positive cells were 
counted at 100X using the optical fractionator technique (StereoInvestigator; 
(Plane, et al., 2004, West, et al., 1996).  Peri-infarct BrdU labeling was quantified 
at the level of the anterior striatum in 3 sections/animal.  Images of the dorsal 
and ventral striatum adjacent to the infarct, nearest the level of the dorsal and 
ventral lateral ventricle, respectively, were captured without knowledge of 
experimental group using a SPOT-RT digital camera at 40X magnification and all 
BrdU-positive cells within these fixed areas were counted. DCx immunoreactivity 
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was quantified in the SVZ in 4 equidistant anterior striatal sections/animal. DCx-
positive SVZ area and density measurements were obtained using Image J from 
10X images of the dorsolateral SVZ.  Ki67-positive cells were counted in the 
lateral SVZ of 3 equidistant striatal sections/animal in 20X images of the lateral 
ventricle. Immunofluorescence double labeling and confocal microscopy (Zeiss 
LSM 510) were used to assess co-localization of immunofluorescence for double 
labeling and to quantify BrdU+ or BrdU/NeuN+ cells (3-6 63X fields/animal).  All 
analyses were performed in a blinded manner.   
 
Statistics 
Analysis of variance (ANOVA) with post-hoc t-tests were used to compare 
differences between treatments for all quantitative analyses.  Results were 
presented as means ± standard error of the mean (SEM) and considered 
significant when p≤0.05.   
 
Results 
RA treatment preserves hemisphere volume after stroke 
RA is a key regulator of neurogenesis in the postnatal and adult SVZ-OB 
pathway (Haskell and LaMantia, 2005, Wang, et al., 2005).  Because RA 
stimulates SVZ neurogenesis and EE increases the survival of adult-born 
neurons in the dentate gyrus, we sought to determine if RA-treatment combined 
with EE would promote adult SVZ neurogenesis and functional recovery after 
stroke.  To evaluate lesion severity, assign animals to treatment groups, and 
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assess long-term effects of treatment on stroke volume, rats received serial MRIs 
on days 7 and 59 after tMCAO.  Animals were randomly assigned to treatment 
groups or excluded from the study based on day 7 MRI results.  All animals had 
similar lesion sizes on day 7, prior to treatment (Figure 4.1A-D, E).  They 
underwent repeat MRI on day 59 post-tMCAO to compare treatment effects on 
stroke volume.  Animals that received an RA-enriched diet had more residual 
hemisphere tissue than those on a standard diet (Figure 4.1A’-D’, E, p<0.05 
RA/EE vs. NML/EE, RA/SE vs. NML/EE or NML/SE).  RA-treated animals also 
had less decline in hemispheric volume over time [(d59-d7)/d7] compared with 
controls (Figure 4.1F, p<0.05 RA/EE vs. NML/EE, RA/SE vs. NML/EE or 
NML/SE).  Results were similar when the entire rostral-caudal extent of the brain 
was analyzed on MRI (Figure 4.2A, p<0.05).  Analysis of cresyl violet stained 
sections (n=4/animal) revealed a similar trend, as smaller differences between 
ipsilateral and contralateral residual hemisphere were observed 61 days after 
MCAO in animals fed the RA-enriched diet (Figure 4.2B). Animals that received 
both RA and EE also lost significantly less striatal volume over time compared 
with untreated animals (Figure 4.1G, p=0.03).   Finally, the ipsilateral SVZ of 
animals treated with RA-alone or RA/EE was substantially larger than that of 
vehicle-treated animals (Figure 4.2C). These differences could potentially be 
confounded by differences in nutrition or food consumption due to the RA-
enriched diet.  However, animals were weighed periodically and there was no 
difference in end weight between animals on normal diet vs. RA-enriched diet 
(Figure 4.2D, p=0.3).  Thus, retinoic acid decreases post-stroke tissue loss 
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assessed by MRI in an area of the rodent brain, the striatum, where stroke-
induced neurogenesis is known to occur.  
 
RA treatment increases SVZ neurogenesis and alters neuroblast migration 61 
days after stroke 
To determine whether our interventions stimulated SVZ neurogenesis as a 
potential explanation for the preservation of tissue after stroke, we first used 
Ki67, an endogenous proliferation marker, to assess SVZ cell proliferation 61 
days after stroke.  As expected, Ki67-positive cells were present in the 
dorsolateral tail of the SVZ and along the lateral wall of the lateral ventricle 61 
days after stroke in the control group; however, rats that received both RA and 
EE showed a strong trend toward greater numbers of Ki67-positive cells in the 
SVZ (Figure 4.3A-D, Figure 4.4A-B; 78.8 ± 8 in RA/EE vs. 53 ± 13 cells in 
NML/SE), although the differences were not statistically significant.  We next 
examined whether the increased cell proliferation was associated with an 
increase in SVZ neurogenesis.  Using DCx immunohistochemistry to identify SVZ 
neuroblasts, we found that the RA/EE-treated group displayed increased SVZ 
DCx expression in an expanded SVZ (Figure 4.3E-H, Figure 4.4C).  The 
enlarged DCx-immunoreactive SVZ area led us to question whether the increase 
was simply a result of the cells being more spread out.  We therefore measured 
the density of DCx immunostaining in the SVZ and found a significant increase in 
the density of DCx-positive cells in the SVZ of RA/EE-treated rats compared with 
controls (Figure 4.4D, p<0.05).  Together, these findings indicate that combined 
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RA and EE treatment increases SVZ neurogenesis in the chronic phase after 
stroke. 
 Previous studies showed that SVZ neuroblasts migrate to the injured 
striatum within the first few weeks after stroke (Arvidsson, et al., 2002, Parent, et 
al., 2002) and continue to do so chronically (Thored, et al., 2006).  To examine 
whether the prolonged increase in SVZ neurogenesis after RA/EE treatment 
corresponded with increased striatal neurogenesis after stroke, we injected adult 
rats with BrdU on days 5-11 after tMCAO and assessed BrdU labeling on day 61 
after tMCAO.  Unbiased stereology was performed on BrdU-immunostained 
sections to determine the number of cells generated after stroke that persisted in 
the ipsilateral striatum 61 days after tMCAO.  There was no difference in the total 
number of striatal BrdU-positive cells between groups (Table 1); however, more 
BrdU-labeled cells appeared close to the infarct border in the three treatment 
groups (Figure 4.5A-E).  This observation led us to quantify BrdU-positive cell 
numbers in the peri-infarct area of the striatum.   Images of the dorsal and ventral 
peri-infarct striatal areas were captured and BrdU-immunoreactive cells counted 
for each area (Figure 4.4A).  We found, on average, more BrdU-positive cells in 
the peri-infarct regions in all 3 treatment groups (Figure 4.5B-E; Table 4.1: 
1272±350 cells for RA/EE, 1146±239 for RA/SE, 1276±253 for NML/EE) 
compared to controls (999±101 cells); however, the differences were not 
statistically significant due to the large variability between animals (Table 4.1). 
We next examined the location of migrating neuroblasts at 2 months after 
stroke.  DCx immunoreactivity was assessed in the peri-infarct region at the level 
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of the dorsal striatum (Figure 4.5F).  We found that, compared to controls, more 
DCx-positive cells appeared in the injured striatum of all three treatment groups 
(Figure 4.5G-J).  DCx-positive neuroblasts were dispersed throughout the injured 
striatum, but more neuroblasts were found closer to the infarct in the three 
treatment groups, particularly in the RA/EE group versus controls (Figure 4.5G-
J).  Together, these results suggest that RA and EE treatment promote migration 
of new cells to the peri-infarct striatum. 
 
Combined treatment with RA and EE increases striatal neurogenesis 
To determine whether RA and EE treatment yielded more surviving striatal 
neurons generated after stroke, double-labeling was performed for BrdU and 
NeuN or Map2 and confocal thin optical z-slices collected from several locations 
in the ipsilateral striatum. Animals received i.p. injections of BrdU on days 5-11 
after MCAO to label proliferating cells and were killed on day 61 post-tMCAO to 
assess the long-term survival of labeled cells.  Rats that received both RA and 
EE showed a 35% increase in the proportion of BrdU-labeled cells that co-
expressed NeuN in the striatum (21±5.7% ) 61 days after tMCAO (Table 4.1, 
Figure 4.6A-D) compared with untreated animals (15.5±3.3% of BrdU+ cells were 
BrdU/NeuN double-labeled; Table 4.1, Figure 4.6E-H).  RA- or EE-alone did not 
increase the proportion of BrdU/NeuN double-labeled cells in the injured striatum 
(15.7±2.5% and 15.6±2.9%, respectively). 
 
Enriched environment may transiently improve functional recovery 
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Behavioral testing was performed on day 6 after tMCAO to determine 
baseline deficits and was repeated on days 28 and 60 to assess functional 
improvements over time. All groups had similar and severe behavioral deficits on 
day 6 after injury on all 3 sensorimotor tests and showed some improvement in 
the cylinder and beam tests by day 28 (Figure 4.7A-B) but not in the vibrissae-
evoked placing test (Figure 4.7C).  The EE-alone group appeared to show the 
most improvement, however, and this trended toward significance on the cylinder 
test (Figure 4.7A, repeated measures ANOVA, p=0.06).  The enrichment was 
stopped on day 27 and the probable beneficial effect was no longer apparent by 
day 60 (Figure 4.7A).  This transient improvement and subsequent loss is likely 
due to the halting of EE-treatment on day 27 but suggests that short durations of 
EE transiently promote functional recovery.  Of note, when higher doses of RA 
were given to animals in pilot studies they often caused weakness of hindlimbs 
and, to a lesser extent, forelimbs, suggesting the possibility of adverse RA effects 
that may have obscured the detection of functional benefit. 
 
Discussion 
Retinoic acid influences patterning and neuronal differentiation in the 
developing brain (Maden, 2007) and is an essential component of early neuronal 
differentiation and cell survival in the adult mouse dentate gyrus (Jacobs, et al., 
2006).  Few studies have examined the effects of retinoic acid in stroke-induced 
neurogenesis and no studies have evaluated the combined effects of a pro-
neurogenic factor and environmental enrichment on stroke-induced neurogenesis 
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and functional recovery.  The goal of this study was to determine whether the 
combined treatments improve both functional recovery and promote 
neurogenesis in the striatum after tMCAO.  We found that RA/EE treatment 
decreased the loss of brain tissue months after stroke, increased neuroblast 
production in the SVZ and striatum, and likely influenced neuroblast migration to 
injury. This treatment, however, did not lead to significant improvements in 
functional recovery.  
Very few studies have examined changes in stroke size after tMCAO 
within animals.  Using MRI, we were able to compare initial stroke volume, prior 
to treatment, with stroke volume after treatment in the same animal to more 
accurately determine beneficial or deleterious effects of treatment. This led us to 
the novel finding that RA-treatment preserves brain tissue.  Only one previous 
study found that pre-treatment with 9-cis RA, but not all-trans RA, decreased 
infarct size after MCAO (Harvey, et al., 2004); unlike our study, however, this 
work only examined the acute phase of cerebral ischemia and not regeneration.  
In our study the brain tissue preservation that resulted from RA-treatment was 
very unlikely to be a neuroprotective effect given that the treatment was not 
started until 8 days after stroke, although we cannot exclude an influence on very 
delayed cell death.  
A number of potential explanations exist for the lack of a functional 
correlate to the tissue preservation.  We found that total brain volume was 
preserved, as was hemisphere volume at the level of the striatum.  Striatal 
volume was also preserved, although to a lesser extent than hemisphere volume, 
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leading to the possibility that RA-treatment preserved tissue in brain regions not 
involved in the sensorimotor tasks used to measure functional recovery. Many 
animals had already sustained 25-30% damage by day 7 after tMCAO so 
perhaps the strokes were too large and functional deficits too severe to see any 
modest effects of RA on functional recovery.  Timing and dosage of RA is also 
important, as too much retinoic acid reduces cell proliferation in the mouse SVZ 
and dentate gyrus, reduces hippocampal neurogenesis (Crandall, et al., 2004) 
and causes changes in bone density (Rohde and DeLuca, 2003).  In pilot 
studies, we observed a number of uninjured adult rats with impaired hindlimb use 
when given higher doses of RA, which recovered after removal of the RA-
enriched diet.  These observations led us to cut the dosage in half for the current 
study, although 3 rats (out of 18) displayed temporary impaired ipsilesional limb 
use with the current dose.   
Another possibility is that the adult-born neurons did not effectively 
integrate after stroke.  Such integration is likely necessary to restore function and 
has not yet been unequivocally demonstrated for stroke-induced striatal 
neurogenesis. However, following small focal cortical infarcts a combination of 
EGF and EPO delivered intraventricularly one week after injury enhanced SVZ 
cell proliferation neuronal migration, cortical tissue generation, and functional 
recovery (Kolb et al., 2007). Removal of the new tissue reversed, though not 
immediately, the functional benefit. Another possibility is that starting RA-
treatment or EE at a later timepoint or for longer durations may be more 
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beneficial for the survival and integration of striatal neurons generated after 
stroke. 
We found increased SVZ neurogenesis 61 days after tMCAO in RA/EE-
treated rats, as shown by Ki67 and DCx labeling.  Most studies assessed cell 
proliferation more acutely after injury and found increased neurogenesis in the 
SVZ in the first few weeks after MCAO (Arvidsson, et al., 2002, Jin, et al., 2001, 
Parent, et al., 2002, Zhang, et al., 2001), although a persistent increase in basal 
stroke-induced neurogenesis has been reported by one group (Thored, et al., 
2006).  Our data suggest that RA further increases SVZ neurogenesis in the 
chronic stages after stroke. Contrary to our findings, a recent study found that 
RA-treatment after photothrombotic stroke decreased BrdU and DCx in the SVZ 
(Jung, et al., 2007).  This study assessed only acute (7 days after injury) 
proliferation effects, which may be one reason for the disparities with our 
findings.  Further, they used photothrombosis to induce cerebral infarction, 
resulting in an isolated cortical infarct which differs from the tMCAO model in 
which rats have both striatal and cortical injury, and this larger injury may 
influence SVZ neurogenesis in different ways (Kolb et al., 2007).  Additionally, 
i.p. injections of RA were administered for the first week after stroke, which 
differs substantially from our 5 week treatment of diet-enriched RA which began 
one week after tMCAO. 
Another finding was that RA/EE treatment increased striatal neuroblast 
numbers and promoted new cells to migrate farther from the SVZ. Numerous 
DCx-positive neuroblasts and BrdU-positive cells were located near the infarct 
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border in RA/EE treated rats, whereas these cells tended to be located closer to 
the dorsolateral tail of the SVZ in untreated rats.   Previously our lab found that 
RA influenced the migration of SVZ neuroblasts in the SVZ-olfactory bulb 
pathway of the early postnatal brain (Wang, et al., 2005), and the results from 
this study suggest that RA and EE may promote the migration of newly formed 
SVZ cells towards the injured striatum or promote their survival near the infarct 
border. RA/EE-treatment also appeared to increase striatal neurogenesis after 
tMCAO, as shown by an increase in the number of BrdU/NeuN double-labeled 
cells. This slight increase in new neuron survival may be a future therapeutic 
target to enhance neurogenesis. As shown in this study, increased neurogenesis 
does not necessarily mean improved function, as we saw no significant 
behavioral recovery in RA/EE-treated animals compared with untreated rats.  In 
order to determine if neurogenesis is in fact necessary for functional recovery, 
further studies in which neurogenesis is eliminated or reversibly inhibited are 
needed.  One would expect to see behavioral outcomes worsened by blocking 
neurogenesis if it is in fact important for functional recovery.   
Most studies that evaluate the effects of EE on neurogenesis continuously 
house the animals in EE and have focused on the dentate gyrus, finding that EE 
enhances DG cell survival. We found that the short duration of EE used in this 
study seems to provide a transient improvement in sensorimotor function.  Using 
only up to a maximum of 3 hours of EE per day, we saw a trend toward 
improvement in forelimb placing at the end of the treatment period.  This 
improvement was lost, however, when the animals were tested again one month 
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after “therapy” was halted, suggesting that perhaps short durations of EE over a 
longer period of time may result in prolonged functional recovery.  Similar results 
were found in a recent study with mice evaluating the effects of environmental 
enrichment for 3 hr/day for 2 weeks after MCAO (Nygren and Wieloch, 2005). 
Interestingly, mice that were housed in continuous EE showed improved 
motor function but also had increased mortality; mice housed in EE for 3 h/d for 2 
weeks, and then in standard cages for 2 weeks showed a loss of the motor 
function that they had recovered.  These investigators also found that 4 weeks of 
3 hr/day EE produced more long-lasting functional recovery.  These results 
support our findings and the notion that a longer treatment period of short 
duration EE may provide substantial functional recovery.  Despite this potential 
recovery, EE alone did not yield an increase in post-stroke neurogenesis, 
suggesting a dissociation between these two processes similar to that found for 
hippocampal-dependent memory effects of EE (Saxe, et al., 2006).   
Other studies that evaluated the effects of EE on post-stroke 
neurogenesis found conflicting effects.  After cortical stroke and EE, BrdU and 
Ki67 labeling increased bilaterally in the rat SVZ (Komitova, et al., 2005) and 
BrdU incorporation increased in the peri-infarct cortex although double-labeling 
revealed that most of these cells were glia (Komitova, et al., 2006).  Another 
study from the same group found that post-stroke EE increased BrdU and DCx 
labeling in the SVZ 5 weeks after stroke (Komitova, et al., 2005), while others 
found that striatal lesioning induced by quinolinic acid or 6-hydroxydopamine plus 
EE increased striatal DCx expression and enhanced neuroblast migration into 
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the striatum (Urakawa, et al., 2007).  In mice, EE increased SVZ progenitor 
numbers after stroke (Hicks, et al., 2007, Nygren, et al., 2006) but decreased the 
migration of DCx-positive cells into the striatum (Nygren, et al., 2006).  Together 
with our results, these studies suggest that differences in species, type of injury, 
and duration of EE lead to varied influences on SVZ and striatal neurogenesis.    
Few neurons typically survive long-term after stroke (Arvidsson, et al., 
2002, Parent, et al., 2002) and our data suggest that the combination of RA and 
EE may provide a first step in promoting their survival.  Future studies are 
needed to determine the most beneficial timing and dose of RA-treatment, such 
as whether a lower dose or longer delay prior to RA treatment may provide 
similar increases in neurogenesis without potential deleterious effects.  Similarly, 
more work is required to determine if a longer timeframe of short-duration EE 
treatment, possibly including a tapering-off of the treatment, would be more 
beneficial to cell survival and functional recovery after stroke. 
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Figure 4.1: RA preserved hemisphere volume after stroke.  
All animals had T2-weighted MRIs on day 7 (A-D) and day 59 (A'-D') after 
tMCAO and were assigned to treatment groups based on day 7 stroke volume 
(≥65% normal signal volume vs. intact hemisphere).  All groups had similar 
stroke volumes prior to treatment (E).    Rats that received an RA-enriched diet 
had more residual hemisphere volume at day 59 after MCAO compared with 
those on a normal diet (E, *p<0.05 vs NML/EE, +p<0.05 vs. NML/SE) as well as 
a smaller change in hemisphere volume over time (F, *p<0.05 vs NML/EE, 
+p<0.05 vs. NML/SE).  Rats that received an RA-enriched diet and 
environmental enrichment maintained more striatal volume over time compared 









Figure 4.2: RA preserved brain volume and increased SVZ area. 
Residual hemisphere tissue was measured on 13 MRI slices on days 7 and 59 
after stroke.  RA/EE and RA/SE animals maintained larger hemisphere volume 
(mm3) over time compared with normal diet rats (A). Cresyl violet staining and 
residual hemisphere measurements at the level of the striatum confirmed MRI 
findings in Figure 1 and Figure 2A (B). The SVZ remained greatly expanded at 
61d after tMCAO in RA/EE and RA/SE rats compared with NML/EE and NML/SE 
rats (C, cresyl violet).  There was no significant difference in body weight on day 
61 in RA-treated vs. vehicle-treated rats (D, p=0.3).  All values are expressed as 
± SEM.  
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Figure 4.3: RA/EE increased SVZ cell proliferation at 61d post-stroke.   
Ki67 labeling was performed to identify proliferating cells at the time of sacrifice.  
All animals had Ki67+ cells present in the dorsolateral tail of the SVZ as well as 
along the lateral wall of the lateral ventricle.  Animals that received the RA-
enriched diet combined with EE had the most Ki67+ cells present in the lateral 
SVZ (A) and animals that received only the RA-enriched diet also displayed 
increased Ki67-immunoreactivity (B) compared with EE-only (C) and  untreated 
rats (D).  The enlarged SVZ contains numerous DCx+ neuroblasts and increased 
DCx immunoreactivity in RA/EE (E), RA alone (F) and EE alone (G), groups 
compared to controls (H) 61 days after MCAO.  LV=lateral ventricle, shown at 










Figure 4.4: Quantification of increased SVZ neurogenesis at 61d post-
stroke.   
RA/EE-treatment increased the average number of Ki67+ cells/section in the 
lateral portion of the SVZ (A)  and the total number of Ki67+ cells along the 
lateral wall of the lateral ventricle (B) compared with controls.  RA/EE rats have a 
significantly larger DCx+ dorsolateral SVZ compared to EE-alone or untreated 
rats (C, *p=0.02).  The enlarged DCx+ SVZ of RA/EE rats also contains 
significantly more densely packed cells (D) than that of EE alone or untreated 




Figure 4.5: RA/EE increased striatal peri-infarct BrdU and DCx. 
Rats were injected with BrdU on days 5-11 after tMCAO. Analysis of peri-infarct BrdU was performed as described in 
the methods section.  BrdU+ cells in the peri-infarct striatum were counted in dorsal and ventral areas as shown (A). 
BrdU+ cells appeared more numerous within the peri-infarct region of RA/EE (B), RA/SE (C) and NML/EE (D) rats 
compared with untreated rats (E).  The distribution of DCx expression in the injured striatum differs as well.  The image in 
F is from a representative RA/EE rat, showing DCx expression extending from the dorsolateral tail of the SVZ, laterally to 
the infarct border and deep into the ventral striatum. DCx+ neuroblasts appear more dense and farther from the ventricle 
in the lesioned striatum in RA/EE (G) and RA/SE (H) than in NML/EE (I) or untreated rats (J).  *denotes infarct border.   




Figure 4.6: RA/EE enhanced the formation of new neurons in the 
injured striatum. 
 Rats were injected with BrdU on days 5-11 and killed 61 days after 
tMCAO.  Double-label immunofluorescence staining for BrdU and NeuN 
identified new neurons born during this time of peak proliferation after 
tMCAO.  There was a distinct border between BrdU+ cells and healthy 
neurons in the injured striatum of most rats, regardless of treatment, 
making it difficult to locate double-labeled cells (A, E).  The injured 
striatum of RA/EE rats contained the most BrdU/NeuN double-labeled 
cells (arrows, B-D).  Of note, very few BrdU/NeuN double-labeled cells 
were strongly BrdU+, rather most contained strong NeuN (C) and lighter 
BrdU immunoreactivity (B,D), suggesting that these cells divided 
numerous times.  Similarly, untreated rats typically displayed strong NeuN 
staining (G) with more diluted BrdU (F) in the same cell (H, arrow), 
however, fewer double-labeled cells were found in these animals.   Scale 








Figure 4.7: EE transiently improves functional recovery after tMCAO. 
Rats were behavior tested 6 days after tMCAO to establish baseline deficits and again on days 28 and 60 after tMCAO to 
assess recovery.  Forelimb asymmetry was assessed using the cylinder test and vibrissae-evoked placing while hindlimb 
asymmetry was assessed on the ledged, tapered beam.   All rats displayed similar deficits on day 6 in the cylinder test (A, 
black bars) and beam test (B, black bars).  Normal behavior in uninjured rats is 0. However, only a few animals had 
successful placing and in only about 10% of all trials in the vibrissae-evoked placing test (C, black bars).  By day 28, all 
groups showed some improvement on the cylinder test (A, gray bars) but only the NML/EE group trended toward 
improvement (+p=0.06 vs. NML/SE).  All groups except RA/SE showed some improvement on the beam test but none 
were significantly different (B, gray bars).  RA/SE showed no improvement on the beam test (B, gray bars) but showed a 
slight but insignificant improvement on the vibrissae-evoked placing test (C, gray bars) while other groups showed no 
improvement on this test.  By day 60, all groups except NML/EE displayed similar deficits on the cylinder test as were 
seen on day 28 (A, white bars).  Interestingly, the NML/EE group had more severe deficits on the cylinder test at day 60 
than at day 28 (A, white bars), suggesting that the improvements seen during the course of treatment were lost one month 
after treatment halted.  All groups remained the same on day 60 as they were on day 28 in the beam test (B, white bars) 









Table 4.1.  Striatal BrdU-positive cell analysis. All values are ± 





 BrdU Stereology Total Peri-infarct BrdU 
% BrdU/ 
NeuN 
RA/EE 711648 ± 114529 1272 ± 350 20.97 ± 3.57 
RA/SE 669720 ± 132478 1146 ± 239 15.72 ± 2.47 
NML/EE 651623 ± 57937 1276 ± 253 15.63 ± 2.87 
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CONCLUSIONS AND FUTURE DIRECTIONS 
 
Summary of thesis work 
The data presented in this thesis provide evidence for the regulation of postnatal 
and adult neural stem cells at three different levels: by factors present within the 
local stem cell microenvironment, by factors outside of the microenvironment but 
present within the brain, and by exogenous factors or conditions.  We found that 
brain insults such as hypoxia or inflammation increase SVZ neural stem cell 
production, neurogenesis and oligodendrogliogenesis but have detrimental 
effects on SVZ neural stem cell expansion and neurogenesis when these insults 
are combined (Figure 5.1).  Our work also shows that factors secreted from 
normal endothelial cells, present within the stem cell niche, function to maintain 
SVZ neural stem cells in a more proliferative and undifferentiated state, while 
factors from stroke-injured endothelial cells promote SVZ neural stem cell 
migration and neuronal maturation (Figure 5.2).  Finally, we found that treatment 
after stroke with retinoic acid, a vitamin-A derivative, and environmental 
enrichment preserves brain tissue in the injured hemisphere, increases SVZ 
neural stem cell proliferation and neuroblast production, but yields minimal 
increases in the long-term survival of neurons generated after stroke and
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provides no benefit to functional recovery (Figure 5.3).  In the following pages, 
the results and interpretations of these studies will be summarized and presented 
with a discussion of the clinical implications of these findings.  Future studies will 
also be proposed to further delineate the various roles of hypoxia, inflammation 
and stroke on the postnatal and adult SVZ neural stem cell populations. 
 
Regulation of the Niche 
 Neurogenesis occurs in very limited areas of the normal postnatal and 
adult brain in most mammals, whereas it is more prevalent in lower vertebrates 
such as lizards, which can regenerate entire brain regions (Harzsch and Dawirs, 
1996, Lledo, et al., 2006).  The diminished capacity for neurogenesis in the 
mammalian brain is likely due to factors within the brain that limit the persistence 
of neural stem cells to certain areas, and they likely serve more specific functions 
(e.g., limited neuronal turnover in plastic regions rather than brain regeneration).  
Currently, the main regions identified in the postnatal/adult rodent, primate or 
human brain that contain neural stem-like cells are the SVZ and the dentate 
gyrus of the hippocampus (Altman, 1969, Altman and Das, 1965, Eriksson, et al., 
1998, Gould, et al., 1999, Kornack and Rakic, 1999, Lois and Alvarez-Buylla, 
1993).  The presence of only 2 neurogenic regions in the adult brains of these 
species suggests that certain environmental cues must be present to support and 
maintain these cells, as such, they reside in a neurogenic niche.  The neural 
stem cells interact with elements in the niche, including each other, astrocytes 
and endothelial cells to maintain their stem cell-like state and actively proliferate, 
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adopt a precursor cell fate and migrate out of the niche (Conover and Notti, 2008, 
Doetsch, 2003, Lim, et al., 2007, Ohab, et al., 2006, Palmer, et al., 2000, Pierret, 
et al., 2007, Riquelme, et al., 2008).   
The factors that regulate maintenance, migration, and differentiation are 
likely derived from intrinsic programs within the cells, factors external to the cell 
but present within the neurogenic niche, and environmental factors.  Each 
component of neurogenesis, i.e., proliferation, migration and differentiation, may 
be regulated by common factors operating on a continuum or by completely 
separate factors/events that do not influence the previous or next step in the 
process of neurogenesis.    The data presented in this thesis suggest that other 
cells within the neurogenic niche, specifically endothelial cells, influence 
proliferation and migration while extrinsic and environmental factors 
(inflammation, hypoxia, stroke-injured endothelial cells, and retinoic acid and 
environmental enrichment) primarily influence neuroblast production, migration 
and differentiation.  These influences are not completely specific entities and may 
interact with each other or other factors to influence additional components of 
neurogenesis. 
 The postnatal SVZ is comprised of three types of neural stem cells, 
defined as type A, type B and type C cells (Alvarez-Buylla and Garcia-Verdugo, 
2002, Doetsch, et al., 1997, Garcia-Verdugo, et al., 1998).  The factors that 
maintain these cells may be the same or different for each cell type, as the role of 
each cell within the neurogenic niche differs.  Type B cells are the putative neural 
stem cells, which have the ability to self-renew and give rise to type C cells.  
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Type B cells express GFAP, vimentin and nestin (See Figure 1.2) and have the 
appearance of radial glia or astrocytes (Doetsch, et al., 1999, Doetsch, et al., 
1997, Garcia-Verdugo, et al., 1998, Lim and Alvarez-Buylla, 1999, Merkle, et al., 
2004).  Type C cells are the transit-amplifying cells which give rise to type A 
cells, known as neuroblasts [Figure 1.2; (Doetsch, et al., 1997)].  Type B cells are 
the only true neural stem cells in the SVZ, as type C cells and type A cells are 
more differentiated progenitor or precursor cells that have limited choices in cell 
fate (Alvarez-Buylla and Garcia-Verdugo, 2002).  Each step in this progression, 
from type B to type C to type A cell, further commits the cell to a more specific 
fate.  Thus, the uniqueness and multipotency of type B cells may require 
regulation by factors different than those that regulate type C and type A cells.  In 
addition, type A cells are the only cell type of the three known to migrate, 
suggesting that factors that regulate this cell and prompt its migration may not 
influence type B or type C cells (Lois, et al., 1996).  The potential factors that 
govern these cells will be discussed below in the context of their functions within 
the neurogenic niche and their role(s) in post-stroke neurogenesis as it pertains 
to the data presented in chapters 2-4.     
   
Regulation of SVZ NSC Proliferation in the Uninjured Brain 
 The experiments in this thesis provide evidence that endothelial cells 
present within the vascular niche function to maintain postnatal SVZ neural stem 
cells in the normal brain.  Previous studies report that endothelial cells regulate 
embryonic NSCs and adult hippocampal NSCs by increasing their self-renewal 
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(Guo, et al., 2008, Shen, et al., 2004).  No studies published to date have 
examined the influence of normal and stroke-injured endothelial cells on the 
postnatal/adult SVZ.  While it is tempting to make generalizations in regard to the 
factors that control and regulate NSCs, these populations are not identical as 
important differences exist between embryonic and postnatal NSCs as well as 
SVZ-derived vs. hippocampal NSCs.  Embryonic NSCs are more plastic in terms 
of final cell fate, and can be directed towards more cell types or neuronal 
subtypes than postnatal NSCs (Delaunay, et al., 2008, Gates, et al., 1995, Gritti, 
et al., 2002, Imura, et al., 2003, Tramontin, et al., 2003, Watanabe, et al., 2005).  
The final destination of cells produced by embryonic NSCs and hippocampal 
NSCs also differs from that of postnatal SVZ NSCs.  While factors regulating 
embryonic or hippocampal NSCs may provide important clues in terms of 
directing attention toward a given factor or stimuli, these important differences 
require investigations into the factors that specifically regulate postnatal SVZ 
NSCs.   
In chapter 3, we report that SVZ NSC expansion in media conditioned by 
endothelial cells results in increased production of NS without a corresponding 
increase in NS size.  SVZ-derived NS consist of type B and C cells (Alvarez-
Buylla and Garcia-Verdugo, 2002, Alvarez-Buylla, et al., 2002, Doetsch, et al., 
1999, Doetsch, et al., 1999, Garcia-Verdugo, et al., 1998), however, ablation of 
the GFAP-expressing NSC (i.e., type B cell) results in an almost complete loss of 
NS formation (Imura, et al., 2003, Morshead, et al., 2003).  These data, together 
with our results, suggest that endothelial cell-secreted factors promote self-
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renewal of the type B cell, and therefore promote the initial formation of 
neurospheres, but do not necessarily influence proliferation of the type C cells, 
which may result in larger spheres rather than more of them.   
In addition to increasing self-renewal via NS formation, ECCM also 
appears to prolong proliferation of SVZ NSCs, as significantly more ECCM-
expanded cells continued to express the endogenous proliferation marker, Ki67, 
after 4 days of differentiation.  These cells may be lineage restricted neuroblasts 
or glioblasts rather than type B cells, but their precise nature is uncertain without 
additional labeling.  These data further support the idea that endothelial cell-
secreted factors function in the niche to maintain the NSC population by 
promoting and maintaining self-renewal. 
 
Regulation of SVZ NSC Proliferation after Injury/Insult 
 The factors that regulate proliferation in the uninjured postnatal and adult 
brain may or may not contribute to increased proliferation after injury.  In the 
normal postnatal and adult brain, SVZ NSCs are relatively quiescent (Doetsch, et 
al., 1999, Morshead, et al., 1994).  The cell cycle is longer for adult NSCs than 
for embryonic NSCs, leading to fewer cell divisions and subsequent decreased 
neurogenesis in the adult compared to the embryonic brain (Lu, et al., 2008, Lu, 
et al., 2007, Maslov, et al., 2004, Zhang, et al., 2006, Zhang, et al., 2008).  This 
makes sense, as the environment of the embryonic brain is very dynamic in order 
to complete development in a timely manner.  In the postnatal and adult brain, 
however, development is complete and new cells are not in high demand.  After 
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injury, however, the necessity and capacity for production of new cells in the 
postnatal and adult brain dramatically increases, rendering it more similar to the 
developing brain in terms of plasticity.  Thus, factors that influence NSCs during 
development may be more likely to contribute to injury-induced neurogenesis 
than factors regulating NSCs in the uninjured adult brain.   
 Retinoic acid is involved in numerous developmental processes and was 
recently found to increase proliferation in the early postnatal SVZ-olfactory bulb 
pathway (Hagglund, et al., 2006, Haskell and LaMantia, 2005, Krezel, et al., 
1999, Luo, et al., 2004, Novitch, et al., 2003, Toresson, et al., 1999, Wagner, et 
al., 2002, Wang, et al., 2005, Wilson and Maden, 2005, Zetterstrom, et al., 1999, 
Zetterstrom, et al., 1994).  The results presented in chapter 4 suggest that RA 
also increases SVZ proliferation after stroke in the adult brain.  RA alone or in 
combination with environmental enrichment increased DCx- and Ki67-
immunoreactivity in the SVZ at 61 days after stroke.  It is unclear as to whether 
this treatment influenced all three types of SVZ NSC, as Ki67 labels actively 
dividing cells, which could be type A, B or C cells.  DCx-labeling is specific to 
type A cells and the RA-treatment was terminated 41 d after stroke.  Therefore, 
the increased DCx population present at 61 days after stroke may be a result of 
initially increased type B or C cells, which have further differentiated into type A 
cells at this time rather than an increase in only type A cells.  Regardless of 
whether RA acts on all 3 types of SVZ NSCs, it is clear that RA functions to 
promote post-stroke SVZ NSC proliferation. 
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 While it is difficult to discern the exact mechanism(s) underlying 
inflammation- or hypoxia-induced increases in SVZ NSC expansion (chapter 2), 
these processes clearly promote postnatal SVZ NS formation.  Postnatal mice 
exposed to hypoxia or systemic inflammation, without direct brain injury, 
produced more SVZ NS than control mice without altering NS size.  Potential 
mediators of the hypoxia-induced changes in SVZ NS production include the 
hypoxia-inducible-factors (HIFs), which are members of the basic helix-loop-helix 
PAS family of transcription factors (Semenza, 2000).  HIFs respond to changing 
oxygen levels in the brain, and are present only in low levels when oxygen is 
present.  HIF-1α expression increases exponentially as brain oxygen levels 
decrease, activating target genes which include those involved in angiogenesis, 
energy metabolism, pH regulation, cell survival and cell proliferation (Buchler, et 
al., 2003, Fukuda, et al., 2003, Iyer, et al., 1998, Kasuno, et al., 2004, Kelly, et 
al., 2003, Semenza, 2000, Semenza, 2000, Semenza, 2000).  Studies examining 
the effects of lowered oxygen and HIFs on stem cells reported increased 
dopaminergic differentiation after HIF-1α overexpression in mesencephalic NSCs 
while knockout of HIF-1α led to impaired survival and proliferation of midbrain 
precursors in addition to decreased dopaminergic differentiation (Milosevic, et al., 
2007, Zhang, et al., 2006).  Thus, HIF-1α activation influences proliferation and 
neuronal differentiation in midbrain and mesencephalic neural stem cells and 
may be responsible for the hypoxia-induced changes in postnatal SVZ NSCs 
reported here.   
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The inflammation induced increases in SVZ NS production are likely a 
result of pro-inflammatory cytokines.  LPS activates its receptor, TLR-4, which 
initiates the inflammatory cascade, including up-regulation of the pro-
inflammatory cytokines IL-1β and TNF-α (Davies, et al., 1998, Fan, et al., 2004, 
Larsen and Henson, 1983, Rothwell and Hopkins, 1995, Stanimirovic and Satoh, 
2000, Stanimirovic, et al., 1997, Stanimirovic, et al., 1997, Zheng and Yenari, 
2004).  We tested whether IL-1β mediates this effect and found that IL-1β 
knockout resulted in decreased NS production.  This suggests that IL-1β, at least 
in part, is involved in the post-inflammation proliferative response in the postnatal 
mouse SVZ.  This contrasts with previous reports which suggested that IL-1β 
either had no effect on adult hippocampal NSCs or decreased proliferation in 
embryonic and adult NSCs. None of these studies, however, examined the role 
of IL-1β in the postnatal SVZ (Koo and Duman, 2008, Monje, et al., 2003, Wang, 
et al., 2007).  However, more work needs to be done to confirm the involvement 
of IL-1β. 
 
Regulation of Postnatal SVZ NSC Migration 
The type A cells in the postnatal SVZ are neuroblasts that normally 
migrate in chains, ensheathed in astrocytes, through the rostral migratory stream 
to the olfactory bulb (Doetsch and Alvarez-Buylla, 1996, Yang, et al., 2005).  
Migration through the rostral migratory stream is regulated by integrins, 
interactions of slit with its receptor robo, ephrin signaling, and matrix 
metalloproteinases (Belvindrah, et al., 2007, Bovetti, et al., 2007, Conover, et al., 
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2000, Murase and Horwitz, 2002, Riquelme, et al., 2008, Yang, et al., 2005).  
Once these cells enter the olfactory bulb, they migrate tangentially via 
astrocyte/endothelial interactions, to the granular and peri-glomerular layers 
(Bovetti, et al., 2007, Doetsch and Alvarez-Buylla, 1996).  After injury, however, 
many of these cells migrate to the stroke-injured striatum or cortex rather than 
the olfactory bulb (Arvidsson, et al., 2002, Jin, et al., 2001, Parent, et al., 2002, 
Plane, et al., 2004, Zhang, et al., 2001).  It is unclear what cues direct SVZ 
neuroblasts to migrate into these injured areas.  Some studies suggest that 
astrocytes and blood vessels may direct SVZ neuroblast migration into the 
injured regions via EGF, stromal-derived factor-1 (SDF-1) interacting with its 
chemokine receptor CXCR4, or MMP-9 (Ohab, et al., 2006, Teramoto, et al., 
2003, Thored, et al., 2007, Wang, et al., 2006).  Few studies have directly 
examined the role of endothelial cells or endothelial-secreted factors on SVZ 
NSCs.  We found SVZ NSC migration to be enhanced by conditioned medium 
from OGD-injured endothelial cells and observed SVZ neuroblast migration 
within the ischemic striatum to closely coincide with blood vessels/endothelial 
cells.  At this time, however, we are unable to identify the specific endothelial-
derived cues that likely direct SVZ neuroblast migration into the injured striatum. 
Some potential candidates include brain-derived neurotrophic factor (BDNF), 
angiopoietins, matrix metalloproteinases (MMPs), ephrins and SDF-1 
(Belvindrah, et al., 2007, Conover, et al., 2000, Murase and Horwitz, 2002, Ohab, 
et al., 2006, Riquelme, et al., 2008, Stumm, et al., 2002, Tsai, et al., 2006, Wang, 
et al., 2006).  Many of these molecules have already been implicated in post-
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stroke migration to the peri-infarct cortex via production by glia or blood vessels 
in the post-stroke angiogenic environment.  For example, evidence supports a 
role for SDF-1 in post-stroke neuroblast migration into the striatum, and the 
source of this factor is likely to be astrocytes and microglia within the ischemic 
striatum (Ohab, et al., 2006) rather than endothelial cells.  It is unclear, however, 
what other cues mediate post-stroke neuroblast migration into the ischemic 
striatum and which are specifically provided by endothelial cells.   
Interestingly, we found that treatment after stroke with RA in combination 
with EE promoted neuroblast migration into the ischemic striatum.  DCx-positive 
neuroblasts appeared to localize to the peri-infarct striatum with greater 
propensity than with either treatment alone or no treatment. However, little 
evidence exists to suggest that RA may regulate adult SVZ NSC migration.  RA-
signaling was recently implicated in regulating migration of SVZ-derived NSCs to 
the olfactory bulb during the early postnatal period but its role in regulating post-
stroke neuroblast migration has not been tested (Wang, et al., 2005).  It is difficult 
to determine if the migratory effect demonstrated in our experiments is due to RA 
alone or works in combination with EE.  Neuroblast migration into the peri-infarct 
region appeared to be increased with each treatment alone but the greatest 
effect was seen with the combination of RA and EE treatment.  The potential 
interactions of RA and EE within the ischemic striatum may be mediated via 
BDNF, which increases with enrichment, and its receptor, trkB, which can be 
induced by RA in vitro (Kaplan, et al., 1993, Lucarelli, et al., 1994, Lucarelli, et 
al., 1995, Rossi, et al., 2006).  These interactions would more likely result in an 
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enhanced differentiation or survival effect rather than migration, as each has 
been shown to promote differentiation/survival (Kempermann, et al., 1998, 
Kempermann, et al., 2003, Kempermann, et al., 1997, Komitova, et al., 2002, 
Komitova, et al., 2005, Nilsson, et al., 1999, Toresson, et al., 1999, Wurm, et al., 
2007).  It is difficult to interpret these results, however, as lesions sizes varied, 
resulting in overall differences in proliferation and migration regardless of 
treatment.  To determine if RA plays a role in post-stroke neuroblast migration, 
an in vitro assay may be more suitable, for example, SVZ explants from MCAO-
treated rats or mice could be cultured in matrigel in media with or without RA and 
effects on migration evaluated.   
 
Regulation of Postnatal SVZ NSC Differentiation and Survival 
As reported in chapter 3, SVZ NSC differentiation was influenced by 
factors from normal and stroke-injured endothelial cells.  Intact ECCM altered 
differentiation by maintaining SVZ NSC-derived neurons and glia in a more 
immature state while OGD-ECCM promoted maturation of SVZ NSC-derived 
neurons.  This suggests that a) normal endothelial cells secrete different factors 
than injured endothelial cells or b) endothelial-secreted factors that maintain SVZ 
NSCs in a more immature state are down-regulated after stroke.  Unfortunately, 
we were unable to identify factors secreted by normal and injured endothelial 
cells in these experiments, and therefore unable to examine whether these 
factors are the same or different from normal versus injured endothelial cells.  
However, the 1-D gel used to identify protein sizes produced bands in the same 
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location for intact- and OGD-ECCM, but fewer bands were present in OGD-
ECCM than intact ECCM.  This suggests that similar factors (or at least proteins 
of similar size) were produced by normal and OGD-exposed endothelial cells, 
and that some of these were down-regulated after OGD-exposure.  In these 
studies, factors from normal and OGD-exposed endothelial cells did not appear 
to alter SVZ NSC fate, only influenced their rate of differentiation/maturation.  
Further, they had no effect on cell survival/death.   
What endothelial-secreted factor or factors manipulate the rate of 
differentiation/maturation in postnatal SVZ NSCs is uncertain.  Endothelial cells 
secrete leukemia inhibitory fact (LIF) and BDNF, both of which can influence 
differentiation, and may play a role in promoting SVZ-derived neuronal 
maturation (Leventhal, et al., 1999, Louissaint, et al., 2002, Mi, et al., 2001, 
Nottebohm, et al., 1990).  More specifically, endothelial cell-derived BDNF 
promotes neuronal recruitment, outgrowth and maturation in the adult songbird 
brain and in cultures of adult NSCs (Leventhal, et al., 1999, Louissaint, et al., 
2002, Nottebohm, et al., 1990).  Most studies identify factors that regulate cell 
fate but the temporal relationship of these factors to differentiation remains to be 
determined.  Some of the known SVZ cell fate determinants include the bone 
morphogenic proteins (BMPs), which instruct SVZ NSCs toward a glial fate, and 
noggin, which directs SVZ NSCs toward a neuronal fate via antagonistic actions 
on BMP signaling (Bonaguidi, et al., 2005, Coskun, et al., 2001, Gross, et al., 
1996, Lim, et al., 2000).  The notch signaling pathway is also involved in directing 
embryonic NSC differentiation and may also regulate postnatal/adult SVZ NSC 
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differentiation.  Notch 1 and Jagged 1 are expressed by astrocytes in the SVZ, 
and promote neural lineage commitment, differentiation and survival of 
embryonic NSCs in vitro (Androutsellis-Theotokis, et al., 2006, Guentchev and 
McKay, 2006, Irvin, et al., 2004, Irvin, et al., 2001, Lowell, et al., 2006, Nyfeler, et 
al., 2005).  Further, administration of delta, one of the notch ligands, to adult rats 
results in increased BrdU labeling in the SVZ and increased expression of the 
neuronal marker Hu in BrdU-positive cells in the cortex 45 days later 
(Androutsellis-Theotokis, et al., 2006).  Notch signaling increases after stroke 
and is also involved in the response of embryonic NSCs to lowered oxygen, and 
together these data implicate notch signaling as a potential regulator of 
postnatal/adult injury-induced SVZ neurogenesis (Androutsellis-Theotokis, et al., 
2006, Arumugam, et al., 2006, Chen, et al., 2007, Guentchev and McKay, 2006, 
Gustafsson, et al., 2005).  These factors, however, are produced by astrocytes 
and ependymal cells that reside along the SVZ.   
We found that differentiation of SVZ NSC into neurons was enhanced by 
hypoxia or inflammation alone, but that the combined insults decreased 
neurogenesis.  Neurogenesis may be enhanced in the inflammation experiments 
via the pro-inflammatory cytokine IL-1β.  To test whether inflammation-induced 
increases in neurogenesis may be mediated by IL-1β, we cultured NS from IL-1β 
knockout mice and examined the effects on neurogenesis after 7 days of 
differentiation.  We found decreased neurogenesis in the IL-1β knockout NS 
compared to wild-type NS.  Preliminary experiments were performed in which IL-
1β was added to primary NS from IL-1β knockout mice during differentiation (at 
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the same time that LPS was administered in previous inflammation experiments) 
to further implicate IL-1β in the inflammation-induced changes in postnatal SVZ 
neurogenesis.  In these experiments, IL-1β appeared to restore SVZ 
neurogenesis in NS from IL-1β deficient mice.   
Most studies evaluating neurogenesis in regard to IL-1β have reported its 
effects on modulating NSC proliferation, but not differentiation (Koo and Duman, 
2008, Wang, et al., 2007).  One recent study reported that blocking IL-1β 
decreased GFAP expression in embryonic NPCs in vitro, with no effect on 
neuron or oligodendrocyte formation (Wang, et al., 2007).  Previous in vitro 
studies have shown beneficial effects of IL-1 on primary neuron survival, 
mediated via induction of nerve growth factor on astrocytes (Bandtlow, et al., 
1990, Carman-Krzan, et al., 1991, Spranger, et al., 1990, Vige, et al., 1991, Vige, 
et al., 1992).  Further, IL-1 increases dopaminergic neuron differentiation in 
mesencephalic progenitor cells and can induce FGF-2, a well-known regulator of 
SVZ NSCs (Albrecht, et al., 2002, Ho and Blum, 1997, Ling, et al., 1998).  
The inflammation-induced increase in SVZ neurogenesis and 
oligodendrogliogenesis in vitro may be mediated by other cytokines as well, such 
as TNF-α, IL-6, and LIF, which may act in conjunction with IL-1β or downstream 
of it.  LIF may also be responsible for decreased neurogenesis after the 
combined hypoxia and inflammation insult, as LIF increases after ischemia and 
has been shown to induce NSC differentiation into astrocytes (Carmichael, 2003, 
Wright, et al., 2003).  The effects of inflammation on SVZ neurogenesis may also 
be mediated by activation of the pro-inflammatory transcription factor nuclear 
230 
 
factor-κ-B, which is involved in many post-insult pathways (Chang and Huang, 
2006, Clemens, et al., 1997, Clemens, et al., 1997, Hu, et al., 2005, Schneider, 
et al., 1999, Seegers, et al., 2000, Stephenson, et al., 2000, Widera, et al., 2006).   
The suppressor of cytokine signaling-3 (SOCS-3) is up-regulated in ischemic 
tissue, negatively regulates the janus kinase/signal transducers and activators of 
transcription pathways (STAT), and promotes neuronal differentiation of CNS 
stem cells, making it another potential molecule of interest (Bates, et al., 2001, 
Larsen and Ropke, 2002, Lu, et al., 2003, Raghavendra Rao, et al., 2002, 
Turnley, et al., 2002). 
 After stroke, treatment with RA and EE, but not either alone, modestly 
increased striatal neurogenesis.  Given the previous reports that EE enhances 
dentate gyrus neurogenesis after stroke, these findings were somewhat 
surprising (Kempermann, et al., 1998, Kempermann, et al., 1997, Kempermann, 
et al., 1998, Komitova, et al., 2005, Komitova, et al., 2002, Komitova, et al., 2005, 
Nilsson, et al., 1999).  We hypothesized that RA combined with EE would 
promote survival of stroke-generated neurons, however, this was not the case.  
RA-treatment preserved tissue after stroke, and in combination with EE, 
increased SVZ cell proliferation and enhanced neuroblast migration, although 
this was not enough to support the generation and survival of new neurons for 2 
months after stroke. This suggests that tissue sparing is not sufficient to promote 
neuron survival (or functional recovery), and it is likely that although this tissue 
was preserved, it did not provide a suitable environment for the propagation of 
new neurons.  Further, differences in EE-induced dentate gyrus neurogenesis 
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have been reported for different strains of mice, suggesting that EE-induced 
neurogenesis is not a universal phenomenon (Kempermann, et al., 1998).  
Enhancing the survival of adult-generated striatal neurons after stroke may lead 
to significantly improved cognitive and motor function, but exogenous or in situ 
cues that promote this process remain unidentified.    
 
Clinical Implications 
 Elucidating the factors that regulate postnatal and adult SVZ NSCs is an 
important step in advancing the potential of NSCs for treatment of brain injury 
and disease.  The presence of NSCs in the postnatal and adult brain and their 
increased proliferation in response to injury or insult suggests that the brain has 
the capacity to repair itself.  However, this response is not sufficient if it does not 
provide long-term benefits to function.  By identifying the factors that regulate 
each step in the process of neurogenesis, including the region-specific cues, we 
may be able to direct postnatal and adult NSCs towards a necessary cell type to 
replace those lost after injury.  There are multiple steps in the process of 
neurogenesis and it appears that each is regulated by a delicate balance of 
factors, both internal and external, which work together to maintain the balance 
between stem cell maintenance/self-renewal and differentiation into specific cell 
phenotypes.  Each step appears to be separately regulated by multiple factors or 
processes but must converge in the end to maintain this balance.  While the 
results reported in this thesis do not necessarily identify specific factors, they 
provide insight into pathways or cell types that could be targeted for development 
of future treatments.   
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 We reported in chapter 2 that hypoxia or inflammation significantly 
increases postnatal SVZ NSC expansion and neurogenesis, but in combination is 
detrimental to postnatal SVZ neurogenesis.  Hypoxia and inflammation are 
commonly encountered clinical problems in critically ill neonates with a broad 
range of cardiorespiratory and other systemic disorders and can lead to cognitive 
deficits later in life.  The data from this thesis suggest that it may be important to 
target the pathways involved in these insults, such as the HIF pathway or the 
cascade of pro-inflammatory cytokines after a second exposure to insult.  For 
example, administration of IL-1β or TNF-α after insult may prompt the postnatal 
NSCs to proliferate and subsequently form new neurons.  Receptors for IL-1β are 
present in embryonic NSCs and IL-1β is present in human neural progenitors 
(Klassen, et al., 2003, Wang, et al., 2007), suggesting that exogenous 
administration could act on these populations. This treatment, however, would 
only be effective if these neurons integrated into the necessary region(s) without 
causing adverse side-effects, which may not be possible, given that IL-1 is 
present within the postnatal brain and amplifies stroke volume in the adult rodent 
by increasing cell death (Dziegielewska, et al., 2000, Loddick, et al., 1996, 
Loddick and Rothwell, 1996, Yamasaki, et al., 1995). 
 The data presented in this thesis also suggest that identification and 
administration of endothelial cell-secreted factors may be useful tools for 
pharmacological intervention after stroke.  For example, factors secreted by 
normal endothelial cells could be administered to increase SVZ proliferation and 
then combined with factors from stroke-injured endothelial cells to promote 
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migration and differentiation of SVZ-derived NSCs in the injured area.  Promoting 
angiogenesis, the formation of new blood vessels, via administration of 
angiogenic factors into the injured area may also serve as a useful tool to 
promote brain recovery, as angiogenesis and neurogenesis appear to be 
coupled.  Potential candidate molecules include vascular endothelial growth 
factor, angiopoeitin, and erythropoietin, all of which are involved in angiogenesis 
and neurogenesis (Chang, et al., 2005, Sun, et al., 2003, Tsai, et al., 2006, 
Wang, et al., 2008, Wang, et al., 2004, Zhang and Chopp, 2002).   However, as 
with the potential use of cytokines to treat neonatal brain injury, these factors 
may have effects on other processes as well and may produce adverse effects 
that outweigh their benefits, hence further investigation is needed.  Although it 
seems ideal to promote recovery via administration of one factor, combining 
treatment by way of initial administration of proliferation-enhancing factors, like 
those from intact endothelial cells, with subsequent treatment using migration 
and differentiation-promoting factors from stroke-injured endothelial cells may 
prove to be more advantageous.  Another potential caveat, however, is that 
promoting differentiation to replace neurons may not be useful if the injured area 
can not sustain these cells or if they do not integrate properly.   
 Although RA/EE treatment did not significantly promote long-term survival 
of stroke-generated neurons or provide substantial functional benefits in this 
study, they may still be useful treatments for stroke.  One of the side effects of 
excessive retinoids or vitamin A is decreased bone density (Hotchkiss, et al., 
2006, Kneissel, et al., 2005, Rohde and DeLuca, 2003, Rohde, et al., 1999).  In 
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preliminary studies in which sham and tMCAO rats were treated with RA, we 
found that our initial dose of RA was too high, as sham-treated rats displayed 
decreased mobility due to limb impairment.  After return to a normal diet these 
rats recovered, but this finding suggested that the benefit of increased 
proliferation came at a price.  Therefore, in the studies presented within this 
thesis, we used a smaller dose of RA, hoping to avoid any potential negative 
effects. However, a few animals in our study displayed forelimb use 
abnormalities on the unaffected side while on the RA-enriched diet.  Other 
animals may have been affected adversely as well, although to a lesser extent, 
which may have masked any benefits of neurogenesis on functional recovery. 
The increases in proliferation and neuroblast migration suggest that RA 
treatment is beneficial, however, and further studies should be performed to 
determine if there is a dose that substantially promotes neurogenesis without 
adverse consequences on motor function.  In addition, perhaps the combination 
of RA with other physical interventions would be more beneficial in promoting 
neurogenesis and functional recovery.  For example, exercise such as running, 
promotes neurogenesis (Rhodes, et al., 2003, van Praag, 2008, van Praag, et 
al., 1999, van Praag, et al., 1999) and when combined with RA-treatment, may 
provide better results than EE.  Forced use of the impaired limbs may also be 
more beneficial in combination with RA, as forced use, when applied at the 
correct timeframe after stroke, promotes functional recovery (Bland, et al., 2001, 
Grotta, et al., 2004, Humm, et al., 1998, Kleim, et al., 2003, Schallert, 2006, 
Schallert, et al., 2002).  Thus, RA could be administered at a low dose to 
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promote proliferation and migration and then combined with exercise or forced 
use to promote striatal neurogenesis and functional recovery.     
 All of these proposed treatment ideas focus on enhancing the endogenous 
neural stem cell population by promoting their proliferation, migration, 
differentiation or survival.  Neural stem cells may also be used for transplantation 
and are often primed or directed towards a given fate prior to transplantation 
using techniques such as hypoxia, which specify neurons towards a 
dopaminergic subtype.  This may not be ideal, as the internal environment into 
which the cells are transplanted may be subsequently altered by another insult.  
Our results suggest that this may lead to detrimental effects on the NSC 
population, rather than providing a mechanism for repair.  Although the use of 
neural stem cells for transplantation should be pursued, we suggest that 
manipulating the endogenous population may be very fruitful, as this approach 
may be applicable to many types of brain injury and disease.  This is especially 
true in brain diseases where proliferation is already enhanced, such as in 
Alzheimer’s disease and Huntington’s disease (Curtis, et al., 2003, Jin, et al., 
2004).  In this case, enhancing differentiation of endogenous NSCs into specific 
neuronal subtypes to replace neurons lost in these diseases may be a useful 
treatment strategy that may be complemented by implanting neural stem cells.   
 
Future Directions 
Further investigation into role of IL-1β in postnatal SVZ NSC regulation is 
needed and will be carried out in our laboratory or with our collaborators.  
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Preliminary experiments were performed to determine if IL-1β could rescue 
neurogenesis in SVZ NSCs from IL-1β knockout mice.  In these initial 
experiments, several doses of IL-1β were applied to primary NS during 
differentiation.  Neurogenesis appeared to be restored in NS from IL-1β knockout 
mice treated with IL-1β protein, compared with those treated with vehicle.  These 
results need to be replicated and the effects of IL-1β on NSCs from wild-type also 
need to be determined.  These experiments will be performed in the same 
manner as those applying exogenous IL-1β to NS from IL-1β knockout mice, and 
following with our previous experiments using LPS.   
Similar experiments could be performed with other cytokines to determine 
if they play a role in inflammation-induced neurogenesis in SVZ neural stem 
cells.  A few other interesting experiments could be performed to determine if 
inflammation-induced changes in SVZ neurogenesis are mediated via IL-1β.  IL-
1β knockout mice could be injected with LPS (or vehicle) using the same protocol 
as detailed in chapter 2, and then NS cultured and evaluated for NS production 
and differentiation effects.  Similarly, LPS could be administered to NS from IL-1β 
knockout mice, rather than to the mice directly, and effects on neurogenesis and 
oligodendrogliogenesis evaluated.  In this experiment, however, NS production 
can not be evaluated since LPS treatment occurs during differentiation.  Since 
LPS administration increased NS production and neurogenesis and IL-1β 
knockout caused the opposite effect, it is hypothesized that these two may 
cancel each other out. However, if the LPS-induced changes were mediated 
through IL-1β and IL-1β is knocked-out, then administration of LPS may not 
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result in any changes.  Another interesting experiment might be to expose IL-1β 
knockout mice to hypoxia and then culture NS from these animals.  The 
mediators of hypoxia were not tested in these experiments and could also be 
evaluated via exposure of mice or NS to factors such as HIF-1α.  
 An important next step to finalize the effects of endothelial cell-secreted 
factors on SVZ neurogenesis is to identify what these factors are and determine 
their specific role in regulating neurogenesis in the normal and stroke-injured 
brain.  Proteomic analysis of the conditioned media is an obvious choice for 
identifying the proteins present in intact and OGD-exposed endothelial 
conditioned medium.  One attempt at proteomic analysis was performed, 
however, few candidate molecules were identified and technical issues suggest 
that these results may not be accurate.   
Another approach that could be used is to perform candidate screening 
with western blot or protein microarray analyses or to perform a screen of 
endothelial cells using RNA interference (RNAi).  Proteins that are suggested in 
the literature to be produced by endothelial cells could be probed for on western 
blots or microarrays or knocked-down using RNAi.  Endothelial cells exposed to 
RNAi could be cultured with NS and then neurogenesis evaluated, as one would 
expect to see opposite effects on neurogenesis from those reported in chapter 3. 
Potential candidate factors could also be directly applied to primary NS and 
evaluated for NS production, proliferation, migration or differentiation effects.  
Another possible approach makes use of multiple levels of conditioned media 
fractioning.  ECCM could be filtered with molecular weight cut-off filters in 
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different ranges, for example, <5kd, 5-10kD, 10-15kD and so on, and then 
applied to NS to determine which of the fractions are involved in expansion, 
proliferation, migration and differentiation.  Further, these fractions could be 
separated by weight of specific subsets of factors (ie-proteins of size X-XX, 
cytokines, chemokines, etc) to further elucidate their influences on SVZ 
neurogenesis.  Once these factors are identified, they can be tested both in vitro 
and in vivo.  In vitro testing would allow for the specific effects presented in 
chapter 3 to be replicated.  Most importantly, these factors need to be applied 
and tested in vivo. Comparison of in vivo and in vitro influences is vital and an 
important next step is to determine if these factors influence endogenous 
postnatal NSCs in the same way that they influence NSCs in vitro.  Finally, these 
factors could also be administered to stroke animals to determine their potential 
in enhancing endogenous repair after injury.   
In the studies described in chapters 2 and 3, the main limitation of these 
experiments is that they focus solely on in vitro analysis.  This was necessary in 
order to compare various conditions in a more controlled environment.  These 
results provide limited advancement to the field if they do not provide 
translational information for endogenous brain repair.  Thus, the influence of 
hypoxia, inflammation, or the combined insult, as well as endothelial cell-
secreted factors needs to be further examined in the postnatal mammalian brain.  
Future experiments could focus on SVZ neurogenesis in IL-1β knockout mice to 
determine if there are alterations in neurogenesis in these animals.  These 
animals could be exposed to hypoxia and SVZ NSC proliferation and 
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differentiation examined as well.  Finally, normal and stroke-injured 
postnatal/adult animals could be examined for changes in SVZ neurogenesis 
after treatment with IL-1β or endothelial cell-secreted factors.   
The promise of RA as a treatment for stroke remains, although more work 
is needed to determine the optimal dose and timing of this treatment. As 
mentioned previously, RA-treatment combined with other types of therapy may 
be more beneficial in enhancing both post-stroke neurogenesis and functional 
recovery.  Exercise enhances neurogenesis in the dentate gyrus and may be 
more beneficial than EE treatment, or EE treatment itself may be more optimal 
combined with RA-treatment if the duration of EE is longer.  In these studies, 
animals received EE for only 21 days.  Perhaps extending the treatment to 41 
days (the timing that was used for RA-treatment) or for the duration of the study 
would be more beneficial than terminating EE treatment at day 28 after MCAO.  It 
has been suggested that the simplicity of housing for laboratory animals may 
actually decrease neurogenesis and that EE actually restores it to baseline 
levels.  In our study, functional improvements were seen with EE-treatment at the 
end of the treatment period but were lost by the time of evaluation on 
neurogenesis, making it difficult to speculate if these animals had EE-treatment 
associated enhancement of neurogenesis that was then diminished by their 
return to the “standard” environment.  Additional studies that evaluate 
neurogenesis and functional recovery at the end of the treatment period and after 
return to standard environment may address this issue, however, comparison of 
240 
 
the same animal over time is not possible, again making it difficult to discern the 
effects of treatment versus return to the standard environment.   
Yet another issue regarding enhanced neurogenesis and functional 
recovery after stroke is whether or not neurogenesis is necessary for enhance 
functional outcome.  To test this, neurogenesis could be enhanced with a given 
treatment (RA and EE, for example) and subsequent behavior testing performed 
to correlate with the time frame in which new neurons have matured and 
contributed processes to existing circuits.  Additionally, experiments in which 
neurogenesis is conditionally ablated after stroke and behavioral and 
electrophysiolocal assessments performed may also provide evidence to 
determine whether neurogenesis is necessary for functional recovery after 
stroke. 
Another potential treatment strategy that could enhance striatal neuron 
survival and functional recovery is to combine RA treatment with forced-limb use.  
Studies from Tim Schallert’s group suggest that forced limb-use, when applied at 
the proper time (too early after injury exacerbates functional deficits and too late 
provides no benefit) results in significant recovery of function after stroke (Grotta, 
et al., 2004, Kleim, et al., 2003, Schallert, et al., 2003).  Although this treatment 
may not enhance neurogenesis alone, when combined with the proper dose and 
timing of RA the two may work coordinately to enhance striatal neurogenesis and 
promote functional recovery.   Finally, once identified, factors secreted from 
OGD-exposed endothelial cells may also be beneficial in combination with RA to 
promote striatal neuron survival or integration.  RA-treatment appeared to 
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influence neuroblast migration after stroke and in combination with stroke-injured 
endothelial cells could promote neuroblast migration and differentiation in the 
injured striatum as well.   
    The process of neurogenesis consists of multiple steps, including 
proliferation, migration, differentiation and cell survival.  The factors that govern 
this process and their relationships to each other may be complex.  Each of 
these processes occurs with specific spatial and temporal regulation and 
although each process is separate and may be regulated by distinct factors, they 
may also influence each other as well.  In many cases, a given molecule may 
regulate more than one step in this process and changes to one step may 
influence the next.  Thus, future research should continue identifying these 
factors and testing their roles in neurogenesis and their relationships to each 
other through the use of both in vivo and in vitro techniques, as demonstrated 
within this thesis. Such experiments should include genetic manipulations, 
retroviral vector labeling, neurogenesis ablation (e.g. irradiation) studies, etc to 








Figure 5.1: Summary of effects of inflammation and hypoxia on postnatal 
SVZ NSCs. 
Exposure to hypoxia or inflammation (LPS) increases SVZ NS expansion, 
neurogenesis and oligodendrogliogenesis.  Exposure to the combined insult 
decreases neurogenesis.  The effects on SVZ neurogenesis and SVZ NS 







Figure 5.2:  Summary of the effects of endothelial cells on postnatal SVZ 
NSCs. 
Endothelial cell-secreted factors increased postnatal SVZ NS self-renewal and 
altered neuron and glial morphology.  Endothelial cell-secreted factors decreased 
process outgrowth and increased oligodendrocyte production.  OGD-exposed 
endothelial cells secreted factors that increased neuroblast migration, process 







Figure 5.3: Summary of RA/EE effects on neurogenesis and recovery after 
stroke. 
Combined RA/EE treatment provided the greatest enhancement of neurogenesis 
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